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A Novel Air Sampling and Analytical Method for Determination of Airborne Bronopol 
 
 
John Charles Smyth 
 
 
ABSTRACT 
 
 
 Bronopol has been used as a preservative in drugs and cosmetics since 1964.  
Bronopol has low dermal irritancy at levels commonly used in cosmetics and 
pharmaceuticals but it is significantly irritating at higher concentrations.  Laboratory 
testing of bronopol indicates a low potential for dermal sensitization; however, a number 
of case reports demonstrate human allergenic reactions.  No reports were identified on the 
allergenic properties of bronopol for the inhalation route of exposure. 
In 1983 approximately 5,200 people in the United States were occupationally 
exposed to bronopol.  Current novel uses of bronopol include mold remediation and the 
sanitizing of ventilation system components.  These new applications have the potential 
to expose vast new populations to the chemical.  Since 89 million people in the United 
States work in indoor environments and 50 million Americans suffer from allergies, it is 
likely that a sizeable portion of these populations will be exposed to bronopol.  This is 
significant since the dermal sensitizing properties of bronopol suggest that the material 
may also be a respiratory sensitizer, potentially resulting in chemically induced asthma.  
More people are being diagnosed with asthma today than at any time in the past; the 
xvii 
causes of this increased prevalence are largely unknown. 
 In this work an existing ultraviolet spectrophotometric method for analysis of 
bronopol has been combined with conventional industrial hygiene air sampling 
techniques.  No combined air sampling and analytical method for bronopol has previously 
been published in the literature. 
 A calibration curve has been developed with a linear range of 1 µg/ml to 25 
µg/ml.  The instrumental limit of detection is 1 µg/ml with an instrumental limit of 
quantitation of ca. 3 µg/ml. 
During chamber sampling trials analytical recovery for treated glass fiber filters 
yielded a sampling recovery efficiency averaging 99.9 %.  Bronopol concentration 
obtained during chamber sampling trials ranged from 10.80 mg/m
3
 to 21.59 mg/m
3
, with 
a pooled coefficient of variation of 4.33 % for all chamber sampling sets. 
 Treated glass fiber filters spiked with bronopol were found to be stable for a 
period of 48 hours; derivatized bronopol solutions were found to be stable for a period of 
fourteen days. 
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Chapter One - Introduction 
Public Health Implications of This Study 
 Bronopol is an important antimicrobial agent commonly used as a biocide in 
various products including cosmetics, medical products, and water treatment systems.  
Recent new uses include remediation of mold-affected building materials and sanitizing 
building ventilation systems.  Bronopol has been shown to produce skin irritation (Frosch 
et al., 1990) and allergic dermatitis on dermal exposure (Wilson & Powell, 1990; Rudzki, 
Rebandel, & Grzywa, 1993) as well as irritation, dyspnea, and profuse mucous generation 
in inhalation studies on laboratory animals (Environmental Protection Agency [EPA], 
1995). 
 Human occupational exposure to bronopol takes place during the manufacture of 
the compound, in preparing products containing the substance, and in the use and 
application of bronopol-containing formulations.  Nonoccupational exposures occur 
when individuals use and consume bronopol-containing products, or when bronopol 
products are applied to building ventilation systems or mold-affected indoor building 
materials. 
 Indoor proliferation of microbiological agents can generate allergens and other 
byproducts in the indoor environment.  It has been estimated that 50 million Americans 
suffer from allergic diseases and that 89 million Americans work in nonindustrial indoor 
environments.  The new uses of bronopol to combat microbiological growth in the indoor 
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environment have the potential to expose vast new populations to this compound, with 
the potential of subsequent adverse health effects in portions of the exposed groups 
(Mendell et al., 2002; American Academy of Allergy, Asthma & Immunology, Inc. 
[AAAAI], 2000). 
 While information is available on human reactions caused by dermal exposures to 
bronopol, currently no standard exists for permissible levels of human inhalation 
exposure of the compound.  Airborne exposure levels in occupational and consumer 
applications are unknown.  Currently, no sampling and analytical method for 
determination of airborne bronopol concentration is offered in the literature.  Availability 
of an air sampling method for bronopol would permit determination of exposures to 
bronopol workers and of building occupants where bronopol is applied. 
 
Purpose and Scope of the Study 
 The purpose of this work is to evaluate an existing bronopol analytical method for 
use in conjunction with industrial hygiene air sampling techniques, with the goal of 
developing a method to determine airborne concentrations of the compound.  The 
analytical method utilized was published by Sanyal, Basu, and Banerjee (1996) and was 
originally intended for determination of bronopol in chemical formulations.  The method 
utilizes a derivatizing reaction to form a stable chromophore suitable for analysis by 
ultraviolet spectrophotometry. 
 The scope of this work includes repetition of the Sanyal et al. (1996) laboratory 
procedures and development of a calibration curve for the analytical procedure.  Filters 
treated with the derivatizing agent are spiked with known bronopol solutions to evaluate 
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analytical recovery and consistency.  Spiked filters and filter extract solutions are 
evaluated for stability upon storage.  Finally, sampling of generated bronopol aerosols is 
conducted using the treated filters.  No attempt is made to characterize the chemical 
reactions occurring during the development of the chromophore in the derivatizing and 
analytical procedures, as these are described in the Sanyal et al. paper. 
 
Uses of Bronopol 
Consumer and Industrial Applications 
 Bronopol reportedly exhibits biocidal activity against a variety of microorganisms 
including bacteria, fungi, and algae (EPA, 1995).  A partial listing of reported uses is 
presented in Table 1. 
 
Bronopol in Indoor Environmental Quality Applications 
 Modern indoor environments in developed countries, sometimes referred to as the 
“built environment”, are generally considered to be safe and healthful places to work and 
live.  However, the widespread introduction of air-conditioning coupled with energy 
conservation measures of the 1970s has led to reductions in the exchange rate of outdoor 
air.  As a result, airborne contaminants released in the indoor environment may reach 
concentrations whereby building occupants complain of specific or nonspecific health 
and/or comfort symptoms (Occupational Safety and Health Administration  
[OSHA], n.d.). 
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Table 1 
A Partial Listing of Reported Uses of Bronopol 
Adhesive preservative in food packaging Mold remediation products 
Antiseptics Paper mill pulp and process water 
Air-conditioning/ventilation systems Paper slimicide 
Coatings preservative Potable water storage tanks, cleaning 
Cooling towers Preservatives 
Cosmetics Sanitizers 
Disinfectants Seed treatment against bacteria 
Household products Soil bacteriostat 
Humidifiers Toiletries 
Metal working fluids Water based inks 
Note:  Information from BBJ Environmental Solutions, Inc. [BBJ], (2006); National 
Library of Medicine [NLM], (2004); & OSP Microcheck, Inc. 1 [OSP 1], (2006) 
 
 
In absolute terms the quantities of indoor air contaminants present may be very 
low in comparison with traditional industrial environments.  The presence of airborne 
contaminants in the built environment may create actual or apparent perceptions of an 
unhealthy environment, especially when contrasted with the typical cleanliness of the 
built environment. 
 Most recently the potential adverse health effects of fungal (mold) growth in the 
indoor environment have resulted in a high level of public awareness.  While mold spores 
are present in the air in most indoor and outdoor environments, adequate moisture must 
be available for the ubiquitous spores to germinate and grow.  In a modern building 
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control of relative humidity and water/moisture intrusion will minimize or eliminate the 
potential for mold growth to occur indoors.  When water intrusion or elevated relative 
humidity does occur, conditions favorable for mold growth may be created. 
 Many building materials such as wood, drywall, and carpeting will sustain mold 
growth when in contact with water for periods of 24 to 48 or more hours, depending on 
ambient temperature and other factors (EPA, 2001).  Prolonged conditions of elevated 
indoor relative humidity may also create conditions amenable to mold growth on various 
surfaces.  Suitable conditions for the proliferation of mold growth are often found on the 
refrigeration coil and adjacent internal components of modern air-conditioning air-
handling units.  Airborne particulate matter impacting the refrigeration coil provides a 
nutrient source for the mold spores present and the cool surfaces of the refrigeration coil 
condense water from the moving air stream.  Mold growth may occur as a result of 
conditions within the air-handling unit, resulting in likely distribution of mold fragments 
into the indoor environment through the ventilation system. 
 Commercial biocide products are available for minimizing mold growth on wetted 
building materials and on ventilation system components.  At least one manufacturer 
utilizes bronopol as the active ingredient in a commercial line of mold remediation and 
ventilation system sanitizing products (BBJ, 2006).  These products are applied as an 
aqueous solution to building material surfaces presenting with mold growth and on 
internal components of air-handling units and associated ductwork.  This is significant 
because of the potential for airborne exposure to bronopol in a variety of new 
occupational and nonoccupational populations. 
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Chemical and Physical Properties of Bronopol 
 The chemical name for bronopol is 2-bromo-2-nitro-1,3-propanediol, with a 
Chemical Abstracts Service Registry Number (CASRN) of 52-51-7 (BBJ, 1999).  A 
representation of the molecular structure is presented in Figure 1.  The empirical formula 
is BrC3H6NO4 and the molecular weight is 199.99 grams per mole.  The odorless material 
exists as white to pale yellow crystals or crystalline powder; the density for homogeneous 
solid bronopol is ca. 1.1 grams per cubic centimeter.  Melting temperature is 131.5 ºC; at 
temperatures above 140 ºC exothermic decomposition is reported which releases 
hydrogen bromide and oxides of nitrogen. 
The substance is stable for a minimum of one year under normal storage 
conditions and no photodecomposition is reported.  Vapor pressure at 20 ºC is  
1.26 x 10
-5
 mmHg. 
 
__________________ 
                 Br 
                  | 
 HOCH2   C   CH2OH 
                  | 
               NO2 
__________________ 
 
Figure 1.  The Molecular Structure of Bronopol 
 
At normal temperatures bronopol is readily soluble in water, low-molecular 
weight alcohols, low-molecular weight glycols, and n-methyl pyrrolidone.  Dissolution in 
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water is exothermic; solutions up to 28 weight percent in water are possible (National 
Library of Medicine [NLM], 2004; OSP 2, 2006). 
 Concentrated solutions of bronopol (20 weight percent) are corrosive to many 
metals with the exception of some grades of stainless steel.  Concentrated solutions may 
degrade rubber and some grades of polyethylene.  Dilute solutions (0.02 weight percent) 
are compatible with stainless steel, aluminum, brass, and copper and with most types of 
rubber and plastics (OSP 3, 2006). 
 
Decomposition and Biocidal Activity of Bronopol 
 Bronopol decomposes more rapidly under conditions of elevated alkalinity and 
temperature.  Decomposition products of bronopol under various conditions include 
formaldehyde, nitromethane, nitrous acid, glycolic acid, hydrogen bromide, oxides of 
nitrogen, formic acid, methanol, and other compounds (OSP 4, 2006).  A listing of 
bronopol decomposition products is presented in Table 2. 
 Bronopol oxidizes thiol-containing amino acids with atmospheric oxygen as the 
final oxidizer.  Products of this reaction include active oxygen species such as superoxide 
and peroxide.  These oxygen species are directly responsible for the biocidal activity of 
the compound and for the suppression of microbial growth rates following application 
(Shepherd, Waigh, & Gilbert, 1988). 
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Table 2 
A Listing of Reported Bronopol Decomposition Products 
Bromine ions 2-Bromo-2-nitroethanol 
Carbon dioxide Formaldehyde 
Formic acid Glycolic acid 
Methanol Nitroethanol 
Nitromethane Nitrous acid 
Oxides of nitrogen Tris(hydroxymethyl) nitromethane 
Note:  Information from OSP 4, (2006) 
 
Importance of This Study 
 As long ago as 1983 it was estimated that 5,176 people in the United States were 
occupationally exposed to bronopol, both in locations where bronopol was produced and 
where it was incorporated into various formulations.  This estimate includes both dermal 
and respiratory exposures (National Institute for Occupational Safety and Health 
[NIOSH], 1983) to workers and does not include exposures to consumers and end-users.  
Since that time the use of bronopol in various formulations and applications has 
increased.  The recent use of bronopol in mold remediation and ventilation system 
applications has added significant new populations to those potentially exposed through 
the airborne route, including HVAC and mold remediation technicians and the occupants 
of the buildings in which the bronopol is applied. 
 The irritating and allergenic properties of bronopol upon dermal exposure have 
been demonstrated in animal and human studies.  The potential sensitizing property of 
bronopol on dermal exposure suggests that the material may also be sensitizing for the 
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inhalation route of exposure.  Recently introduced indoor environmental quality 
applications of bronopol place biocide applicators and building occupants at risk of 
airborne exposures.  Bronopol applied to HVAC components may become entrained in 
the ventilation system and distributed into the building interior.  Bronopol used in mold 
remediation applications is applied to affected surfaces as an aqueous solution using a 
powered spray nebulizer, producing bronopol aerosols.  Little information is available as 
to residual levels in building air following application of bronopol.  Given the importance 
of bronopol as a preservative and biocide and its expanding uses in indoor environmental 
quality applications, it is important to develop an understanding of airborne exposure 
levels. 
The reported vapor pressure of 1.26 x 10
-5
 mmHg is equivalent to an airborne 
concentration of ca. 0.14 mg/m
3
.  Given the reported stability of bronopol under normal 
conditions, the vapor pressure suggests that persons in building areas where bronopol has 
been applied may be subjected to continuous low-level exposures. 
 No air sampling method for bronopol currently exists in the scientific literature.  
Therefore airborne bronopol levels cannot be reliably measured.  Without an air sampling 
methodology, airborne exposure levels for workers and building occupants cannot be 
characterized.  Further, investigation of the dose-response relationship between airborne 
exposure levels and potential adverse health outcomes cannot be accomplished. 
 This paper presents the development of an air sampling method for bronopol.  The 
existing Sanyal et al. (1996) analytical method and conventional industrial hygiene air 
sampling techniques are combined for the first time.  This work produces a calibration 
curve using the Sanyal et al. analytical method and modifies the method to analyze 
 10
bronopol collected on filters, both from filter spiking and from collection of aerosols 
generated in chamber studies. 
 
Limitations of This Study 
 This paper utilizes an existing analytical method in combination with a limited 
number of analytical recovery studies from filter spiking and chamber experiments.  
Excluded from the study are large numbers of duplicate samplings from generated 
atmospheres and long-term sample and filter extract stability studies. 
 The chemical interactions taking place in the derivatizing reaction have already 
been described in the Sanyal et al. (1996) paper, and the decomposition pathways and 
products of bronopol are known.  Although bronopol will decompose under certain 
conditions, the known decomposition products reportedly do not interfere with the 
analytical method.  This study does not determine what, if any, compounds may interfere 
with the analytical method. 
 This study does not evaluate potential adverse health effects associated with 
dermal or inhalation exposures to bronopol.  No field sampling activities are included in 
the study. 
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Chapter Two - Review Of Pertinent Literature 
Health Effects Associated with Exposure to Bronopol 
Animal and Human Studies 
Animal oral and subcutaneous toxicity.  In 1964 bronopol was a new 
antimicrobial compound.  Croshaw, Groves, and Lessel (1964) reported on the toxicity of 
bronopol in laboratory animals.  LD50 for mice was reported as 350 mg/kg orally and  
20 mg/kg intraperitoneally; for rats the reported LD50 was 400 mg/kg orally and  
200 mg/kg subcutaneously.  No further information was available on the age, variety, or 
sex of the rodents in the reported studies.  Male and female albino rats (5 to 6 weeks old) 
were fed bronopol at 100 ppm and 1,000 ppm in food for twelve weeks; both dose 
amounts were tolerated with no adverse health effects noted. 
 Frear (1969) reported oral LD50 values of 180 mg/kg for rats and 270 mg/kg in 
mice.  No further information was available on the age, variety, or sex of the rodents. 
In animal studies of acute toxicity Bryce, Croshaw, Hall, Holland, and Lessel 
(1978) reported mouse oral LD50 values of 374 mg/kg for males and 327 mg/kg for 
females; and rat oral LD50 values of 307 mg/kg for males and 342 mg/kg for females.  
Intraperitoneal values were 34.7 mg/kg for male mice and 32.8 mg/kg for female mice; 
intraperitoneal values were 22.0 mg/kg for male rats and 30.2 mg/kg for female rats.  No 
further information was available on the age or variety of the rodents. 
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Animal inhalation toxicity.  A four-hour LC50 of approximately 0.18 mg/L is 
reported for inhalation exposure on ten male and ten female rats of unspecified age or 
variety (Elder, 1980).  Irritation is reported on the ears and paws of survivors. 
 Two acute inhalation studies were submitted to the Environmental Protection 
Agency (EPA, 1995) for pesticide registration approval of bronopol.  In one study an 
LC50 (rats) of greater than 0.588 mg/L is reported with diffuse red lungs, sore eyelids, 
and severe dermatitis and ulceration on the head; the head effects are attributed to dermal 
exposure.  In the second study a male rat LC50 of greater than 5 mg/L was determined.  
No further information was available on rodents used in the studies.  Clinical signs noted 
during the study were eye irritation, dyspnea, profuse mucus production, and lethargy 
with chronic pneumonitis following cessation of exposure. 
 
Animal dermal irritancy properties.  A 2 % application to eye and skin of rabbits 
was irritating after one application (Croshaw et al., 1964). 
 A 0.4 ml application of 20 % aqueous bronopol solution on both abraded and 
unabraded rabbit skin produced severe irritation.  In a study of acute inhalation toxicity 
irritation is reported on the ears and paws of male and female rate survivors (Elder, 
1980). 
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Animal eye irritancy properties.  A 2 % application to the eyes of rabbits was 
irritating after one application (Croshaw et al., 1964).  Application of 1.0 ml of 20 % 
aqueous bronopol solution applied to the eyes of rabbits produced severe damage (Elder, 
1980). 
 
Human dermal patch testing.  Marzulli and Maibach (1974) conducted Draize 
patch testing of bronopol on human volunteers.  Bronopol in petrolatum was applied to 
the upper lateral portion of the arm and covered; the patch was left in place 48 or  
72 hours.  Ten successive induction applications were made at the same site.  Following a 
two-week rest period a challenge patch was applied and left in place for 72 hours.  For 66 
subjects no positive reactions were noted for induction with 2 % bronopol and subsequent 
challenge with 2.5 % bronopol.  However, when induction was performed with 5 % 
bronopol an allergic reaction was observed in 11 of 93 subjects upon subsequent 
challenge with 2.5 % bronopol. 
 Following the prior Marzulli and Maibach (1974) positive patch testing for 
dermal sensitization, Maibach (1977) conducted further skin sensitization potential patch 
testing using bronopol in yellow soft paraffin.  A 21-day preliminary assessment of eight 
normal subjects with patches of varying bronopol concentrations determined an irritancy 
threshold of approximately 0.5 to 1.0 %.  Following this 120 subjects were fitted with  
5 % bronopol patches over a period of 21 days; many subjects reported irritation from the 
patch.  After a two-week rest period, a 0.25 % bronopol challenge patch was applied for 
72 hours.  Among the 93 subjects completing the challenge test no evidence of 
sensitization was reported. 
 14
 Work reported by Bryce et al. (1978) indicate that closed patch testing of 
bronopol in soft paraffin produced slight erythema in two of ten human subjects at a 
concentration of 1 % and moderate erythema in four of ten subjects at 2 % concentration.  
Allergenic sensitization of test subjects was not observed in this study. 
 Frosch et al. (1990) reported on dermal irritant and allergic testing of 8,194 
European patients in seven dermatology clinics.  Of these, 10 cases presented with 
irritation and 38 presented with allergic reactions.  Clinically relevant reactions to 
bronopol were reported in 17 of the patients. 
 
Case Reports 
 Occupational exposure data was developed for workers of the Boots Company, 
Limited and submitted to the Cosmetic, Toiletry & Fragrance Association.  Boots is a 
manufacturer and distributor of bronopol.  In the period from 1970 to 1978, 23 of 50 
Boots workers reported rashes and/or superficial burns following dermal exposure to 
bronopol powder or concentrated aqueous solutions.  Eight employees reported two 
occurrences, six employees reported three occurrences, and three employees reported a 
fourth occurrence.  It was reported that the adverse reactions were irritant rather than 
allergenic in nature (Elder, 1980). 
 Eucerin is a retail nonprescription topical moisturizing skin cream; acute allergic 
dermatitis was experienced by seven patients on using Eucerin on previously dermatitic 
skin for periods of time from 5 weeks to 2 years.  At that period in time Eucerin 
contained bronopol as a preservative.  Bronopol and Eucerin patch testing on the patients 
was positive.  As bronopol is a formaldehyde donor the patients were tested for 
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formaldehyde allergy.  None of the patients tested positive for formaldehyde or other 
preservatives that generate formaldehyde (Storrs & Bell, 1983). 
 In a case report a 35-year old large animal veterinarian presented with an 
erythematous dermatitis from the fingers to mid upper left arm.  The man performed full 
arm rectal examinations on thoroughbred mares.  In this procedure a glove was worn and 
a bronopol-containing lubricant was used; frequent soiling of the skin of the arm is 
reported in spite of the full-length surgical gloves used.  As the cause of the condition 
was thought to be cellulitis the initial treatment was with antibiotics.  Forced to use his 
right arm to perform the examinations he returned to the clinic four days later with an 
identical condition on that arm as well.  The lubricant used during the equine 
examinations had been changed to a bronopol-containing formulation just prior to the 
onset of symptoms.  Switching to another lubricant not containing bronopol resulted in a 
resolution of the condition.  The man patch tested positive for allergic reaction to both 
bronopol and the bronopol-containing lubricant (Wilson & Powell, 1990). 
 Two additional case reports are made for cosmetics production workers.  The first 
was a 25-year-old man that had been weighing cosmetic ingredients including bronopol 
for six months.  The dermatitis developed on his hands and forearms and the patient 
patch-tested positive for bronopol.  After a job change in which he did not handle 
bronopol the patient was symptom free after six months.  The second case was a 54-year-
old man that also handled bronopol in cosmetics production.  After seven years in this job 
he developed dermatitis on both hands.  Following a four-day sick leave his lesions were 
significantly reduced so he resumed work.  The condition resumed after two weeks back 
on the job.  The patient also patch-tested positive for bronopol.  Following cessation of 
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bronopol exposure the patient was symptom free in nine months of follow-up (Rudzki et 
al., 1993). 
 
Summary of Health Effects 
 A summary of acute animal toxicological studies for bronopol is presented in 
Table 3.  In general, no evidence of bronopol carcinogenic, embryotoxic, teratogenic, or 
mutagenic effects have been noted in the literature reviewed.  Bronopol is moderately 
toxic orally in laboratory animals; intraperitoneally its toxicity is high in rodents (Elder, 
1980).  Reported acute LD50 toxicity by the oral route in laboratory rodents was in the 
range of 180 mg/kg for rats (Frear, 1969) to 400 mg/kg for rats (Croshaw et al., 1964).  
Chronic oral toxicity values reported are in the range of a well tolerated 20 mg/kg/day 
dose (rat) to daily doses of 80 to 160 mg/kg/day (rat) resulting in respiratory distress and 
some deaths.  Intraperitoneal LD50s reported range from 20 mg/kg (mouse) to a  
200 mg/kg rat value (Bryce et al., 1978).  Inhalation LC50 values for rats of 0.18 mg/l 
(Elder) to greater than 5 mg/l (EPA, 1995) are reported.  The cause(s) of the disparity in 
acute animal values is not known; little information on variables such as age, variety, and 
sex for the laboratory animals was presented in the studies available. 
 Skin irritancy in humans and laboratory animals at levels commonly used in 
cosmetics (0.01 to 0.1 %) is low.  Bronopol in higher concentrations (1 % and greater) is 
significantly irritating in human skin patch studies (Maibach, 1977).  The evidence for 
dermal sensitization and allergenic dermal reaction to bronopol is mixed.  Laboratory 
testing of the allergenic properties of bronopol indicate a low potential for dermal 
sensitization; however, a number of case reports indicate isolated incidences of human 
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allergenic reactions in various exposure situations (Bryce et al., 1978; Storrs & Bell, 
1983; Frosch et al., 1990; Wilson & Powell, 1990; Rudzki et al., 1993). 
No reports were identified on the allergenic properties of bronopol for the 
inhalation route of exposure. 
 
Table 3 
Reported Results for Acute Toxicological Studies of Bronopol 
Evaluation Parameter Minimum Value 
(Reference) 
Maximum Value 
(Reference) 
Oral LD50, Mouse 270 mg/kg 
(Frear, 1969) 
 
350 mg/kg 
(Croshaw et al., 1964) 
Oral LD50, Rat 180 mg/kg 
(Frear) 
 
400 mg/kg 
(Croshaw et al.) 
Intraperitoneal LD50, Mouse 20 mg/kg 
(Croshaw et al.) 
 
32.8 mg/kg (female) 
(Bryce et al., 1978) 
Intraperitoneal LD50, Rat 22.0 mg/kg (male) 
(Bryce et al.) 
 
200 mg/kg 
(Croshaw et al.) 
Eye Irritant, Rabbit 2 % in Solution 
(Croshaw et al.) 
 
20 % in Solution 
(Elder, 1980) 
Skin Irritant, Rabbit 2 % in Emulsion 
(Croshaw et al.) 
 
20 % in Solution 
(Elder) 
Inhalation LC50, Rat 0.18 mg/L 
(Elder) 
> 5.0 mg/L 
(EPA, 1995) 
LD50 = lethal dose for half of the study group mg/L = milligrams per liter 
LC50 = lethal concentration for half of the study group % = percent 
mg/kg = milligrams per kilogram of body weight > = greater than 
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Dermal and Respiratory Sensitizing Agents 
Formaldehyde 
 Formaldehyde is a compound that is used as a sanitizing agent, as an embalming 
material, and in numerous chemical synthesis processes.  Formaldehyde is a dermal 
sensitizer that can result in allergic contact dermatitis upon repeated skin contact (Marks 
& DeLeo, 1997).  Although it is a respiratory irritant, formaldehyde is likely not a 
respiratory sensitizer (Rosenstock & Cullen, 1994). 
 
Diphenymethane Diisocyanate (MDI) 
 The primary health effect associated with the isocyanate chemicals as a group is 
respiratory sensitization.  Individuals sensitized to MDI may suffer from asthmatic 
symptoms even at very low exposure concentrations (NIOSH, 1986).  MDI is also a 
potent skin sensitizer that produces allergic contact dermatitis in sensitized individuals, 
again at very low levels (Estlander, Keskinen, Jolanki, & Kanerva, 1992). 
 
Bronopol 
The evidence for dermal sensitization and allergenic dermal reaction to bronopol 
is mixed, with a number of case reports indicating incidences of human dermal allergenic 
reactions.  The potential sensitizing property of bronopol on dermal exposure suggests 
the possibility that the material may be sensitizing for the inhalation route of exposure, 
although dermal sensitizers are not always respiratory sensitizers. 
Given the wide spread use and the variety of new applications for the material, 
even low contact sensitization potential materials such as bronopol may produce 
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sensitization in a large number of people when the exposure population is large.  
Continued exposure to a sensitizer may eventually sensitize susceptible individuals 
(Marzulli & Maibach, 1973). 
 
Indoor Environmental Quality and Human Health 
Indoor Air Quality 
While many factors can affect the quality of the indoor environment, this discussion is 
focused on indoor air quality.  People in the built environment may be subjected to 
building-related factors and agents that can degrade the actual or perceived quality of the 
air in the building.  A partial listing of factors governing the perception of good indoor air 
quality is presented in Table 4.  Good control of these factors should produce air quality 
that is acceptable to the majority of building occupants. 
 
Table 4 
A Partial Listing of Factors Affecting Perceived Building Air Quality 
Sources of odors, contaminants, dusts, or allergens 
 
Consistent temperature and relative humidity 
 
Temperature and relative humidity at appropriate levels for the season of 
year, occupant clothing, and occupant activity 
 
Circulation of air/drafts 
 
Housekeeping and cleanliness 
 
Facility lighting 
 
Note:  Information from EPA & NIOSH, (1991) 
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 There are four basic elements in the development of indoor air quality problems.  
A source of contaminants or discomfort must be present in the building.  Potential indoor 
contaminant sources include chemicals, particulate sources, biological agents, and 
bioeffluent materials from the building occupants themselves.  Then, a pathway must be 
present and available to facilitate transport of the contaminant from the source to the 
building occupants.  The pathway is generally a moving body of air located in 
appropriate proximity to the source(s) and receiver(s).  The pathway may exist as a result 
of differential air pressure between interior and exterior portions of the building, or the 
contaminant may be entrained and distributed by the building ventilation system.  Next, 
the building must be occupied for any adverse perceptions and/or health effects to be 
manifested.  If people are not present then air quality will not be an issue.  Lastly, the 
heating, ventilating, and air-conditioning system may not be able to adequately control 
temperature and/or relative humidity, may not adequately dilute indoor contaminants 
with conditioned outdoor air, may not adequately filter airborne particulates, and may 
itself serve as a source of indoor contaminants.  In this instance the source and pathway 
will function together to deliver the contaminant(s) to the building occupants. 
 Complaints of poor indoor air quality may be a result of comfort factors such as 
temperature and humidity control, stuffiness, or perception of moving air currents 
(drafts).  Unpleasant odors are sometimes associated with poor indoor air quality, even if 
they are not associated with health complaints.  Air quality complaints are often 
manifested as nonspecific health symptoms rather than a clearly defined illness.  Certain 
subpopulations may have different tolerances for agents present in indoor air.  The term 
‘sick building syndrome’ refers to building occupants experiencing health or discomfort 
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effects associated with their time in a building.  A list of common indoor air quality 
health complaints is presented in Table 5.  It is important to note that all of these 
symptoms may be present as a result of other factors not related to the building 
environment (EPA & NIOSH, 1991). 
 
Table 5 
Frequently Cited Indoor Air Quality Health Complaints 
Headache Fatigue 
Shortness of breath Sinus congestion 
Cough Sneezing 
Eye, nose, and throat irritation Skin irritation 
Dizziness Nausea 
Note:  Information from EPA & NIOSH, (1991) 
 
Building related illness (BRI) refers to a clearly diagnosable illness brought on by 
an exposure to an agent present in indoor air.  While these may be caused by chemicals or 
other agents of anthropogenic origin, BRIs are usually allergic reactions or specific 
infections associated with exposure to bioaerosols.  For example, Legionnaire’s disease is 
associated with proliferation of Legionella bacteria in ventilation system cooling water 
(EPA & NIOSH, 1991). 
The impact of biological agents on indoor air quality is currently an active field of 
scientific and medical investigation.  Indoor growth of fungi has generated attention from 
the mass media and has resulted in legislative activity to regulate the mold assessment 
and remediation industry.  The three major health effects attributed to exposure to mold 
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include infection, allergic reaction, and adverse reactions associated with generated 
mycotoxins.  Humans with compromised immune systems are susceptible to 
opportunistic fungal infections that would not otherwise present a threat (American 
College of Occupational and Environmental Medicine [ACOEM], 2002).  Nine percent 
of nosocomial infections are caused by fungi (Redd, 2002).  Some pathogenic fungi such 
as Blastomyces, Coccidioides, Cryptococcus, and Histoplasma can infect people of 
normal health status (ACOEM, 2002). 
 The allergenic properties of mold are well known, generally resulting in hay 
fever-like symptoms in allergic individuals.  Irritation of the eyes and upper respiratory 
tract as well as rhinitis is often reported and may be triggered by low-level exposures in 
sensitive individuals.  People with no allergies may experience similar symptoms from 
high-level mold exposure.  Those with allergies, asthma, or having preexisting respiratory 
diseases often report symptoms associated with exposure to mold (EPA & NIOSH, 
2002).  However, current scientific and medical inquiry generally does not support claims 
of adverse health effects as a result of mycotoxins from mold growth in water-contacted 
indoor environments (ACOEM, 2002). 
Mold growth in the indoor environment is not acceptable from an indoor air 
quality standpoint.  Mold growth results in unpleasant odors, damages materials on which 
it grows, and produces allergenic materials. 
 Mold spores are found in all indoor environments with the exception of special 
clean rooms or medical isolation rooms.  The majority of indoor mold spores originate 
outdoors and drift indoor with moving air, are transported in on the person of the 
occupants, or are carried in on objects moved to the indoors.  Readily available nutrient 
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sources are available indoors in the form of building materials, furniture, and other 
contents.  Mold colonization will generally not occur in the indoor environment unless a 
water leak or elevated relative humidity condition exists.  Mold growth can occur on 
interior surfaces of air-conditioning air-handling units unless the nutrient source 
consisting of impacted particulate material is periodically removed. 
 Remediation of mold growth on indoor materials consists of four basic steps.  
First, since mold colonization has occurred as a result of water intrusion or elevated 
relative humidity, the source(s) of water intrusion or elevated humidity must be remedied.  
Then wetted materials should be dried as quickly as feasible.  Thirdly, porous materials 
and materials that are impractical to effectively clean are removed and discarded.  Lastly, 
remaining structural and finish materials are cleaned and sanitized and permitted to 
thoroughly dry (EPA, 2001).  While biocides are not necessarily recommended in 
authoritative guidelines for mold remediation, these materials are often used in 
conjunction with cleaning solutions and high efficiency particulate air (HEPA) 
vacuuming to treat mold-affected areas. 
 
Workers in Indoor Environments 
 Approximately 89 million people work in nonindustrial nonagricultural indoor 
environments in the United States.  This represents about seventy percent of American 
workers.  Workers may spend 2,000 hours or more per year in the occupational 
environment, a little less than one-fourth of every year of life in the working years.  The 
occupational environment is unique in that most employees may have little direct control 
over their surroundings.  In many cases the building will have mixed uses such as a 
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having a laboratory or printing operation in the same building and sharing the same 
ventilation system with office occupants, allowing the possibility that airborne chemicals 
and particulates in these areas will enter the office areas of the building. 
 It is estimated that thirty-five to sixty million workers will experience one or more 
nonspecific building-related symptoms.  The total financial impact of these symptoms 
including health care, lost time and productivity is estimated to be between twenty to 
seventy billion dollars annually (Mendell et al., 2002). 
 
Nonoccupational Indoor Environments 
 In the United States about 50 million people suffer from allergic diseases each 
year.  Allergies are the sixth leading cause of chronic disease, with health care costs 
estimated at over eighteen billion dollars annually.  Americans spend more time indoors 
than ever before, making indoor air quality and exposure to indoor allergens important to 
a greater number of people.  Nonoccupational indoor environments include homes, 
apartments, schools, day care, and shopping and entertainment venues.  Exposures in 
nonoccupational settings include a wider range of occupant ages and health status than 
exposures associated with the workplace. 
 Asthma affects more than fifteen million people in the United States annually; of 
these approximately five million are children.  Asthma accounts for more than five 
thousand deaths, eleven million doctor visits, ten million missed school days, and over 
one hundred million days of restricted activity.  A portion of these statistics can be 
attributed to exposure to indoor allergens and other indoor air quality agents (AAAAI, 
2000). 
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Analytical Methods for Bronopol 
 A number of analytical methods have been published for quantitative 
determination of bronopol.  Many of these are assay methods for quantifying bronopol in 
cosmetic and pharmaceutical products or purity verification of bronopol antimicrobial 
formulations.  None of the published methods reviewed included analysis of bronopol 
from collected air samples. 
 
Polarographic Assay 
 Bryce et al. (1978) published a treatise on bronopol analytical methods and other 
topics.  The first method fully described in the paper used McIlvaine’s buffer solution as 
a base electrolyte; this solution as described will maintain a constant pH of 4.0.  Aqueous 
solutions of bronopol in the concentration range of 10
-3
 to 10
-5
 molar could be analyzed 
directly.  Bronopol in fatty-base formulations such as cosmetic products could be 
analyzed following phase-transfer extraction of bronopol using the base electrolyte 
solution.  Dissolved oxygen was removed by passing oxygen-free nitrogen through the 
analytical solution for ca. 10 to 15 minutes.  Analysis was then performed using a 
suitable polarograph. 
 The polarographic method estimates the concentration of the nitro group in the 
analyte solution; therefore, any compound with a nitro group will potentially interfere 
with the method.  Since some breakdown products of bronopol retain the nitro group, this 
analytical method was recommended for freshly prepared formulations.  Given the lack 
of specificity for bronopol of the polarographic method, a calibration curve must be 
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prepared for each formulation analyzed.  Reported precision of the method in the absence 
of interfering compounds is ca. ± 2 %. 
 
Gas-Liquid Chromatography 
 The Bryce et al. (1978) paper describes various GLC analytical methods for 
bronopol in aqueous solutions.  One method involves an acetylation step whereby 
bronopol in chloroform is reacted with acetyl chloride.  The solution is sealed in a vial 
and reacted in a steam bath for three hours.  Using nitrogen as the carrier gas and 
injecting a sample into a packed column, the resultant reaction compound of bronopol 
diacetate is detected on a flame ionization detector.  Another acetylation method 
described uses an electron capture detector. 
 In another Bryce et al. (1978) GLC method bronopol in chloroform is reacted 
with a silylating reagent containing trifluoroacetic acid and hexamethyldisilazane.  The 
solution is sealed in a vial and reacted in a steam bath for one hour.  Using nitrogen as the 
carrier gas and injecting a sample into a packed column, the resultant reaction compound 
of bronopol di(trimethylsilyl)ether is detected on a flame ionization detector. 
 The GLC methods described have been used to determine bronopol content in 
aqueous solution at concentrations as low as 5 to 50 ppm. 
 
Titrimetric Assay 
 A titrimetric assay for bronopol is reported in a General Medical Council 
publication (1993).  The assay combines bronopol, sodium hydroxide, and nickel-
aluminum alloy; the mixture is refluxed for 1 hour.  Following heating, nitric acid and 
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silver nitrate are added; the mixture is titrated with ammonium thiocyanate using 
ammonium ferric sulfate as an indicator.  The quantity of titration agent is proportional to 
the concentration of bronopol in the sample.  The procedure must be repeated in the 
absence of bronopol to obtain a reference value for comparison. 
 
Enzymic Assay 
 Sanyal, Chowdhury, and Banerjee (1993) described a method to assay liquid 
pharmaceutical formulations for bronopol based on the inhibition of a thiol protease, 
papain.  An aliquot of the pharmaceutical formulation to be analyzed is added to  
10 ml of a standard solution of 60 µg bronopol per milliliter concentration.  The mixture 
is shaken for two hours at 40 ºC and the total volume is increased to 50 ml.  The solution 
is then clarified by centrifugation at 3,000 g for 15 minutes. 
 Samples and calibration standards are cooled in an ice bath.  A pH 5.5 enzyme 
solution containing papain, formic acid, and ethylenediaminetetraacetic acid (EDTA) is 
added to the samples and standards and these are incubated at 40 ºC for 15 minutes.  
Samples and standards are quickly cooled in an ice bath and a pH 8.0 buffered solution of 
azoalbumin, tris(hydroxymenthyl)methylamine, and hydrochloric acid is added.  These 
are then incubated at 37 ºC for 15 minutes and cooled in an ice bath.  A trichloroacetic 
acid mixture is then added to precipitate out residual solid material.  Following 
centrifugation the absorbance is read at 390 nm for samples and standards and compared 
to a reaction blank.  The method is linear in the range of 0.8 to 4.0 µg/ml. 
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Ultraviolet Spectrophotometric Method 
 Sanyal et al. (1996) described a UV-VIS spectrophotometric method for bronopol 
analysis in raw materials using a derivatizing reaction step.  The retroaldol reaction of 
aqueous bronopol with aqueous sodium hydroxide generates a bromonitroethanol 
chromophore.  Experiments in the paper demonstrate complete conversion of bronopol to 
bromonitroethanol through the use of thin-layer chromatography (TLC) techniques.  The 
bronopol spot with a retention factor (Rf) of 0.62 completely disappeared upon addition 
of sodium hydroxide and was replaced by a spot on the film with an Rf of 0.74.  The 
compound with an Rf of 0.74 has been identified as bromonitroethanol. 
The absorbance maximum of 244 nanometers is specific to bromonitroethanol; 
Sanyal et al. report that aqueous solutions of bronopol only (15 µg/ml) have practically 
no absorbance in the ultraviolet region of 220 to 350 nm.  The reported molar absorption 
coefficient of bromonitroethanol at 244 nm is 8330; the method is reportedly linear in the 
concentration range of 5 to 25 µg/ml. 
 
Spectrophotometric Analysis - Background 
 A spectrophotometer is a device for determining the amount of light that is 
transmitted through the sample being analyzed.  A light passes through a series of slits 
and over a diffraction grating that serves to limit the light wavelength directed through 
the sample to a very narrow band.  This portion of the spectrophotometer is called the 
monochrometer.  The monochrometer may be motor driven to scan through a range of 
light wavelengths at a predetermined fixed rate.  The light passes through the sample and 
is directed to a detector to determine the amount of light transmitted through the sample.  
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The result is a spectral scan of light transmission through the sample (Skoog & West, 
1980). 
 Under certain circumstances spectrophotometry can be used for the identification 
of unknown compounds.  Different compounds will absorb light of different wavelengths 
in a unique pattern, which can be thought of as a "fingerprint".  Identification depends on 
the presence or absence of spectral curve maxima and minima, the wavelength at which 
they occur, and sometimes the amplitude of transmission. 
 Spectrophotometry may also be used to determine the concentration of a 
particular compound in a sample, if the identities of the compounds in a sample are 
known.  This is done by comparing the intensity of light transmitted through the sample 
of unknown concentration to the intensity of light transmitted through standards of 
known concentration (Stearns, 1969). 
 The term transmittance (T) can be thought of as the optical density of a substance 
at a particular wavelength of light and is defined as the fraction of the incident light 
power (Po) transmitted through the sample (P).  This is shown in Equation 1. 
 
 
  T = P/Po        (1) 
 
 
 Transmittance is often expressed as a percentage.  Absorbance (A) is defined as 
the negative logarithm to the base ten of the transmittance as shown in Equation 2. 
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  A = -log10T = log10Po/P      (2) 
 
 
 In contrast to transmittance, the numerical magnitude of absorbance increases as 
the attenuation of the light beam through the sample becomes greater.  It should be noted 
that absorbance cannot be measured directly as can transmittance; absorbance must be 
calculated from transmittance data.  The relationship between absorbance and 
concentration of a species in a sample is described by Beer's law, which is expressed in 
Equation 3.  In this equation a is the absorbtivity of the analyte species at a specific 
wavelength of light, b is the path length of light through the sample, and c is the 
concentration of the analyte in solution.  The term “a” is sometimes called the extinction 
coefficient of the analyte and is unique for each particular compound. 
 
 
  A = abc        (3) 
 
 
 This relationship holds for dilute solutions; at high concentrations interaction 
between the absorbing species in solution alters their ability to absorb a given wavelength 
of light.  It can be seen from this equation, that since a and b are fixed values, the 
absorbance varies linearly with concentration.  Within the concentration limits described 
above, concentration can be determined by reading the absorbance and comparing to the 
absorbance for a known concentration of the same species (Skoog & West, 1980). 
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Good spectrophotometric practices call for the sample cell orientation to be 
repeated consistently.  Also, the use of a reference solution is called for to minimize 
handling and contamination variables.  The reference solution must be handled in exactly 
the same manner as the sample(s) (Everett, 1981). 
 
Air Sampling Methods Utilizing Treated Filters 
OSHA Sampling and Analytical Method for MDI 
 OSHA (1989) Method 47 for diphenylmethane diisocyanate (MDI) utilizes glass 
fiber filters impregnated with 1-(2-pyridyl) piperazine (1-2PP).  The spontaneous reaction 
of MDI with 1-2PP forms a stable derivative, which can be analyzed by high 
performance liquid chromatography using a fluorescence detector.  This reaction takes 
place on the surface of the filter fibers.  Citing difficulties in the generation of controlled 
MDI test atmospheres, method development utilized MDI derivative spiked onto coated 
filters.  Analysis of samples collected during field trials indicates that MDI is collected 
and reacted on the 1-2PP treated filters under non-laboratory conditions. 
Retention of the MDI derivative was verified by flowing 20 liters of humid air 
through spiked filters.  A retention efficiency of 97 % is reported, accompanied by an 
extraction efficiency of 96.3 %.  Detection limit of the overall sampling and analytical is 
11.6 nanograms per sample. 
 
OSHA Sampling and Analytical Method for Ozone 
 OSHA (1995) Method ID-214 for ozone utilized glass fiber filters impregnated 
with sodium nitrite, potassium carbonate, and glycerin.  Ozone reacts with the nitrite to 
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form nitrate via oxidation.  The nitrate is analyzed by ion chromatography using a UV-
VIS detector at 200 nanometers.  The qualitative detection limit reported is  
0.37 micrograms per milliliter of filter extract solution.  Collection efficiency and 
desorption efficiency are each reported to be approximately 100 %. 
 The reaction of ozone with nitrite takes place in an aqueous film on the surface of 
the filter fibers.  The presence of highly hydroscopic glycerin (Hawley, 1981) on the 
glass fiber filter surface sequesters ambient atmospheric water, providing an appropriate 
medium for the reaction. 
 
Glass Fiber Filtration Media 
 Glass fiber filters used in industrial hygiene air sampling are generally 
constructed of multiple layers of randomly oriented fibers.  Due to the nature of their 
construction the pore size is inconsistent and is by definition undefined; the pore size 
rating for glass fiber filters is usually assigned an approximate rating through testing.  
The thickness of glass fiber filters used for air sampling is usually in the hundreds of 
micrometers.  Particles collected in glass fiber filters are captured within the fiber matrix 
as the air stream negotiates the tortuous pathway through the filter.  For this reason these 
types of filters are often referred to as depth filters. 
 Glass fiber filters are of a random fiber composition and commonly have little 
mechanical strength.  These commercially produced filters are available in two basic 
forms, with binder and binder-free.  Those with binder are often used in applications 
where gravimetric analysis will be performed since the binder serves to minimize filter 
fiber loss during handling and sampling.  Because the filter is comprised of glass, these 
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filters are usually hydrophobic; therefore they perform efficiently under a wide ambient 
humidity range. 
 The high void volume of glass fiber filters results in a high loading capacity and 
the ability to flow high volumes of air.  Glass fiber filters are useful for their high capture 
efficiency and the ability to trap very fine particulates (Hering, 1989; SKC Inc., 2005).  
These types of filters are also used where a pretreatment or derivatizing agent is desired 
at the point of sample collection (OSHA, 1989; OSHA, 1995). 
 
Sampling and Analytical Method Validation 
 In 1995 NIOSH published a document providing a process for sampling and 
analytical method development.  This document was part of the continuation of the 
Standards Completion Program.  Generation of standard test atmospheres, evaluative 
methodologies, and statistical protocol and validation criteria for the air sampling 
methods and laboratory analysis are presented in this publication.  Elements of this 
publication are utilized in this body of work. 
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Chapter Three - Research Design 
Overview 
 Investigations of bronopol determination using gas chromatography (GC) and 
high-pressure liquid chromatography (HPLC) were previously attempted in the current 
work.  Analytical results obtained were inconsistent in nature; no suitable analytical 
method was developed using GC or HPLC.  Based on the results of these prior 
investigations, it was felt that the irregular analytical results were due to the reactive 
nature of bronopol itself.  As a result, the Sanyal et al. (1996) derivatizing procedure was 
evaluated as a method to form a stable compound suitable for analysis.  The results of 
this line of investigation follow. 
In general, the derivatizing and UV-VIS analytical techniques in the Sanyal et al. 
(1996) paper will comprise the analytical portion of this work.  A calibration curve is 
generated and is used as a reference against which samples are compared.  Glass fiber 
filters are treated with the derivatizing agent used in the Sanyal et al. work plus a 
humectant agent to sequester atmospheric moisture.  Treated filters are spiked with 
aqueous bronopol solutions and are analyzed to gauge recovery efficiency from the 
filters.  A chamber containing bronopol aerosol is sampled simultaneously with treated 
glass fiber filters and inert filters; the inert filters are used as a benchmark method.  
Finally, bronopol samples are generated and evaluated for sample storage stability. 
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Reagents and Materials Used 
 Standard wet chemistry glassware was used.  Glassware was washed and rinsed 
using distilled tap water and Aconox, Inc. laboratory detergent, part number 1104-1.  
Spectrophotometric analysis was performed on a Beckman Coulter, Inc. DU-64 single 
path UV-VIS Spectrophotometer.  Cuvettes were 1.0-centimeter pathlength quartz with a 
Teflon stopper, Fisher Scientific International part number 14-385-904D.  Cuvettes were 
rinsed with acetone.  Filter treatment solution and filter spiking solution were applied 
using microsyringes from the Hamilton Company.  Chemical reagents used are listed in 
Table 6. 
 The filters used for filter spiking and derivatizing air sampling were SKC Inc. 
brand glass fiber (GFF), 25 mm diameter, part number 225-702.  These filters are binder 
free, have a nominal pore size of 1.0 µm, and have a cross-sectional thickness of 0.31 to  
0.35 mm. 
 Inert reference filters used for air sampling were Millipore Corporation 25 mm 
diameter Durapore® brand polyvinylidene fluoride (PVDF) membrane filters, 0.45 µm 
pore size, part number HVHP02500.  Syringe filters used to purify filter extract solutions 
were Millipore Corporation Millex®-LCR brand 25 mm PTFE, 0.45 µm pore size, part 
number SLCR 025 NS. 
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Table 6 
Chemical Reagents Used 
Reagent Use 
Bronopol, 2-bromo-2-nitro-1,3-propanediol, 
Sigma-Aldrich Company, part number 13,470-8. 
 
Used in all laboratory procedures. 
Sodium hydroxide 50 weight percent solution 
(approximately 19 Molar), Fisher Scientific 
International, part number SS254-1. 
 
Derivatizing agent for all laboratory 
procedures. 
Glycerin, Certified/Spectroanalyzed, Fisher 
Scientific International, part number G153-1. 
 
Humectant agent for treating glass 
fiber filters. 
Water, spectrophotometric grade, Fisher Scientific 
International, part number W7-4 Optima. 
 
Used in all laboratory procedures. 
Nitrogen, Airgas, Inc., Ultra High Purity, product 
number NI UHP 300. 
 
Used for chamber sampling trials. 
Acetone, spectrophotometric grade, Fisher 
Scientific International, part number A19-1. 
Used for rinsing cuvettes. 
 
 
 Bronopol as obtained from the supplier was in the form of small granular crystals.  
Bronopol used in air sampling experiments was ground for 10 minutes in a dry nitrogen 
atmosphere using a glass mortar and pestle.  The quantity used for each chamber run was 
determined using a 5 ml volumetric flask. 
 
Laboratory Equipment 
Introduction 
 A schematic representation of the dust generator and sampling chamber utilized is 
presented in Figure 2. 
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Figure 2.  Schematic Diagram of the Dust  
Generator and Sampling Chamber. 
 
 
Dust Generator 
 The dust generator was constructed of 3-inch nominal inner diameter PVC pipe 
and related components.  The main body of the dust generator consisted of a 33 cm long 
segment of pipe; the dust generator was configured with the main body oriented 
vertically.  Calculated dust generator internal volume is 1.5 liters.  A membrane 
consisting of consumer grade Glad® polyethylene food cling wrap was stretched across 
the bottom end of the pipe; a loudspeaker was located directly beneath the polyethylene 
membrane.  The loudspeaker was powered by a consumer type radio.  Nitrogen gas was 
38 
introduced at the bottom of the dust generator and flowed vertically out of the top of the 
dust generator into the sampling chamber.  The top of the dust generator consisted of a 
series of tapered plumbing fixtures culminating in a nozzle of a nominal five eights inch 
inner diameter PVC pipe.  Prior to the addition of pulverized bronopol the dust generator 
was purged with nitrogen gas for 10 minutes at 5 LPM. 
 In operation bronopol was placed directly on the membrane at the bottom of the 
dust generator and the loudspeaker was activated to vibrate the powder into the flowing 
nitrogen gas stream.  Nitrogen gas was flowed at a nominal 2.0 liters per minute. 
 Aside from introducing a bronopol aerosol into the moving nitrogen stream, the 
dust generator also functions as a vertical elutriator.  Subsequent to grinding with the 
mortar and pestle the bronopol is expected to be of a diverse particle size distribution.  In 
order to introduce only fine particulates into the sampling chamber, size selection is 
performed by maintaining nitrogen gas flow at a specific velocity through the dust 
generator.  With an inner diameter of 3 inches, the dust generator has an internal cross-
sectional area of 45.6 cm
2
.  Burton (1991) provides a method to calculate the average gas 
velocity (Vavg) through the dust generator as follows: 
 
 
  Vavg = Q/A        (4) 
 
 
In Equation 4 V is the average gas flow velocity, Q is the volumetric gas flow 
rate, and A is the cross-sectional area of the vessel through which the gas is flowing.  At a 
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nitrogen flow rate of 2 liters per minute the average vertical gas velocity through the dust 
generator is 0.365 cm/sec.  A gas flowing through a pipe will experience friction as it 
moves against the interior surfaces.  As a result gas flowing near the walls of the vessel 
will have a reduced velocity as compared with gas flowing nearer the center of the pipe 
(Burton, 1991).  The relationship between average gas flow velocity through the pipe 
(Vavg) and the gas velocity at the centerline of the pipe (Vcl) is described as follows: 
 
 
  Vavg = 0.9 x Vcl       (5) 
 
 
 The calculated maximum gas flow velocity at the centerline of the dust generator 
is 0.406 cm/sec. 
 In the dust generator, bronopol particles in the nitrogen gas stream will tend to 
move downward under the influence of gravity.  This motion is counteracted by the 
upward direction of travel of the nitrogen gas stream.  The settling velocity of a particle is 
determined by the physical size and density of the particle and the viscosity of the gas 
surrounding the particle.  The extent to which a particle will travel upward or fall 
downward in the flowing nitrogen is determined by the settling velocity of the particle.  
In this experiment particles with a settling velocity slower than the velocity of the gas 
stream in the dust generator will travel upward and be carried into the sampling chamber.  
The terminal settling velocity (Vts) of a particle is determined by the following 
relationship:
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  Vts = ρpda
2
g/18η       (6) 
 
 
 In Equation 6 ρp is the density of the particle, da is the aerodynamic diameter of 
the particle, g is the acceleration of gravity, and η is the viscosity of the gas in which the 
material is traveling (Reist, 1993).  Aerodynamic diameter is defined as the diameter of a 
sphere with a density of 1 gm/cm
3
 having the same aerodynamic characteristics as the 
particle of interest.  For bronopol (ρ of 1.1 gm/cm
3
) particles with a settling velocity 
equivalent to the average nitrogen upward velocity of 0.365 cm/sec have an aerodynamic 
diameter of 10.4 µm.  Particles with a settling velocity equivalent to the maximum 
nitrogen upward centerline velocity of 0.406 cm/sec have an aerodynamic diameter of 
11.0 µm.  Since the dust generator is tapered inward at the top, gas velocity will increase 
in this area.  The result is that particles of increasing da will travel with the gas stream.  
Therefore it is likely that the bronopol particles with a da of up to 11 µm will be entrained 
in the moving stream of nitrogen and will be introduced into the sampling chamber. 
 The PVC pipe nozzle at the terminal end of the dust generator is 1.98 cm
2
 in area.  
Using Equation 4 the nitrogen gas velocity as it exits the dust generator nozzle into the 
sampling chamber is 16.8 cm/sec (see Appendix A for all dust generator calculations). 
 
Sampling Chamber 
 The sampling chamber was constructed of stainless steel residential chimney 
tubing fitted with flat caps for the top and bottom.  The chamber has an internal diameter  
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of 24.8 cm and a height of 48.9 cm.  Calculated internal volume of the chamber is  
23.6 liters. 
Three sampling ports were located on the top of the sampling chamber in an 
equidistant fashion; the center of each sampler is 7.3 cm from the center of the chamber 
top.  The sampling ports were of the same approximate diameter as the samplers used.  
Each port was fitted with a rubber o-ring that sealed against the body of the sampler.  The 
bodies of the samplers were in contact with the sampling chamber, which provided an 
electrical bond.  The sampling chamber and dust generator were electrically bonded to 
each other and connected to an earth ground to minimize the influence of static charges 
on the airborne bronopol particulate. 
A small hole of approximately 1 cm diameter was centrally located on the top of 
the chamber to vent excess nitrogen flowing through the system.  The bottom of the 
sampling chamber was fitted with a rubber grommet of a suitable size to accept the dust 
generator terminal nozzle. 
 Nitrogen gas and entrained bronopol particulate exit the circular dust generator 
nozzle in the form of a jet at 16.8 cm/sec.  A jet will retain approximately 10 % of its 
initial velocity at 30 times the diameter of the jet exit (American Conference of 
Governmental Industrial Hygienists, Inc. [ACGIH], 1998).  With a jet diameter of  
1.59 cm the 10 % velocity boundary is at 30 x 1.59 cm = 47.7 cm away from the nozzle, 
very close to the 48.9 cm height of the chamber. 
 Nitrogen gas jet velocity at the top of the sampling chamber is 16.8 cm/sec x 0.1 
= 1.7 cm/sec.  The lowest sampler flow rate used in the experiments was approximately 
300 ml/min.  With a filter of 25 mm diameter the calculated filter face velocity at the 
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lowest flow rate used is approximately 1 cm/sec.  The nitrogen gas jet velocity at the top 
of the chamber is greater than the maximum velocity through the dust generator; 
therefore, the entire size range of bronopol particles introduced into the chamber should 
be available in the vicinity of the samplers.  Ignoring the dynamics of the nitrogen jet 
flow within the chamber the average nitrogen gas velocity through the chamber is  
0.069 cm/sec at 2 LPM flow.  Particles with a settling velocity equivalent to the average 
nitrogen upward velocity of 0.069 cm/sec have an aerodynamic diameter of 4.5 µm.  
Bronopol particles with a da larger than 4.5 µm will likely settle out to the floor of the 
chamber interior unless captured by the samplers on the first pass. 
 For experimental sampling events nitrogen flow through the chamber was 2 LPM.  
Sampler flow rates ranged between 300 to 600 ml/min.  Total flow volume for the three 
samplers ranged from 0.9 LPM to 1.8 LPM; consequently, excess nitrogen flow through 
the chamber ranged from 0.2 LPM to 1.1 LPM. 
 A NIOSH (1973) publication indicated that the spread angle of a circular 
unbounded jet gas stream is approximately 22 degrees.  The nitrogen gas stream entering 
the sampling chamber from the dust generator enters the chamber at 16.8 cm/sec and 
flows upward toward the samplers; at the top of the chamber the jet has spread to a 
diameter of 19.8 cm based on the 22° expansion.  The samplers are arranged equidistantly 
in a circle around the top of the chamber; the outer diameter of the circle formed by the 
samplers is 17.1 cm (see Appendix B for all sampling chamber calculations).  Based on 
these calculations, the samplers are completely enclosed within the nitrogen gas stream 
from the dust generator.  Other sources (Burton, 1999) reference spread angles for jets of 
upwards of 28°.
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Sampling Equipment 
SKC Inc. brand Button Aerosol Samplers were used to hold the sampling filters, 
part number 225-360.  These samplers are designed to sample inhalable particulate when 
used at 4 LPM; in these experiments the airflow rates used were lower than the rate 
specified for the sampler.  The sampler is provided with a stainless steel back up screen 
for the filter.  These samplers are of metal construction and provide electrical 
conductivity, ease of assembly/disassembly, and ease of cleaning. 
Air sampling pumps were SKC Inc. brand AirChek Sampler model number 224-
PCXR7.  For low-flow sample collection at rates less than 0.4 liters per minute, a Gillian 
Instrument Corporation brand triple critical orifice manifold part number THK-TVM-200 
was used with a single sampling pump. 
 
Laboratory Methods 
Examination of Chromophore Development 
Analytical reference solution.  All bronopol samples were analyzed using a 
sodium hydroxide/glycerin blank as a reference.  The quantities of constituents in the 
blank solution are identical with the quantities in an analyte solution or with the 
quantities present on a treated glass fiber filter with the exception that no bronopol is 
added. 
 
Verification of absorbance maximum.  Sanyal et al. (1996) report an absorbance 
maximum for derivatized bronopol of 244 nm.  To evaluate this, a 9.94 µg/ml bronopol 
solution was derivatized using the standard methods previously described.  A second 
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solution of 9.94 µg/ml bronopol was formulated in spectrophotometric grade water 
containing only glycerin in the same concentration as when the derivatizing agent is used.  
Appropriate blank solutions were prepared to provide analytical references.  
Spectrophotometric scans were obtained to verify the absorbance maximum and to 
evaluate any potentially interfering peaks. 
A wavelength scan of the non-derivatized bronopol solution was obtained through 
the range of 900 to 200 nm at a rate of 500 nm/min; this represents the working limit of 
the spectrophotometer used.  A second scan of the non-derivatized bronopol solution was 
made to focus on the region of interest from 320 to 230 nm, again at a rate of  
500 nm/min.  Finally, a scan of the derivatized bronopol solution was made from 320 to 
230 nm at a rate of 500 nm/min.  All scans were recorded graphically using an Epsom 
LX-800 dot-matrix printer. 
Additionally, absorbance readings for a derivatized 10.11 µg/ml bronopol solution 
versus a blank solution were recorded manually in the range of 248 to 236 nm.  
Absorbance values were recorded in one-nanometer increments. 
 
Chromophore development with time.  The absorbance of a derivatized bronopol 
solution of 10.10 µg/ml bronopol was recorded at one minute after mixing; absorbance 
readings were then obtained every five minutes thereafter for a total of one hour.  Sanyal 
et al. (1996) reported the reaction to be essentially instantaneous. 
 
Concentration of sodium hydroxide.  The effect of varying the sodium hydroxide 
concentration on the absorbance of the analyte was determined.  One mole of sodium 
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hydroxide is needed to react with one mole of bronopol.  Bronopol was added to sodium 
hydroxide concentrations of 0.005, 0.01, 0.02, 0.04, 0.1, 0.2, 0.3, and 0.4 molar; final 
bronopol concentration in solution was 10.18 µg/ml.  Absorbance at 244 nm was 
recorded for each solution. 
 
Calibration Curve 
 A calibration curve for derivatized bronopol was developed.  The range of 
bronopol concentrations in solution was 1 to 25 µg/ml in an approximation of the linear 
range described by Sanyal et al. (1996).  Nine different concentrations of bronopol were 
targeted in formulating the calibration curve solutions: 1, 2, 4, 6, 8, 10, 15, 20, and  
25 µg/ml.  Six solutions of each concentration were developed and analyzed at 244 nm. 
 
Preparation and Use of Glass Fiber Filters 
Treatment of glass fiber filters with derivatizing agent.  Glass fiber filters were 
treated with a derivatizing solution consisting of sodium hydroxide and glycerin in 
aqueous solution.  Sodium hydroxide is the derivatizing agent as described in Sanyal et 
al. (1996); the reaction of sodium hydroxide with bronopol in an aqueous environment 
yields bromonitroethanol, which is a stable chromophore. 
 OSHA (1995) Method ID-214 for ozone utilizes glass fiber filters impregnated 
with derivatizing agents and glycerin.  Glycerin is hygroscopic and functions as a 
humectant (Hawley, 1981) on the surface of the glass fibers comprising the filters in the 
ID-214 ozone sampling method. 
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Glycerin was incorporated on the surface of the glass fiber filters in the current 
experiment; glycerin quantity used per filter (4 µl) was the same as the ID-214 method.  
The reaction of bronopol with sodium hydroxide takes place in an aqueous media.  The 
highly hydroscopic glycerin on the glass fiber filter surface sequesters ambient 
atmospheric water, providing an appropriate medium for the reaction.  Glycerin was 
applied to filters in this experiment in the same quantity as in the OSHA (1995) ozone 
method. 
 The reported linear range of the Sanyal et al. (1996) method is 5 to 25 µg/ml of 
bronopol.  In this experiment filters are extracted in 5 ml of water; therefore, the 
maximum bronopol loading desired on each filter is 125 µg.  Bronopol has a molecular 
weight of 199.99 gm/mol; 125 µg of bronopol is 6.25 x 10
-7
 mol. 
 The 50 weight percent sodium hydroxide reagent used in this experiment has a 
concentration of approximately 19 molar.  The filter treatment solution used in this 
experiment consists of 2.0 ml of 50 weight percent NaOH and 1.0 ml of glycerin; final 
volume in aqueous solution is 50 ml.  A 0.2 ml aliquot of the filter treatment solution is 
applied to each filter.  This results in a 240-fold molar excess of sodium hydroxide to 
bronopol at the maximum desired filter loading.  A large molar excess of sodium 
hydroxide is desirable to move the reaction equilibrium strongly toward the formation of 
bromonitroethanol (see Appendix C for all glass fiber filter treatment calculations). 
 Filters to be treated were placed on a clean glass surface.  A 0.2 ml aliquot of the 
filter treatment solution was added to each filter while ensuring that the filter was 
thoroughly wetted over the entire surface.  Filters were allowed to air dry under ambient 
laboratory conditions for approximately two hours prior to use. 
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Filter spiking.  Treated glass fiber filters were spiked with aqueous bronopol 
solutions of known concentration; the filters were manually spiked using a microsyringe 
while holding the filter with a pair of forceps.  Each filter received 40 µl of bronopol 
solution in concentrations ranging from 0.48 to 2.8 mg/ml.  The filter spike volume of  
40 µl was chosen since it saturates only a portion of the filter surface; this allows the 
filter to be held at the dry edge of the filter without the spike solution contacting the 
forceps.  This minimizes the loss of bronopol spiked onto the filters.  Following spiking 
the filters were allowed to air-dry prior to extraction and analysis at 244 nm. 
 Spiked filters were grouped into low, medium, or high bronopol loading sets.  
Filters in the low group were spiked with approximately 19 µg bronopol, in the medium 
group approximately 44 µg bronopol, and in the high group approximately 113 µg 
bronopol.  Ten filters were spiked in each of the three sets.  Following extraction in  
5.0 ml spectrophotometric grade water the final bronopol concentrations in solution were 
3.8, 8.8, or 22.6 µg/ml. 
 
Filter extraction procedures.  Glass fiber filters containing bronopol were placed 
in glass screw cap 16 mm by 125 mm culture tubes and 5.0 ml of spectrophotometric 
grade water was added.  Each tube and filter was placed in an ultrasonic bath for  
5 minutes followed by gentle shaking.  Since glass is strongly absorbing in the ultraviolet 
region, any glass fibers released from filters will be present in the filter extract solution 
and will create an interference with the spectrophotometric analytical method.  Therefore, 
extract solutions were filtered through a syringe filter prior to placement into a cuvette for 
spectrophotometric analysis. 
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 PVDF filters containing bronopol were placed in a culture tube containing 4.8 ml 
of spectrophotometric grade water and 0.2 ml of filter treatment solution.  From this point 
forward extraction procedures for PVDF filters were identical to that for glass fiber 
filters. 
 
Filter blank count.  Treated glass fiber filters with no bronopol were extracted and 
analyzed using the techniques previously described.  GFF extract solutions were drawn 
through a syringe filter prior to analysis.  Twelve blank values were obtained in this 
manner. 
 
Chamber Verification and Chamber Sampling 
Preparation of the sampling chamber for experimental trials.  Prior to activation 
of the dust generator, nitrogen was allowed to flow through the chamber at 5 LPM for 50 
minutes to purge water vapor and oxygen.  Following this, nitrogen gas flow was reduced 
to 2 LPM and the dust generator was activated.  The dust generator and sampling 
chamber were allowed to equilibrate for 2 hours prior to initiation of sampling. 
 
Chamber sampling procedures.  In general three chamber runs were performed 
sequentially with each chamber run generating 3 samples.  Between sampling runs the 
nitrogen flow of 2 LPM was maintained and the dust generator loudspeaker was 
operating.  Following the conclusion of sampling the dust generator and chamber were 
rinsed with tap water and air-dried. 
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Distribution of bronopol particulate concentration in the sampling chamber.  To 
verify consistent presentation of the bronopol aerosol to the chamber samplers, inert 
PVDF filters were used to collect samples from the chamber for several trials.  A total of 
nine chamber particulate concentration distribution runs were performed, generating a 
total of twenty-seven samples.  Each sampling event lasted 20 minutes.  Sampling at 
different filter flow rates varied the quantity of bronopol collected on the filters; flow 
rates used were 300, 450, and 600 ml/min.  The filters were extracted in a derivatizing 
solution and analyzed for bronopol. 
 
Sampling of generated bronopol atmospheres.  For sampling of bronopol 
particulate in the chamber, one inert PVDF filter and two treated glass fiber filters were 
used simultaneously.  Each sampling event lasted 20 minutes.  Sampling at different filter 
flow rates varied the quantity of bronopol collected on the filters. 
One sampling trial was performed at 300 ml/min filter flow rate, one trial was 
performed at 450 ml/min, and one trial was performed at 600 ml/min; each sampling trial 
consisted of three chamber runs.  In all this generated eighteen bronopol samples 
collected on treated glass fiber filters.  The analytical results from the treated glass fiber 
filters were compared against the nine inert PVDF filters that were sampled concurrently. 
 
Sample Storage Stability 
Derivatized bronopol solutions.  Aqueous bronopol was spiked onto 18 treated 
glass fiber filters; the filters were allowed to air dry.  Six filters were spiked with 25 µg 
bronopol, six with 60 µg bronopol, and six with 125 µg bronopol.  The filters were 
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extracted and analyzed on the same day.  The solutions from day one were stored and 
analyzed after fourteen days.  All stored samples were kept in a laboratory cabinet under 
ambient laboratory conditions in glass screw cap 16 mm by 125 mm culture tubes. 
 
Bronopol on treated glass fiber filters.  Aqueous bronopol was spiked onto 36 
treated glass fiber filters; the filters were allowed to air dry.  Twelve filters were spiked 
with 25 µg bronopol, twelve with 60 µg bronopol, and twelve with 125 µg bronopol.  Six 
of each set were extracted and analyzed on the same day; six of each set were extracted 
and analyzed after forty-eight hours. 
 
Data Evaluation 
Examination of Chromophore Development 
Absorbance spectrum.  Spectral curves of a 9.94 µg/ml non-derivatized bronopol 
solution was obtained in the range of 900 to 200 nm and 320 to 230 nm and recorded 
graphically.  A derivatized bronopol solution of the same concentration was scanned 
from 320 to 230 nm.  Absorbance in the 244 nm range was noted and compared against 
the absorbance maximum of 244 nm as reported by Sanyal et al. (1996).  Observations 
were made of any potentially interfering peaks in the region of interest. 
 
Verification of absorbance maximum.  The absorbance for a derivatized  
10.11 µg/ml bronopol solution was compared against the 244 nm maximum as reported 
by Sanyal et al. (1996). 
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Chromophore development with time.  The 244 nm absorbance of a 10.10 µg/ml 
derivatized bronopol solution was read at 1 minute and 5 minutes following addition of 
the derivatizing agent, and then every 5 minutes thereafter for a total of one hour.  
Absorbance read at each 5-minute interval was compared with the 1-minute value.  
Average, standard deviation, and percent coefficient of variation (CV %) analysis were 
obtained. 
 
 Concentration of sodium hydroxide.  The 244 nm absorbance values of  
10.18 µg/ml bronopol solutions were obtained at 0.005, 0.01, 0.02, 0.04, 0.2, 0.3, and  
0.4 molar sodium hydroxide concentrations.  These values were compared against the 
absorbance of bronopol in 0.1 molar sodium hydroxide.  The sodium hydroxide 
concentration used in the Sanyal et al. (1996) work was 0.1 molar.  Average, standard 
deviation, and percent coefficient of variation analysis were obtained. 
 
Calibration Curve 
Regression analysis.  Regression analysis was performed using the Microsoft 
Excel data analysis tools, including a least-squares graph of the regression line.  The 
abscissa of the graph is the derivatized bronopol concentration in µg/ml of the solution 
analyzed.  The ordinate is detector response in Absorbance units.  The calculated 
coefficient of determination value R
2
 for the regression line is reported. 
 The equation of the calibration curve as determined by regression analysis is used 
to predict absorbance values for comparison in subsequent experimental trials to include 
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filter spiking, chamber particulate concentration distribution trials, chamber sampling 
trials, and sample storage stability studies. 
 
Molar absorption coefficient.  The molar absorption coefficient of derivatized 
bronopol was calculated for each calibration curve data point.  Values obtained were 
compared against the value of 8330 liter/cm mol as reported by Sanyal et al. (1996).  No 
data or statistical information was available in the Sanyal article for calculation of the 
reported molar absorbtivity.  Lacking this, no statistical comparison was made of the 
molar absorption coefficient determined in this work versus the value reported in the 
literature. 
For molar absorbtivity data generated by this work, average, standard deviation, 
and percent coefficient of variation analysis were obtained.  To determine if the molar 
absorption coefficient varies with the concentration of derivatized bronopol in solution, 
analysis of variance was performed among the different concentration levels.  If the 
molar absorption coefficient changes with concentration, then the analysis of variance 
test should show that the means of the data sets of the various concentrations are 
different.  Analysis of variance was performed using the Microsoft Excel ANOVA data 
analysis tool with α = 0.05. 
 
Limit of detection.  NIOSH (1995) describes a method for calculating the 
instrumental limit of detection (LOD) using low-level calibration standards.  The 
procedure uses calibration standard concentrations ranging from less than the anticipated 
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limit of detection to no more than ten times the expected LOD.  The standard error of the 
regression for these calibration standards is first calculated using Equation 7. 
 
 
  sy = [∑(ŷi – yi)
2
/(N – 2)]
1/2
       (7) 
 
 
 In Equation 7 sy is the standard error of the regression, ŷi is the predicted detector 
response for a given analyte mass as calculated from the regression equation, yi is the 
actual detector response at each given analyte mass, and N is the number of calibration 
points used in the sy calculation.  For this work, calibration standards with a concentration 
of 10 µg/ml or less bronopol were used in the calculation of sy. 
The LOD is then calculated using standard error of the regression sy and the slope 
of the regression equation m as shown in Equation 8. 
 
 
  LOD = 3 sy/m        (8) 
 
 
 The instrumental LOD to be used for the analytical method should then be the 
highest of the following three alternatives:  (a) the calculated LOD, (b) the lowest 
concentration calibration standard, or (c) the X-intercept if the regression equation has a 
negative Y-intercept. 
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Limit of quantitation.  The instrumental limit of quantitation (LOQ) is calculated 
using Equation 9 (NIOSH, 1995). 
 
 
  LOQ = 3.33 x LOD       (9) 
 
 
Analytical Recovery 
Filter blank count.  Treated glass fiber filters with no bronopol were extracted and 
analyzed.  Filter extract solutions were drawn through a syringe filter prior to analysis.  
Twelve blank values were obtained in this manner.  The average filter blank count was 
calculated. 
 All glass fiber filters and PVDF filters were extracted using the syringe filters.  
The adjusted absorbance reading obtained from a bronopol-bearing GFF or PVDF filter is 
the actual absorbance measurement read from the filter extract minus the filter blank 
count. 
 
Filter spiking.  Treated glass fiber filters were spiked with aqueous bronopol 
solutions then evaluated for analytical recovery by comparing the adjusted absorbance 
reading obtained (i.e., actual absorbance read minus filter blank count) versus that 
calculated from the bronopol spike quantity.  Bronopol spike quantities were selected to 
approximate the linear range of the analytical method.  Three sets of ten each treated 
filters were spiked with 19, 44, or 113 µg bronopol. 
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Filters were evaluated for recovery efficiency as the adjusted absorbance value 
versus the quantity of bronopol spiked onto the filter.  Intra-set data values were 
evaluated for outliers using the Q-test at a 95 % confidence level; the variances of the two 
data sets were then compared for consistency using the F-test.  One-sided F-test analysis 
was performed with Microsoft Excel using the data analysis tools with α = 0.05. 
A cumulative pooled CV was obtained for all filter-spiking trials.  NIOSH (1995) 
specifies that spiked filter recovery should be at least 75 %.  The Q-test for outliers was 
performed using Equation 10; pooled coefficient of variation for the filter spiking sets is 
calculated using Equation 11. 
 
 
  Q = Gap/Range       (10) 
 
 
 A data set to be analyzed for outliers using the Q-test is arranged in increasing 
numerical order.  In Equation 10, Q is the calculated test value and Range is the 
difference between the lowest and highest data point.  Gap is the difference between the 
lowest value and its next lowest value, or the highest value and its next lower value; 
whichever difference is numerically greater.  The calculated Q value from the data in 
question is then compared against a table of critical values; different critical Q values are 
indicated for data sets containing between 3 and 10 data points.  Data points with a 
calculated Q value in excess of the critical Q value are rejected as outliers (Shoemaker, 
Garland, & Steinfield, 1974).
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  Sr = [∑fi{CVi}
2
/f]
1/2
       (11) 
 
 
 In Equation 11, Sr is the pooled coefficient of variation, fi is the degrees of 
freedom for each spike set equal to n-1, CVi is the coefficient of variation for each filter 
spiking set, and f is the sum of the degrees of freedom for all of the CVs included in the 
calculation. 
 
Distribution of Bronopol Particulate Concentration in the Sampling Chamber 
Pump flow calibration.  Ten each pump flow measurements were made for both 
the pre- and post-calibration of sampling pumps.  Pump calibration sets were analyzed for 
within set and between set variations for each calibration series.  Pump calibration was 
deemed acceptable if all data points in both pre- and post-calibration sets were within  
5 % of each other and if the averages of the pre-and post-calibration sets were within 5 % 
of each other (NIOSH, 1995). 
 
Chamber flow calibration.  Ten each chamber nitrogen flow measurements were 
made for both the pre- and post-calibration.  Chamber flow calibration sets were analyzed 
for within set and between set variations for each calibration series.  Chamber calibration 
was deemed acceptable if all data points in both pre- and post-calibration sets were within 
5 % of each other and if the averages of the pre-and post-calibration sets were within 5 % 
of each other.  Chamber flow calibration is important to assure proper particle size 
selection in the dust generator. 
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Chamber particulate distribution runs.  Bronopol collected on PVDF filters was 
extracted in a derivatizing solution and analyzed.  Intra-set data values were evaluated for 
outliers using the Q-test at a 95 % confidence level.  The three filters from each chamber 
run were compared for consistency via coefficient of variation analysis.  Pooled CV was 
obtained for all chamber particulate concentration distribution trials. 
 
Sampling of Generated Bronopol Atmospheres 
Pump and chamber flow calibration.  Pump and chamber flow calibration during 
bronopol sampling were accomplished in the same manner as for the chamber particulate 
concentration distribution trials. 
 
Sampling and analytical recovery.  For each individual chamber run two treated 
glass fiber filters and one PVDF filter were used.  Intra-set data values were evaluated for 
outliers using the Q-test at a 95 % confidence level.  Each individual GFF value was 
compared against the concurrent PVDF filter value and expressed as percent recovery, 
with the PVDF value as 100 % recovery.  Intra-set values were compared for consistency 
via coefficient of variation analysis.  Pooled CV was obtained for all sampling of 
generated bronopol atmosphere trials. 
 
Overall Sampling and Analytical Method 
Calculation of airborne bronopol concentration.  The adjusted absorbance is 
obtained by subtracting the filter blank count from the absorbance reading obtained from 
a derivatized and extracted filter.  The bronopol mass concentration in the filter extract 
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solution may then be obtained using the linear regression equation.  Once the mass of 
bronopol present on the filter is known, the airborne bronopol concentration may then be 
calculated in terms of mass per unit volume 
 
Sample Storage Stability 
Derivatized bronopol solutions.  The value of each of the derivatized filter extract 
solutions on day fourteen was compared against the respective value read on day one.  
Intra-set data values were evaluated for outliers using the Q-test at a 95 % confidence 
level; the variances of the two data sets were then compared for consistency using the F-
test.  One-sided F-test analysis was performed with Microsoft Excel using the data 
analysis tools with α = 0.05.  Coefficient of variation analysis was performed for filter 
sets at each spike loading level; a change of 10 % or less was considered acceptable 
(NIOSH, 1995). 
 
Bronopol on treated glass fiber filters.  Average values for spiked filters extracted 
and analyzed on the day of formulation were compared against average values for filters 
extracted and analyzed after forty-eight hours.  Intra-set data values were evaluated for 
outliers using the Q-test at a 95 % confidence level; the variances of the two data sets 
were then compared for consistency using the F-test.  One-sided F-test analysis was 
performed with Microsoft Excel using the data analysis tools with α = 0.05.  
Coefficient of variation analysis was performed for filter sets at each spike loading level; 
a change of 10 % or less was considered acceptable (NIOSH, 1995). 
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Chapter Four - Results And Data Analysis 
Examination of Chromophore Development 
Absorbance Spectrum 
 The spectral curve of three 9.94 µg/ml bronopol solutions were obtained and 
recorded graphically.  One curve for non-derivatized bronopol in water was obtained in 
the range of 900 to 200 nm; water was used as a reference for this scan.  No strong 
absorbance bands are observed in the scanned region.  This curve is presented in  
Figure 3. 
Two curves were obtained in the range of 320 to 230 nm.  Figure 4 shows the 
results of the scan of non-derivatized bronopol versus a water reference.  No strong 
absorbance bands are observed in the scanned region.  Figure 5 shows the result of 
derivatized bronopol versus a reference solution containing the derivatizing agent.  The 
absorbance band centered at approximately 244 nm is in agreement with the absorbance 
maximum of 244 nm as reported by Sanyal et al. (1996). 
 
Verification of Absorbance Maximum 
Absorbance readings for a derivatized 10.11 µg/ml bronopol solution were 
obtained manually in one nm increments from 248 to 236 nm.  Results of this analysis are 
presented in Table 7. 
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 The absorbance was compared against the 244 nm maximum as reported by 
Sanyal et al. (1996).  The maximum absorbance value for the derivatized 10.11 µg/ml 
bronopol solution was obtained at 244 nm, in agreement with the published value. 
 
_______________________________________________________________________ 
 
_______________________________________________________________________ 
Figure 3.  Spectrophotometric Scan of Non-Derivatized Bronopol, Full Range. 
Concentration 9.94 µg/ml, scan range 900 to 200 nm.
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_______________________________________________________________________ 
 
_______________________________________________________________________ 
Figure 4.  Spectrophotometric Scan of Non-Derivatized Bronopol, Limited Range. 
Concentration 9.94 µg/ml, scan range 320 to 230 nm. 
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_______________________________________________________________________ 
 
_______________________________________________________________________ 
Figure 5.  Spectrophotometric Scan of Derivatized Bronopol, Limited Range. 
Concentration 9.94 µg/ml, scan range 320 to 230 nm.  Bronopol derivatized with sodium 
hydroxide at a final NaOH concentration of 0.03 molar. 
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Table 7 
Evaluation of the Absorbance Maximum of Derivatized Bronopol 
Wavelength 
(nm) 
Absorbance Value 
 
248 0.421 
247 0.424 
246 0.426 
245 0.428 
244 0.433 
243 0.431 
242 0.431 
241 0.430 
240 0.430 
239 0.429 
238 0.428 
237 0.425 
236 0.421 
Note.  Bronopol concentration in solution 10.11 µg/ml.  
Underlined entries represent detected absorbance at the 
wavelength used by Sanyal et al. (1996). 
 
 
Chromophore Development with Time 
The 244 nm absorbance of a 10.10 µg/ml derivatized bronopol solution was read 
at 1 minute and 5 minutes following addition of the derivatizing agent, and then every  
5 minutes thereafter for a total of one hour.  Absorbance read at each 5-minute interval 
was compared with the 1-minute value.  Results of this analysis are presented in Table 8. 
Sanyal et al. (1996) reported the reaction to be essentially instantaneous.  The data 
in Table 8 shows essentially no change in the absorbance value over the 60-minute 
period, with a calculated coefficient of variation of ca. 0.2 % for the data set. 
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Table 8 
Development of Derivatized Bronopol Chromophore with Time 
Elapsed Time after Formulation 
(minutes) 
Absorbance Value 
 
1 0.434 
5 0.433 
10 0.433 
15 0.432 
20 0.431 
25 0.433 
30 0.433 
35 0.432 
40 0.432 
45 0.431 
50 0.432 
55 0.432 
60 0.431 
 Average 0.432 
 Standard Deviation 0.0009 
 Coefficient of Variation % 0.21 % 
Note.  Bronopol concentration in solution 10.11 µg/ml. 
 
 
Concentration of Sodium Hydroxide 
 The 244 nm absorbance values of 10.18 µg/ml bronopol solutions were obtained 
for 0.005, 0.01, 0.02, 0.04, 0.2, 0.3, and 0.4 molar sodium hydroxide concentrations.  
These values were compared against the absorbance of bronopol in 0.1 molar sodium 
hydroxide as used in the Sanyal et al. (1996) work.  Results are presented in Table 9. 
 The data in Table 9 shows little change in the absorbance value over the range of 
sodium hydroxide concentrations, with a calculated coefficient of variation of ca. 0.6 % 
for the data set. 
 The filter treatment process deposits 0.00015 mole of sodium hydroxide on each 
glass fiber filter; following the extraction of the filter in 5.0 ml water the sodium 
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hydroxide concentration in solution is 0.03 molar.  Although this is only 30 % of the 
sodium hydroxide concentration used in Sanyal et al. (1996), the molar quantity of 
sodium hydroxide on each filter is still 240 times the desired molar quantity of bronopol 
per filter; this should be well within the concentration needed to drive the derivatizing 
reaction equilibrium towards completion. 
 
Table 9 
Development of Bronopol Chromophore 
with Change in Sodium Hydroxide Concentration 
Sodium Hydroxide Concentration 
(Molar) 
Absorbance Value 
 
0.005 0.441 
0.01 0.439 
0.02 0.444 
0.04 0.443 
0.1 0.442 
0.2 0.438 
0.3 0.437 
0.4 0.439 
 Average 0.440 
 Standard Deviation 0.003 
 Coefficient of Variation % 0.57 % 
Note.  Bronopol concentration in solution 10.18 µg/ml.  
Underlined entries represent detected absorbance at the sodium 
hydroxide concentration used by Sanyal et al. (1996). 
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Calibration Curve 
Regression Analysis 
 The calculated equation of the least-squares regression line is shown in  
Equation 12, where Y is the absorbance of the derivatized bronopol solution and X is the 
derivatized bronopol concentration in µg/ml solution. 
 
 
  Y = 0.0435X – 0.0015      (12) 
 
 
 A representation of the calibration curve for derivatized bronopol is presented in 
Figure 5.  The bronopol mass portion (µg) as part of the concentration (µg/ml) in solution 
represents the bronopol mass prior to the derivitization reaction with sodium hydroxide.  
The calculated coefficient of determination value R
2
 for the regression line is 0.9996.  
Calibration curve data and regression analysis information are presented in Appendix D. 
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_______________________________________________________________________ 
Derivatized Bronopol Calibration Curve
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Figure 5.  Calibration Curve for Derivatized Bronopol.  N = 6 at each concentration.  
Bronopol derivatized with sodium hydroxide at a final NaOH concentration of 0.03 
molar; concentration indicated is for bronopol prior to derivitization. 
 
 
Molar Absorption Coefficient 
 The molar absorption coefficient of derivatized bronopol was calculated for each 
calibration curve data point.  The average molar absorption coefficient obtained from the 
calibration curve data is 8,660 liter/cm mol with a calculated coefficient of variation of 
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ca. 2.0 % for the data set.  A value of 8,330 liter/cm mol was reported by Sanyal et al. 
(1996). 
 The ANOVA analysis of the molar absorption coefficient information does not 
indicate a different mean for each bronopol concentration level.  This demonstrates that 
the conversion rate of bronopol to bromonitroethanol upon addition of sodium hydroxide 
is not dependent on bronopol concentration in the concentration range studied.  Molar 
absorption coefficient data and calculations are presented in Appendix D. 
 
Limit of Detection 
 The most appropriate instrumental limit of detection (LOD) is the highest of the 
following three procedures:  (a) the LOD calculated using Equation 7 and Equation 8, 
(b) the lowest concentration calibration standard, or  (c) the X-intercept if the equation of 
the least-squares regression line for an analytical method has a negative Y-intercept 
(NIOSH, 1995). 
 For option (a), the limit of detection calculated using the low-level calibration 
standards is 0.31 µg/ml.  For option (b), the lowest calibration curve standards used in 
this work were 1 µg/ml.  For option (c), the regression line does have a negative Y 
intercept of  -0.0015.  The X intercept of the regression line is calculated using the 
regression line by setting Y = 0; the calculated X intercept is then 0.034 µg/ml. 
 The highest value of the three methods is the low concentration calibration 
standard used at 1 µg/ml; this option (b) result is the appropriate limit of detection to use 
for this work.  Limit of detection data and calculations are presented in Appendix D. 
 69
Limit of Quantitation 
 The instrumental limit of quantitation (LOQ) is calculated using Equation 9 
(NIOSH, 1995).  Since the LOD for this work was determined to be 1 µg/ml, the 
calculated instrumental LOQ is then 3.33 µg/ml.  The limit of quantitation calculation is 
presented in Appendix D. 
 
Analytical Recovery 
Filter Blank Count 
 Treated glass fiber filters with no bronopol were extracted and analyzed.  Filter 
extract solutions were drawn through a syringe filter prior to analysis.  Twelve blank 
values were obtained in this manner.  The average filter blank count obtained was  
0.015 absorbance units.  Filter blank count data and calculations are presented in 
Appendix E. 
 
Filter Spiking 
 Treated glass fiber filters were spiked with aqueous bronopol solutions then 
evaluated for analytical recovery by comparing the actual absorbance reading obtained 
(minus filter blank count) versus that calculated from the bronopol spike quantity.  Three 
sets of ten each treated filters were spiked with 19, 44, or 113 µg bronopol. 
 No filter spiking data points were rejected as outliers.  F-test analysis of intra-set 
data values did not indicate a different mean for the filter spiking sets, demonstrating that 
same-concentration filters spiked on different days yielded similar recoveries. 
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 Recovery data is summarized in Table 10.  Recovery efficiency for the low, 
medium, and high range filter spiking sets ranged from 94.5 % to 96.8 %, with an overall 
recovery of 95.7 %.  NIOSH (1995) specifies that spiked filter recovery should be at least 
75 %. 
 Pooled coefficient of variation for the low, medium, and high range filter spiking 
sets was 2.02 %, 1.05 %, and 1.31 %, respectively, with an overall pooled coefficient of 
variation for the spiked filter sets of 1.52 %.  Filter spiking data and calculations are 
presented in Appendix E. 
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Table 10 
Summary of Bronopol Recovery from Treated Glass Fiber Filters 
LOW RANGE FILTERS 
Set No. 1, filter spike quantity 19.04 µg bronopol. 
Filter Recovery Average 95.4 % 
Standard Deviation 2.18 
Coefficient of Variation % 2.28 % 
Set No. 2, filter spike quantity 19.00 µg bronopol. 
Filter Recovery Average 98.2 % 
Standard Deviation 1.69 
Coefficient of Variation % 1.73 % 
Combined Average Filter Recovery - Low 96.8 % 
 
 
MEDIUM RANGE FILTERS 
Set No. 1, filter spike quantity 43.04 µg bronopol. 
Filter Recovery Average 92.1 % 
Standard Deviation 1.12 
Coefficient of Variation % 1.21 % 
Set No. 2, filter spike quantity 44.16 µg bronopol. 
Filter Recovery Average 96.8 % 
Standard Deviation 0.84 
Coefficient of Variation % 0.87 % 
Combined Average Filter Recovery - Medium 94.5 % 
 
 
HIGH RANGE FILTERS 
Set No. 1, filter spike quantity 113.24 µg bronopol. 
Filter Recovery Average 94.0 % 
Standard Deviation 1.31 
Coefficient of Variation % 1.39 % 
Set No. 2, filter spike quantity 113.12 µg bronopol. 
Filter Recovery Average 97.3 % 
Standard Deviation 1.20 
Coefficient of Variation % 1.23 % 
Combined Average Filter Recovery - High 95.7 % 
Note:  N = 5 for each for each filter spike set, a total of 30 filters spiked 
and analyzed.  Each filter extracted in 5.0 ml spectrophotometric grade 
water. 
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Distribution of Bronopol Particulate Concentration in the Sampling Chamber 
 Inert PVDF filters were used to collect samples from the chamber for several 
trials.  A total of nine chamber particulate concentration distribution runs were 
performed, generating a total of twenty-seven samples.  The quantity of bronopol 
collected on the filters was varied by sampling at different filter flow rates.  Flow rates 
used were 300, 450, and 600 ml/min and were designated as the Low, Medium, and High 
Ranges, with three sets per filter flow rate.  The filters were extracted in a derivatizing 
solution and analyzed for bronopol at 244 nm. 
 
 Chamber particulate distribution runs.  Chamber particulate concentration 
distribution data is summarized in Table 11.  Overall airborne bronopol concentration for 
the low, medium, and high range chamber particulate distribution sets ranged from  
12.31 mg/m
3
 to 19.67 mg/m
3
.  No chamber particulate concentration distribution data 
points were rejected as outliers.  Pooled coefficients of variation for the low, medium, 
and high range chamber particulate distribution sets were 3.32 %, 3.16 %, and 3.01 % 
respectively, with an overall pooled coefficient of variation of 3.17 % for all nine 
chamber particulate concentration distribution sets. 
 
 Pump and chamber flow calibration.  Pre- and post-calibration of sampling 
pumps agreed within the 5 % variance allowed by NIOSH (1995), as did the chamber 
flow calibration sets.  Chamber particulate concentration distribution data and 
calculations are presented in Appendix F. 
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Table 11 
Summary of Chamber Distribution of Bronopol Particulate Concentration Results 
LOW RANGE SETS – 300 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 19.67 
 Standard Deviation 0.63 
 Coefficient of Variation % 3.21 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 14.68 
 Standard Deviation 0.14 
 Coefficient of Variation % 0.95 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 12.31 
 Standard Deviation 0.57 
 Coefficient of Variation % 4.68 % 
 
 
  
MEDIUM RANGE SETS – 450 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 19.11 
 Standard Deviation 0.36 
 Coefficient of Variation % 1.90 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 18.17 
 Standard Deviation 0.72 
 Coefficient of Variation % 3.98 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 14.42 
 Standard Deviation 0.46 
 Coefficient of Variation % 3.23 % 
 
 
  
HIGH RANGE SETS – 600 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 18.74 
 Standard Deviation 0.13 
 Coefficient of Variation % 0.71 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 16.65 
 Standard Deviation 0.79 
 Coefficient of Variation % 4.75 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 12.80 
 Standard Deviation 0.26 
 Coefficient of Variation % 2.03 % 
Note:  N = 3 for each for each chamber particulate concentration distribution 
set, total of 27 PVDF filters sampled and analyzed.  Mg/m
3
 is the calculated 
bronopol concentration expressed as milligrams per cubic meter of air. 
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Sampling of Generated Bronopol Atmospheres 
 For sampling of bronopol particulate in the chamber, one inert PVDF filter and 
two treated glass fiber filters were used simultaneously during each chamber run.  The 
quantity of bronopol collected on the filters was varied by sampling at different filter 
flow rates.  Flow rates used were 300, 450, and 600 ml/min and were designated as the 
Low, Medium, and High Ranges, with three sets per filter flow rate.  PVDF filters were 
extracted in a derivatizing solution; glass fiber filters were extracted in 
spectrophotometric grade water.  All were analyzed at 244 nm.  In all this produced 
eighteen bronopol samples collected on treated glass fiber filters.  The analytical results 
from the treated glass fiber filters are compared against the nine inert PVDF filters that 
were sampled concurrently and expressed as percent recovery, with the PVDF value 
assumed to have 100 % recovery. 
 
 Chamber sampling analytical recovery.  Chamber sampling recovery data is 
summarized in Table 12.  Average bronopol recovery from glass fiber filters for the 
individual low, medium, and high range chamber sampling sets ranged from 92.9 % to 
110.7 %, with n = 2 GFF per set.  Overall average GFF bronopol recovery from all nine 
chamber sampling runs was 99.9 %.  No chamber sampling data points were rejected as 
outliers.  Pooled coefficients of variation for the low, medium, and high range chamber 
sampling sets including only GFF filters were 4.43 %, 3.82 %, and 3.72 % respectively, 
with an overall pooled coefficient of variation of 4.00 % for all nine chamber sampling 
sets. 
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 Chamber sampling bronopol concentration.  Chamber sampling concentration 
data is summarized in Table 13.  Calculated bronopol concentration in the sampling 
chamber ranged from 10.80 mg/m
3
 to 21.59 mg/m
3
 for the nine chamber sampling sets.  
Pooled coefficients of variation for the low, medium, and high range chamber sampling 
sets including PVDF and GFF filters were 3.91 %, 4.50 %, and 4.57 % respectively, with 
an overall pooled coefficient of variation of 4.33 % for all nine chamber sampling sets. 
 
 Pump and chamber flow calibration.  Pre- and post-calibration of sampling 
pumps agreed within the 5 % variance allowed by NIOSH (1995), as did the chamber 
flow calibration sets.  All chamber sampling data and calculations are presented in 
Appendix G. 
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Table 12 
Summary of Bronopol Chamber Sampling Recovery Results 
LOW RANGE SETS – 300 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Recovery for Treated GFF 96.2 % 
 Standard Deviation 4.13 
 Coefficient of Variation % 4.30 % 
Set No. 2. Average Recovery for Treated GFF 96.4 % 
 Standard Deviation 5.63 
 Coefficient of Variation % 5.83 % 
Set No. 3. Average Recovery for Treated GFF 104.8 % 
 Standard Deviation 2.66 
 Coefficient of Variation % 2.54 % 
 Combined Average GFF Recovery - Low 99.1 % 
 
 
  
MEDIUM RANGE SETS – 450 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Recovery for Treated GFF 94.1 % 
 Standard Deviation 4.61 
 Coefficient of Variation % 4.90 % 
Set No. 2. Average Recovery for Treated GFF 105.1 % 
 Standard Deviation 3.04 
 Coefficient of Variation % 2.89 % 
Set No. 3. Average Recovery for Treated GFF 92.9 % 
 Standard Deviation 3.14 
 Coefficient of Variation % 3.38 % 
 Combined Average GFF Recovery - Medium 97.4 % 
 
 
  
HIGH RANGE SETS – 600 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Recovery for Treated GFF 95.8 % 
 Standard Deviation 2.94 
 Coefficient of Variation % 3.06 % 
Set No. 2. Average Recovery for Treated GFF 110.7 % 
 Standard Deviation 0.56 
 Coefficient of Variation % 0.50 % 
Set No. 3. Average Recovery for Treated GFF 102.8 % 
 Standard Deviation 5.81 
 Coefficient of Variation % 5.65 % 
 Combined Average GFF Recovery - High 103.1 % 
Note:  N = 2 GFF for each for each chamber sampling set, total of 18 GFF filters 
sampled and analyzed.  Average Recovery for Treated GFF is the average 
concentration for both GFF filters as a percent of the concentration for the 
concurrently sampled PVDF filter. 
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Table 13 
Summary of Bronopol Chamber Sampling Concentration Results 
LOW RANGE SETS – 300 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 20.46 
 Standard Deviation 0.77 
 Coefficient of Variation % 3.76 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 15.70 
 Standard Deviation 0.72 
 Coefficient of Variation % 4.59 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 13.68 
 Standard Deviation 0.45 
 Coefficient of Variation % 3.26 % 
 
 
  
MEDIUM RANGE SETS – 450 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 21.59 
 Standard Deviation 1.06 
 Coefficient of Variation % 4.91 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 21.38 
 Standard Deviation 0.75 
 Coefficient of Variation % 3.52 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 18.23 
 Standard Deviation 0.90 
 Coefficient of Variation % 4.92 % 
 
 
  
HIGH RANGE SETS – 600 ML/MIN FILTER FLOW RATE 
Set No. 1. Average Bronopol Concentration (mg/m
3
) 18.12 
 Standard Deviation 0.60 
 Coefficient of Variation % 3.29 % 
Set No. 2. Average Bronopol Concentration (mg/m
3
) 16.50 
 Standard Deviation 0.95 
 Coefficient of Variation % 5.74 % 
Set No. 3. Average Bronopol Concentration (mg/m
3
) 10.80 
 Standard Deviation 0.47 
 Coefficient of Variation % 4.33 % 
Note:  N = 3 for each for each chamber sampling set, all PVDF and GFF filters 
included in all chamber sampling concentration calculations.  Mg/m
3
 is the 
calculated bronopol concentration expressed as milligrams per cubic meter of 
air. 
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Sample Storage Stability 
Derivatized Bronopol Solutions 
 Aqueous bronopol was spiked onto 18 treated glass fiber filters; the filters were 
allowed to air dry.  Six filters were spiked with 25 µg bronopol, six with 60 µg bronopol, 
and six with 125 µg bronopol.  The filters were extracted and analyzed on the same day.  
The solutions from day one were stored and analyzed after fourteen days.  All stored 
samples were kept in a laboratory cabinet under ambient laboratory conditions in glass 
screw cap 16 mm by 125 mm culture tubes. 
 No derivatized bronopol solution data points were rejected as outliers.  F-test 
analysis of intra-set data values did not indicate a different mean for the solution storage 
sets on different days, demonstrating that no significant change had taken place in the 
samples over the 14-day storage period. 
 Derivatized bronopol solution storage stability data is summarized in Table 14.  
Adjusted absorbance was obtained by subtracting the filter blank count of  
0.015 absorbance units from the actual absorbance read at 244 nm.  The calculated 
difference in average adjusted absorbance values from day one to day fourteen ranged 
from 0.58 % to 0.95 %, with a cumulative average change of 0.71 % for all stored 
bronopol solutions.  A change of 10 % or less is considered acceptable (NIOSH, 1995).  
Sample storage stability data and calculations for derivatized bronopol solutions are 
presented in Appendix H. 
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Table 14 
Summary of Derivatized Bronopol Solution Storage Stability Results 
 Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
Day Fourteen 
 
Recovery 
(%) 
  
 
   
LOW RANGE SET – Each filter spiked with 25.2 µg bronopol, predicted absorbance 
is 0.218. 
AVG 0.210 96.6 0.212 97.1 
SD 0.004 2.03 0.003 1.47 
CV % 2.10 % 2.10 % 1.52 % 1.52 % 
Change in average absorbance values from first day to day fourteen is 0.95 % 
 
 
 
   
MEDIUM RANGE SET – Each filter spiked with 59.76 µg bronopol, predicted 
absorbance is 0.518. 
AVG 0.495 95.4 0.492 94.8 
SD 0.008 1.47 0.010 1.88 
CV % 1.54 % 1.54 % 1.98 % 1.98 % 
Change in average absorbance values from first day to day fourteen is 0.61 % 
 
 
 
   
HIGH RANGE SET – Each filter spiked with 126.12 µg bronopol, predicted 
absorbance is 1.096. 
AVG 1.043 95.2 1.037 94.6 
SD 0.022 2.02 0.024 2.18 
CV % 2.12 % 2.12 % 2.30 % 2.30 % 
Change in average absorbance values from first day to day fourteen is 0.58 % 
Note.  N = 6 for each filter spike set.  Treated glass fiber filters were spiked, extracted 
and analyzed the first day; the filter extract solutions were then stored under ambient 
laboratory conditions and analyzed again after fourteen days.  The adjusted 
absorbance is calculated as the absorbance read from each sample minus the filter 
blank count of 0.015 absorbance units; Recovery is then the adjusted absorbance 
divided by the predicted absorbance expressed as percent. 
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Bronopol on Treated Glass Fiber Filters 
 A preliminary trial of spiked filters revealed a significant change in bronopol 
recovery after storage for fourteen days; therefore a 48-hour storage period was selected 
for the spiked filter stability study.  Industrial hygiene samples taken in the field are 
typically sent to a laboratory for analysis via a commercial overnight carrier; based on 
this it was felt that a 48-hour storage period would be more than adequate for many 
foreseeable sampling and shipment situations. 
 Aqueous bronopol was spiked onto 36 treated glass fiber filters; the filters were 
allowed to air dry.  Twelve filters were spiked with 25 µg bronopol, twelve with 60 µg 
bronopol, and twelve with 125 µg bronopol.  Six of each set were extracted and analyzed 
on the same day; six of each set were extracted and analyzed after forty-eight hours.  All 
stored samples were kept in a laboratory cabinet under ambient laboratory conditions in 
glass screw cap 16 mm by 125 mm culture tubes. 
 No spiked filter data points were rejected as outliers.  F-test analysis of intra-set 
data values did not indicate a different mean for the spiked filter sets on different days, 
demonstrating that no significant change had taken place in the samples over the 48-hour 
storage period. 
 Spiked treated glass fiber filter storage stability data is summarized in Table 15.  
Adjusted absorbance was obtained by subtracting the filter blank count of  
0.015 absorbance units from the actual absorbance read at 244 nm.  The calculated 
difference in average adjusted absorbance values from day one to 48 hours later ranged 
from 0.48 % to 1.01 %, with a cumulative average change of 0.73 % for all stored spiked 
filters.  A change of 10 % or less is considered acceptable (NIOSH, 1995).  Sample 
 81
storage stability data and calculations for spiked treated glass fiber filters are presented in 
Appendix H. 
 
Table 15 
Summary of Treated and Spiked Glass Fiber Filter Storage Stability Results 
 Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
48 Hours 
 
Recovery 
(%) 
  
 
   
LOW RANGE SET – Each filter spiked with 25.88 µg bronopol, predicted absorbance 
is 0.224. 
AVG 0.210 93.9 0.209 93.6 
SD 0.007 3.15 0.006 2.78 
CV % 3.35 % 3.35 % 2.97 % 2.97 % 
Change in average absorbance values from first day to 48 hours later is 0.48 % 
 
 
 
   
MEDIUM RANGE SET – Each filter spiked with 59.36 µg bronopol, predicted 
absorbance is 0.515. 
AVG 0.492 95.6 0.497 96.6 
SD 0.011 2.15 0.006 1.07 
CV % 2.25 % 2.25 % 1.11 % 1.11 % 
Change in average absorbance values from first day to 48 hours later is 1.01 % 
 
 
 
   
HIGH RANGE SET – Each filter spiked with 124.08 µg bronopol, predicted 
absorbance is 1.078. 
AVG 1.016 94.2 1.023 94.9 
SD 0.026 2.41 0.021 1.95 
CV % 2.56 % 2.56 % 2.05 % 2.05 % 
Change in average absorbance values from first day to 48 hours later is 0.69 % 
Note.  N = 12 for each filter spike set.  Six of each set of spiked treated glass fiber 
filters were extracted and analyzed the first day; the remaining six spiked filters from 
each set were stored under ambient laboratory conditions then extracted and analyzed 
after 48 hours.  The adjusted absorbance is calculated as the absorbance read from 
each sample minus the filter blank count of 0.015 absorbance units; Recovery is then 
the adjusted absorbance divided by the predicted absorbance expressed as percent. 
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Chapter Five - Conclusions And Recommendations 
Findings of the Study 
Summary 
 An existing ultraviolet spectrophotometric method for analysis of derivatized 
bronopol has been combined with conventional industrial hygiene air sampling 
techniques.  The derivatizing characteristic of this new air sampling method will serve to 
minimize loss of the reactive bronopol during sampling and analysis.  No air sampling 
method for bronopol has previously been published in the literature. 
 A calibration curve has been developed for the analytical method with a linear 
range of 1 µg/ml to 25 µg/ml.  The instrumental limit of detection is 1 µg/ml with an 
instrumental limit of quantitation of ca. 3 µg/ml. 
 Sampling of airborne bronopol from generated atmospheres has been conducted 
under laboratory conditions.  Analytical recovery for treated glass fiber filters versus the 
benchmark method yielded a sampling recovery efficiency averaging 99.9 %.  Calculated 
bronopol concentration obtained during chamber sampling trials ranged from  
10.80 mg/m
3
 to 21.59 mg/m
3
, with a pooled coefficient of variation of 4.33 % for all 
chamber sampling sets. 
 Treated glass fiber filters spiked with bronopol were found to be stable for a 
period of 48 hours; derivatized bronopol solutions were found to be stable for a period of 
fourteen days. 
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Ultraviolet Spectrophotometric Method for Bronopol Analysis 
 Analytical wavelength.  The Sanyal et al. (1996) spectrophotometric method for 
reacting bronopol with sodium hydroxide and analyzing for the derivatized chromophore 
at 244 nm is used in this body of work.  A spectrophotometric scan of derivatized 
bronopol as shown in Figure 5 confirms the absorbance maximum at 244 nm, as does a 
manual wavelength scan as shown in Table 7. 
 
 Chromophore development.  Development of the chromophore upon addition of 
sodium hydroxide was found to be essentially instantaneous as reported by Sanyal et al. 
(1996).  Repeated absorbance measurements of a derivatized bronopol solution over a 
period of 60 minutes showed very little change of the absorbance value with time as 
shown in Table 8. 
 Variations in the sodium hydroxide concentration of the derivatizing solution 
showed little change in detected absorbance within the range evaluated.  Sanyal et al. 
(1996) used a 0.1 molar solution, but sodium hydroxide concentrations in the range of 
0.005 molar to 0.4 molar were equally effective as shown in Table 9.  The concentration 
in solution used in this work is 0.03 molar.  Given the known linear range of the 
analytical method, 0.00015 mol of sodium hydroxide applied to a sampling filter will 
have at least a 240-fold molar excess when compared to the desired molar concentration 
of bronopol on a sampling filter. 
 
 Calibration curve.  Derivatized bronopol solutions of known concentration 
yielded a linear calibration curve in the concentration range from 1 µg/ml to 25 µg/ml, 
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which is beyond the reported Sanyal et al. (1996) range of 5 to 25 µg/ml.  The resulting 
linear regression line as shown in Equation 12 has a calculated coefficient of 
determination (R
2
) value of 0.9996.  In all the calibration curve data provides 54 
measurements comprising of six measurements at each of nine bronopol concentrations.  
The calculated average molar absorption coefficient obtained was 8,660 liter/cm mol 
versus the published Sanyal et al. value of 8,330 liter/cm mol.  No difference was found 
in molar absorption coefficient for low versus high bronopol concentrations, indicating 
that the conversion rate of bronopol to bromonitroethanol upon addition of sodium 
hydroxide is not dependent on bronopol concentration in the concentration range studied. 
 
 Limits of detection and quantitation.  The instrumental limit of detection of  
1 µg/ml was equal to the lowest calibration curve concentration used.  The calculated 
instrumental limit of quantitation was 3.33 µg/ml. 
 
Sampling and Analysis of Bronopol on Filters 
 Filter spiking.  The Sanyal et al. (1996) spectrophotometric method for analysis of 
bronopol in cosmetic materials has been adapted to analyze bronopol collected on air 
sampling filters.  The sodium hydroxide derivatizing agent, along with a humectant 
material, has been applied to glass fiber filters. 
 Bronopol spiked onto treated glass fiber filters demonstrated average recovery 
efficiency of 95.7 %, with a pooled coefficient of variation of 1.52 % for analytical 
recovery from all filter spiking sets. 
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 Distribution of bronopol particulate concentration in the sampling chamber.  A 
dust generator and sampling chamber were constructed to introduce pulverized bronopol 
aerosol to three sampling filters simultaneously.  Nitrogen gas flow through the dust 
generator was regulated in a manner to limit the maximum particle size of the bronopol 
particulate introduced into the sampling chamber.  Bronopol particles no greater than 
11.0 µm aerodynamic diameter pass through the nozzle of the dust generator into the 
sampling chamber.  Due to a gas velocity of ca. 16.8 cm/sec at the dust generator nozzle a 
jet of nitrogen gas and bronopol particles is transmitted to the sampling filters at the top 
of the sampling chamber. 
To demonstrate consistent presentation of bronopol particles to the samplers, 
chamber particulate concentration distribution runs were performed using inert PVDF 
filters.  PVDF filters were extracted in a derivatizing solution and analyzed at 244 nm.  A 
total of nine chamber particulate distribution runs were performed consisting of three 
runs at each of three filter sampling flow rates.  Calculated bronopol concentration 
obtained during the nine chamber particulate concentration distribution runs ranged from 
12.31 mg/m
3
 to 19.67 mg/m
3
, with a pooled coefficient of variation of 3.17 % for all sets. 
 
Sampling of generated bronopol atmospheres.  For sampling of bronopol 
particulate in the chamber, one inert PVDF filter and two treated glass fiber filters were 
used simultaneously during each chamber run.  PVDF filters were extracted in a 
derivatizing solution; glass fiber filters were extracted in spectrophotometric grade water.  
All filters were analyzed at 244 nm. 
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A total of nine chamber sampling runs were performed consisting of three runs at 
each of three filter sampling flow rates.  Calculated bronopol concentration obtained 
during the nine chamber sampling sets ranged from 10.80 mg/m
3
 to 21.59 mg/m
3
, with a 
pooled coefficient of variation of 4.33 % for all chamber sampling sets including all GFF 
and PVDF filters.  Calculated recovery as measured by average GFF concentration versus 
the benchmark PVDF filter sampled concurrently averaged 99.9 %. 
 
Sample Storage Stability 
 Aqueous bronopol was spiked onto treated glass fiber filters, the filters were 
allowed to air dry.  Filters were stored, extracted, and analyzed over varying periods of 
time to evaluate stability of derivatized bronopol in solution and on filters. 
 
Storage stability of derivatized bronopol solutions.  Bronopol of three different 
quantities was spiked onto 18 treated glass fiber filters.  The filters were extracted and 
analyzed on the same day.  The solutions from day one were stored and analyzed after 
fourteen days.  The average change for all stored sample solutions was 0.71 %.  NIOSH 
(1995) considers a change of 10 % or less to be acceptable. 
 
 Storage stability of bronopol on treated GFF.  Bronopol of three different 
quantities was spiked onto 36 treated glass fiber filters.  Six of each set were extracted 
and analyzed on the same day; six of each set were stored then extracted and analyzed 
after forty-eight hours.  The average change for all stored spiked filters was 0.73 %, 
against the reference NIOSH (1995) value of 10 % or less. 
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Limitations of This Study 
Sampling and Analytical Method 
 Derivitization reaction.  The Sanyal et al. (1996) method describes a complete 
conversion of bronopol to bromonitroethanol upon addition of sodium hydroxide, 
however; only thin-layer chromatography analysis is offered as evidence of this assertion. 
 In the current work supporting evidence is developed which supports the Sanyal 
et al. claim of complete conversion of bronopol to bromonitroethanol.  First, ANOVA 
analysis was performed on the molar absorbtivity data.  If the molar absorption 
coefficient changes with concentration, then the analysis of variance test should show 
that the means of the data sets of the various concentrations are different.  This would 
indicate that the derivitization conversion of bronopol differed with varying 
concentrations.  This was not found to be the case, indicating that the conversion of 
bronopol to bromonitroethanol upon addition of sodium hydroxide takes place at a 
constant rate in the concentration ranges studied. 
 Secondly, in all cases the sodium hydroxide molar concentration was at least 240 
times the bronopol concentration.  While this is not a guarantee of complete derivitization 
of bronopol, a large molar excess would be expected to drive the reaction towards 
completion. 
 While these factors are supporting evidence of a significant conversion rate, the 
current study did not offer a definitive analysis to verify the conversion rate of bronopol 
to bromonitroethanol upon addition of sodium hydroxide. 
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 Calibration curve.  The calibration curve range studied was limited to the range of 
1 µg/ml to 25 µg/ml.  While this is beyond the reported Sanyal et al. (1996) range of  
5 to 25 µg/ml, further studies may expand the known linear range of the analytical 
method. 
 
 Limits of detection and quantitation.  The instrumental limit of detection of  
1 µg/ml was limited to the lowest concentration calibration curve standard used.  
Similarly, the calculated instrumental limit of quantitation of 3.33 µg/ml is based on the 
lowest calibration curve analytical standard used.  No attempt was made to evaluate 
calibration curve standards in the concentration range less than 1 µg/ml. 
 
 Filter spiking.  Spiking of treated glass fiber filters was limited to the range of  
19 µg to 113 µg of bronopol per filter.  The quantities of bronopol loading on a treated 
filter were limited by the bounds of the known linear range of the calibration curve.  
Spike quantities at higher or lower ranges were not evaluated. 
 
 Sampling of generated bronopol atmospheres.  The sampling chamber used was 
limited by design to using three samplers simultaneously.  This was based on the 
maximum total flow rate of 1,800 ml/min through the samplers versus the total chamber 
flow rate of 2 LPM.  The 2 LPM flow rate through the dust generator and subsequently 
through the sampling chamber was necessary to achieve appropriate size selection in the 
vertical elutriator portion of the dust generator.  The flow rate through the sampling 
chamber could not be altered from the 2 LPM flow rate used. 
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 Filter sampling flow rates used in the study were limited to 300, 450, and  
600 ml/min.  Traditional industrial hygiene sampling flow rates for airborne particulates 
are often upwards of one and even as much as four LPM. 
 Control of bronopol aerosol concentration collected on the sampling filters was 
attained through changing the sampler flow rates, by selecting a fixed sampling time, and 
by selecting an appropriate sampling chamber equilibration time prior to activation of the 
samplers.  With the laboratory apparatus used it was not possible to directly control the 
airborne bronopol concentration.  Within these limitations calculated airborne bronopol 
concentrations obtained were in the range of 10.80 mg/m
3
 to 21.59 mg/m
3
. 
 The dust generator and sampling chamber used in this study were designed to 
eliminate specific variables that would be present under actual field sampling conditions.  
Oxygen and water vapor were excluded from the dust generator and the sampling 
chamber through the use of a dry nitrogen gas atmosphere.  While the temperature of the 
laboratory apparatus was not controlled per se, the ambient laboratory temperature was 
maintained within a normal range for the interior of an air-conditioned building.  
Sampling under actual field conditions would draw atmospheric oxygen and water vapor 
through the treated glass fiber filters containing collected bronopol aerosol.  Temperature 
under actual field conditions would at times likely be outside the range normally 
maintained inside air-conditioned buildings.  Of course, the airborne bronopol present in 
the atmosphere to be sampled would be subjected to uncontrolled environmental 
conditions; understanding the implications of these variables is beyond the scope of this 
study. 
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Sample storage stability.  Industrial hygiene media that has been used to collect 
samples may be subjected to environmental conditions that can alter the stability or 
recovery of the analyte on the media.  Several variables may come into play such as 
storage temperature, relative humidity, transit time, exposure to oxygen, exposure to 
light, vibration, and potential interactions of the analyte with the media.  In addition, the 
laboratory analyzing the samples may not process the samples immediately upon receipt. 
 In this work derivatized bronopol in solution was determined to be stable for at 
least 14 days.  No stability studies were performed on derivatized bronopol solutions in 
excess of this time period. 
 Preliminary studies for stability of derivatized bronopol on treated glass fiber 
filters indicated that this combination was not stable for 14 days.  The 48-hour period 
selected for bronopol on treated GFFs in this study is a very minimal storage period and 
would require close coordination between field sampling personnel and the receiving 
laboratory to assure that the 48-hour time frame was met.  At the very minimum the 
received samples would need to be extracted upon receipt; the analysis could then be 
performed at a later date. 
 
Field Trials 
No field trials of bronopol workplaces or bronopol application areas were 
conducted in this work. 
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Health Effects of Bronopol 
 Animal or human studies to determine the potential health effects associated with 
bronopol exposure were not within the scope of this work 
 
Public Health Importance of This Study 
Populations with Potential Exposure to Bronopol 
 While bronopol has been used as a preservative in drugs and cosmetics since at 
least 1964, recent formulations for mold remediation and the sanitizing of ventilation 
system components have the potential to expose vast new populations to the chemical.  
The most recent statistic available for United States workers occupationally exposed to 
bronopol specifies exposure of 5,176 individuals (NIOSH, 1983).  This is prior to the 
recent novel applications of this biocidal compound for mold and ventilation systems.  
Given that 89 million workers in the United States work in nonindustrial nonagricultural 
indoor environments and 50 million Americans suffer from allergic diseases each year 
(Mendell et al., 2002), it is likely that a sizeable portion of these populations will be 
exposed to bronopol used to control indoor microbiological growth. 
 
Health Effects Associated with Exposure to Bronopol 
 Skin irritancy in humans and laboratory animals at levels commonly used in 
cosmetics is low.  Bronopol in higher concentrations (1 % and greater) is significantly 
irritating in human skin patch studies (Maibach, 1977).  The evidence for dermal 
sensitization and allergenic dermal reaction to bronopol is mixed.  Laboratory testing of 
the allergenic properties of bronopol indicate a low potential for dermal sensitization; 
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however, a number of case reports demonstrate incidences of human allergenic reactions 
in various exposure situations (Bryce et al., 1978; Storrs & Bell, 1983; Frosch et al., 
1990; Wilson & Powell, 1990; Rudzki et al., 1993). 
Given the widespread use of bronopol and the variety of uses for the material, 
bronopol may produce sensitization in a large number of people when the exposure 
population is large.  Continued exposure to a sensitizing agent may eventually sensitize 
susceptible individuals (Marzulli & Maibach, 1973).  The potential sensitizing property 
of bronopol on dermal exposure suggests that the material may be sensitizing for the 
inhalation route of exposure. 
 
Importance of the Study 
 Currently this is the only air sampling and analytical method for bronopol 
described in the scientific literature.  Based on the potential health effects of bronopol 
exposure and the large and diverse populations that may be exposed to bronopol in the 
workplace and in their place of residence, understanding the duration and intensity of 
exposure to these populations is critical. 
 
Recommendations for Further Research Efforts 
Sampling and Analytical Method for Bronopol 
 Derivitization reaction.  While Sanyal et al. (1996) described the conversion of 
bronopol to bromonitroethanol upon addition of sodium hydroxide, only thin-layer 
chromatography analysis was offered as evidence of this conversion.  A definitive 
quantitation of the conversion rate would be beneficial to the analytical method. 
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Calibration curve.  It is not known over what concentration range the regression 
line will remain linear beyond the 1 to 25 µg/ml range demonstrated in this work.  It 
would be useful to determine the full extent of the linear range of the analytical method in 
order to allow a wider range of effective air sampling rates, volumes, and concentrations 
for the sampling and analytical method.  The linearity of the regression line at the upper 
concentration range may allow for extension of the calibration curve data in this 
direction, although absorbance values are in the range of 1.1 absorbance units at 25 µg/ml 
bronopol concentration.  Good UV-VIS spectrophotometric technique may limit the 
desirability of absorbance values much in excess of one, since at this level only 10 % of 
the incident light is passing through the sample. 
 
Limit of detection and quantitation.  Extending the range at the low end of the 
calibration curve would permit a more accurate determination of the instrumental limit of 
detection and limit of quantitation.  The calculated instrumental limit of detection of  
1 µg/ml was equal to the lowest calibration curve concentration used.  Further 
experimentation may result in a smaller LOD by developing additional calibration curve 
data in the concentration range below 1 µg/ml.  The calculated instrumental limit of 
quantitation of 3.33 µg/ml may also be reduced in value by developing additional 
calibration curve data in the lower concentration regime. 
 The filter extraction procedure used in this work results in a five ml filter extract 
volume.  Filter extraction trials using a smaller volume of water such as two to three 
milliliters may demonstrate adequate analytical recovery from the filters.  A smaller filter 
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extract volume would serve to reduce the dilution factor of the bronopol collected on the 
filter, resulting in a lowered overall method limit of detection and quantitation. 
 
 Sampling of generated bronopol atmospheres.  The sampling chamber used in this 
study presented a very controlled atmosphere to the samplers.  To more thoroughly 
evaluate the efficacy of the treated glass fiber filters for collection of airborne bronopol 
the environmental parameters of the sampled atmosphere should be closer to the 
conditions found under actual field conditions.  For example, in subsequent work the 
sampled atmosphere used should consist of air instead of nitrogen.  The effects, if any, of 
moisture content of the sampled atmospheres should be evaluated.  Although exclusion of 
oxygen and water vapor in sampled atmospheres was essential to this current work, field 
sampling using this method will be subjected to atmospheric oxygen and variable 
temperatures and relative humidity levels. 
 The concentration range of bronopol atmospheres sampled in this work was 
limited; no means were available to directly control the bronopol concentration.  These 
limitations restricted the sampled bronopol concentration range to 10.80 mg/m
3
 to 21.59 
mg/m
3
.  Further work is needed to determine the effective range of treated glass fiber 
filters in sampling airborne bronopol particulate. 
 
 Sample storage stability.  While the 14 day storage stability of derivatized 
bronopol solutions is generally adequate, it would not be unreasonable to evaluate the 
storage stability of bronopol solutions over a longer period of time.  Additionally, it is not 
unreasonable to expect samples in transit to be subjected to a wide range of 
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environmental conditions.  Based on this, it is recommended that derivatized bronopol 
solutions be subjected to stability studies under an expanded range of storage conditions. 
 Further study of the stability of derivatized bronopol on treated glass fiber filters 
would potentially allow an industrial hygienist or laboratory using the method to relax the 
48-hour extraction timeframe.  This short time frame was selected as a minimum 
necessary time frame for the stability study.  As discussed previously the 48-hour 
threshold would require close coordination between field sampling personnel and the 
receiving laboratory to assure that the 48-hour time frame was met.  As with the 
derivatized bronopol solutions it is recommended that bronopol collected on treated GFFs 
be subjected to stability studies under an expanded range of storage conditions. 
 It may be possible to develop a method that would allow storage of the filters in 
the extraction solution without the benefit of the complete extraction procedure.  This 
would permit field personnel to place the sampled filter in a vial for transport and storage 
at the laboratory prior to extraction and analysis. 
 
 Field testing trials.  Field testing will be necessary to develop an understanding of 
workplace exposures to bronopol during formulation and application of bronopol-
containing products.  Field testing will also serve to quantify the exposures, if any, of 
building occupants during bronopol application to ventilation system components or to 
indoor materials that have developed microbiological growth. 
 
 Use of the analytical method to determine bronopol concentration in other media.  
Bronopol applied during mold remediation and in ventilation system components has the 
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potential to be present in other environmental media in the build environment, including 
on surfaces and in carpeting.  In combination with sampling techniques appropriate for 
the individual media, the analytical method from the current work could be used to 
determine residual bronopol concentrations. 
 Children playing on carpeting with bronopol residuals have a potential for 
exposure through both dermal contact and through inhalation from re-entrainment of 
bronopol particulate into the air.  Sampling of the carpeting using a vacuum source and a 
glass fiber filter treated with the derivatizing agent should produce results similar to those 
obtained in this publication.  The filter extract solution would need to be filtered to 
exclude not only glass fibers from the filter but also any fine particulates captured during 
sampling.  Quantitative results in terms of bronopol mass per unit of area would be 
obtained if the sampling were confined to a measured area. 
 Similar results could be obtained from sampling of impervious indoor horizontal 
surfaces.  Sampling would be conducted using a wetted filter or wipe media.  The sample 
would be immersed in the derivatizing solution and then the extracted solution would be 
filtered and analyzed.  Again, quantitative results would be obtained if the sampled 
region were confined to a measured area. 
 
Health effects of bronopol exposure.  The skin irritancy of bronopol in humans 
and laboratory animals at levels commonly used in cosmetics (0.01 to 0.1 %) is low; 
however, at higher concentrations (1 % and greater) it is significantly irritating in human 
skin patch studies (Maibach, 1977).  The evidence for dermal sensitization and allergenic 
dermal reaction to bronopol is mixed. 
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Inhalation LC50 values for rats of 0.18 mg/l (Elder, 1980) to greater than 5 mg/l 
(EPA, 1995) are reported. 
The potential sensitizing property of bronopol on dermal exposure suggests the 
possibility that the material may be sensitizing for the inhalation route of exposure, 
although dermal sensitizers are not always respiratory sensitizers. 
Further research is needed to identify the possible health effects from airborne and 
dermal exposures. 
 
Summary 
 The results from this research are favorable enough to recommend continued 
development of this sampling and analytical method, with the ultimate aim of providing a 
fully validated method to evaluate airborne exposures to bronopol under a wide range of 
environmental conditions. 
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Appendix A: Dust Generator Calculations 
 
 
Calculation of Dust Generator Cross Sectional Area 
 
 
 Inner diameter of the dust generator is nominally 3 inches; radius (r) is 1.5 inches. 
 
 
r  =   1.5 inch 2.54 cm =  3.81 cm 
  1 inch  
 
 
 The internal area of the dust generator (AREADG) is then calculated: 
 
 
AREADG  =  (3.81 cm)
2
 π =  45.6 cm
2
 
    
 
 
Calculation of Average Nitrogen Gas Velocity Inside the Dust Generator 
 
 
Average gas velocity (Vavg) through the dust generator is calculated using 
Equation 4: 
 
 
Vavg = Q/A          (4) 
 
 
Vavg  =   2 liter  1,000 cm
3
 1 min =  0.365 cm/sec 
 min 45.6 cm
2
 1 liter 60 sec  
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Calculation of Maximum Nitrogen Gas Velocity Inside the Dust Generator 
 
 
Maximum or centerline gas velocity (Vcl) through the dust generator is calculated 
by rearranging Equation 5: 
 
 
Vavg = 0.9 x Vcl         (5) 
 
 
Vcl  =   0.365 cm  =  0.406 cm/sec 
 sec 0.9  
 
 
Calculation of Particle Aerodynamic Diameter using Average Nitrogen Gas Velocity 
 
 
 Factors used in these calculations are shown in Table A1: 
 
 
Table A1 
Factors Used in Calculation of Aerodynamic Diameter 
Factor Name Symbol Factor and Units Reference Source 
Absolute Viscosity 
(Nitrogen) 
 
η 178.1 x 10
-6
 gm/cm sec (poise) 
(at 27.4 °C) 
Weast, 1982 
Particle Density 
(Bronopol) 
 
ρp 1.1 gm/cm
3
 OSP 2, 2006 
Acceleration of 
Gravity 
 
g 981 cm/sec
2
 Weast, 1982 
 
 
 The aerodynamic diameter (da) of a bronopol particle with a terminal settling 
velocity (Vts) equal to the average upward gas velocity of 0.365 cm/sec is calculated by 
rearranging Equation 6 as follows: 
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Vts = ρpda
2
g/18η         (6) 
 
 
da  =   Vts 18 η 
1/2 
 ( ρp g )  
 
da  =  0.365 cm 18 178.1 x 10
-6
 gm cm
3
 sec
2
 
1/2 
=  1.04 x 10
-3
 cm 
 ( sec  cm sec 1.1 gm 981 cm )   
 
 
da  =   1.04 x 10
-3
 cm 10 mm 1,000 µm =  10.4 µm 
  1 cm 1 mm  
 
 
Calculation of Particle Aerodynamic Diameter using Maximum Nitrogen Gas Velocity 
 
 
 The aerodynamic diameter of a bronopol particle with a terminal settling velocity 
equal to the maximum upward gas velocity of 0.406 cm/sec is calculated using the 
rearranged Equation 6 as follows: 
 
 
da  = 0.406 cm 18 178.1 x 10
-6
 gm cm
3
 sec
2
 
1/2 
=  11.0 µm 
 ( sec  cm sec 1.1 gm 981 cm )   
 
 
Calculation of Dust Generator Nozzle Cross Sectional Area 
 
 
 Inner diameter (d) of the dust generator nozzle is nominally 0.625 inches; radius 
(r) is 0.3125 inches. 
 
 
r  =   0.3125 inch 2.54 cm =  0.794 cm 
  1 inch  
 
 
AREANozzle  =   (0.794 cm)
2
 π =  1.98 cm
2
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Calculation of Dust Generator Nozzle Nitrogen Gas Velocity 
 
 
Gas velocity through the dust generator nozzle (VNozzle) is calculated using 
Equation 4: 
 
 
VNozzle  =   2 liters  1,000 cm
3
 1 min =  16.8 cm/sec 
 min 1.98 cm
2
 1 liter 60 sec  
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Appendix B: Sampling Chamber Calculations 
 
 
Calculation of Sampling Chamber Cross Sectional Area 
 
 
 The inner diameter of the sampling chamber is 24.8 cm; radius is 12.4 cm. 
 
 
AREAChamber  =   (12.4 cm)
2
 π =  483 cm
2
 
    
 
 
Calculation of Average Nitrogen Gas Velocity through the Sampling Chamber 
 
 
Nitrogen gas flow through the chamber is 2 LPM.  Ignoring the dynamics of the 
nitrogen jet flow within the chamber the average nitrogen gas velocity through the 
chamber is calculated using Equation 4: 
 
 
Vavg  =   2 liter  1,000 cm
3
 1 min =  0.069 cm/sec 
 min 483cm
2
 1 liter 60 sec  
 
 
Calculation of Particle Aerodynamic Diameter using Average Nitrogen Gas Velocity 
 
 
 The da of a bronopol particle with a settling velocity Vts equal to the average 
upward gas velocity of 0.069 cm/sec is calculated by using the rearranged Equation 6 as 
follows: 
 
 
da  =  0.069 cm 18 178.1 x 10
-6
 gm cm
3
 sec
2
 
1/2 
=  4.53 x 10
-4
 cm 
 ( sec  cm sec 1.1 gm 981 cm )   
 
 
da  =   4.53 x 10
-4
 cm 10 mm 1,000 µm =  4.5 µm 
  1 cm 1 mm  
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Calculation of Dust Generator Nozzle Jet Diameter at Top of the Sampling Chamber 
 
 
 In NIOSH (1973) the spread angle of an air jet is reported to be approximately 22 
degrees.  This is used to calculate the diameter of the jet stream at the top of the sampling 
chamber as follows.  The chamber height is 48.9 cm.  Ignoring the width of the jet 
nozzle, the diameter of the nitrogen gas jet in the vicinity of the samplers will be: 
 
 
WIDTHJet  =   48.9 cm x tan(22°) =  19.8 cm 
 
 
Calculation of Outer Diameter of Sampler Region 
 
 
The samplers are configured on the top of the sampling chamber in an equidistant 
manner with the center of each sampler 7.3 cm from the centerline of the chamber.  Each 
sampler is 2.5 cm in diameter; one-half of each sampler diameter extends beyond the 
sampler center. 
 
 
DSamplers  =  (7.3 cm x 2) + (1.25 cm x 2)  =  17.1 cm 
 
 
Calculation of Sampling Filter Face Velocity 
 
 
 Filter diameter is 2.5 cm.  The lowest sampling flow rate used is approximately 
0.3 LPM.  The area of the filter is calculated first, and then minimum filter face velocity 
is obtained by solving Equation 4 as follows: 
 
 
AREAFilter  =   (1.25 cm)
2
 π =  4.91 cm
2
 
    
 
 
VFilter  =   300 cm
3
  1 min   =  1.02 cm/sec 
 min 4.91 cm
2
 60 sec  
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Appendix C: Glass Fiber Filter Treatment Calculations 
 
 
Maximum Desired Bronopol Loading per Filter 
 
 
 Based on Sanyal et al. (1996) the linear range of the analytical method is 5 to 25 
µg/ml.  In this experiment filters are extracted in 5 ml of water; therefore, the maximum 
bronopol (BNPD) loading desired on each filter is: 
 
 
MASSBNPD  =   25 µg 5 ml   =  125 µg 
 ml   
 
 
MOLBNPD  =   125 µg mol 1 mg 1 gm   =  6.25 x 10
-7
 mol 
  199.99 gm 1000 µg 1000 mg  
 
 
6.25 x 10
-7
 mol is the maximum bronopol quantity desired on each filter.  
 
 
Molar Concentration of Reagent Sodium Hydroxide 
 
 
The specific gravity of 50 weight percent sodium hydroxide is 1.5253 (Perry, 
1950).  Fifty percent of 1.5253 is approximately 0.763 gm/ml; the molecular weight of 
sodium hydroxide is 40 grams per mole.  The concentration of the sodium hydroxide 
reagent is calculated to be approximately 19 molar as follows: 
 
 
CONCENTRATIONNaOH  =   0.763 gm 1 mol 1000 ml   =  19.01 molar 
 ml 40 gm 1 liter  
 
 
Quantity of Sodium Hydroxide on Treated Glass Fiber Filters 
 
 
 Each glass fiber filter is treated with 0.2 ml of filter treatment solution.  The 
solution is formulated from 2.0 ml of 50 weight percent NaOH and 1.0 ml of glycerin; 
final volume in aqueous solution is 50 ml. 
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The quantity of sodium hydroxide on each filter can be calculated as follows: 
 
 
MOLNaOH  =   2 ml 19.01 mol 0.2 ml 1 liter   =  0.00015 mol 
 50 ml liter  1000 ml  
 
 
 1.5 x 10
-4
 mol of sodium hydroxide is present on each treated glass fiber filter. 
 
 
Sodium Hydroxide Concentration in Filter Extract Solutions 
 
 
 In the 5 ml filter extract solution 1.5 x 10
-4
 mol of sodium hydroxide is present.  
The molar concentration of sodium hydroxide in solution is calculated as follows: 
 
 
CONCENTRATIONNaOH  =   1.5 x 10
-4
 mol 1000 ml   =  0.03 molar 
 5.0 ml 1 liter  
 
 
 The concentration of sodium hydroxide in filter extract solutions is 0.03 molar. 
 
 
Sodium Hydroxide Molar Excess on Treated Filters 
 
 
 A large molar excess of sodium hydroxide on the derivatizing filters is desirable 
to quickly drive the reaction with bronopol to completion.  The ratio of the amount of 
sodium hydroxide per filter to the maximum desired bronopol per filter is as follows: 
 
 
RATIONaOH/BNPD  =   0.00015 mol NaOH   =  240-fold molar excess of NaOH 
 0.000000625 mol BNPD  
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Appendix D: Calibration Curve 
 
 
Calibration Curve Data 
 
 
A calibration curve for derivatized bronopol was developed.  The range of 
bronopol concentrations in solution was 1 to 25 µg/ml in an approximation of the linear 
range described by Sanyal et al. (1996); bronopol mass as part of the concentration 
represents the bronopol mass prior to the derivitization reaction with sodium hydroxide.  
Sodium hydroxide concentration in solution was 0.03 molar.  Nine different 
concentrations of bronopol were targeted in formulating the calibration curve solutions: 
1, 2, 4, 6, 8, 10, 15, 20, and 25 µg/ml.  Six solutions of each concentration were 
developed and analyzed at 244 nm.  Calibration curve data is presented in Table D1. 
 
 
Regression Analysis 
 
 
 Regression analysis was performed with Microsoft Excel using the regression 
data analysis tool.  The results of the regression analysis are presented in Table D2. 
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Table D1 
Calibration Curve Data 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Abs. at 
244 nm 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Abs. at 
244 nm 
1 1.010 0.043 4 1.020 0.045 
 2.020 0.085  2.040 0.087 
 4.040 0.171  4.080 0.175 
 6.060 0.256  6.120 0.264 
 8.080 0.346  8.160 0.356 
 10.100 0.433  10.200 0.446 
 15.150 0.672  15.300 0.671 
 20.200 0.882  20.400 0.890 
 25.250 1.102  25.500 1.107 
2 1.028 0.045 5 1.006 0.047 
 2.056 0.089  2.012 0.090 
 4.112 0.178  4.024 0.169 
 6.168 0.266  6.036 0.253 
 8.224 0.355  8.048 0.345 
 10.280 0.443  10.060 0.449 
 15.420 0.675  15.090 0.671 
 20.560 0.892  20.120 0.851 
 25.700 1.117  25.150 1.084 
3 1.044 0.046 6 1.012 0.043 
 2.088 0.089  2.024 0.087 
 4.176 0.179  4.048 0.169 
 6.264 0.264  6.144 0.267 
 8.352 0.359  8.192 0.359 
 10.440 0.453  10.120 0.451 
 15.660 0.673  15.729 0.669 
 20.880 0.913  20.480 0.910 
 26.100 1.130  25.600 1.110 
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Appendix D (continued) 
 
 
Molar Absorption Coefficient 
 
 
The molar absorption coefficient of derivatized bronopol was calculated for each 
calibration curve data point.  Values obtained were compared against the value of  
8330 liter/cm mol as reported by Sanyal et al. (1996).  Calculated results are presented in 
Table D3.  To determine if the molar absorption coefficient varies with the concentration 
of derivatized bronopol in solution, analysis of variance was performed among the 
different concentration levels.  Results of this analysis are presented in Table D4. 
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Table D3 
Molar Absorption Coefficient Data 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Absorbance at 
244 nm 
Molar 
Concentration 
(mol/liter) 
Molar Absorbtivity 
(liter/cm mol) 
1 1.010 0.043 0.00000505 8515 
 2.020 0.085 0.0000101 8416 
 4.040 0.171 0.0000202 8465 
 6.060 0.256 0.0000303 8449 
 8.080 0.346 0.0000404 8564 
 10.100 0.433 0.0000505 8574 
 15.150 0.672 0.00007575 8871 
 20.200 0.882 0.000101 8733 
 25.250 1.102 0.00012625 8729 
2 1.028 0.045 0.00000514 8755 
 2.056 0.089 0.00001028 8658 
 4.112 0.178 0.00002056 8658 
 6.168 0.266 0.00003084 8625 
 8.224 0.355 0.00004112 8633 
 10.280 0.443 0.0000514 8619 
 15.420 0.675 0.0000771 8755 
 20.560 0.892 0.0001028 8677 
 25.700 1.117 0.0001285 8693 
3 1.044 0.046 0.00000522 8812 
 2.088 0.089 0.00001044 8525 
 4.176 0.179 0.00002088 8573 
 6.264 0.264 0.00003132 8429 
 8.352 0.359 0.00004176 8597 
 10.440 0.453 0.0000522 8678 
 15.660 0.673 0.0000783 8595 
 20.880 0.913 0.0001044 8745 
 26.100 1.130 0.0001305 8659 
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Table D3 (continued) 
Molar Absorption Coefficient Data 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Absorbance at 
244 nm 
Molar 
Concentration 
(mol/liter) 
Molar Absorbtivity 
(liter/cm mol) 
4 1.020 0.045 0.0000051 8824 
 2.040 0.087 0.0000102 8529 
 4.080 0.175 0.0000204 8578 
 6.120 0.264 0.0000306 8627 
 8.160 0.356 0.0000408 8725 
 10.200 0.446 0.000051 8745 
 15.300 0.671 0.0000765 8771 
 20.400 0.890 0.000102 8725 
 25.500 1.107 0.0001275 8682 
5 1.006 0.047 0.00000503 9344 
 2.012 0.090 0.00001006 8946 
 4.024 0.169 0.00002012 8400 
 6.036 0.253 0.00003018 8383 
 8.048 0.345 0.00004024 8574 
 10.060 0.449 0.0000503 8926 
 15.090 0.671 0.00007545 8893 
 20.120 0.851 0.0001006 8459 
 25.150 1.084 0.00012575 8620 
6 1.012 0.043 0.00000506 8498 
 2.024 0.087 0.00001012 8597 
 4.048 0.169 0.00002024 8350 
 6.144 0.267 0.00003072 8691 
 8.192 0.359 0.00004096 8765 
 10.120 0.451 0.0000506 8913 
 15.729 0.669 0.000078645 8507 
 20.480 0.910 0.0001024 8887 
 25.600 1.110 0.000128 8672 
   Average 8660 
   SD 173.9 
   CV % 2.01 % 
Note.  Molar Concentration is the bronopol concentration in solution calculated using 
the bronopol molecular weight of 199.99 grams/mol.  Molar Absorbtivity is calculated 
by rearranging Equation 3 and solving for the extinction coefficient; cuvette path 
length is 1 cm. 
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Table D4 
Analysis of Variance Results for Molar Absorption Coefficient 
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Calculated Instrument Limit of Detection 
 
 
The procedure uses calibration standard concentrations ranging from less than the 
anticipated limit of detection to no more than ten times the expected LOD.  The standard 
error of the regression for these calibration standards is first calculated using Equation 7.  
Calculations for the standard error of regression for bronopol calibration standards 
ranging in concentration from 1 µg/ml to 10 µg/ml are presented in Table D5.  The 
calculated instrumental limit of detection is then calculated using Equation 8. 
 
 
Table D5 
Calculation of the Standard Error of Regression for Low Level Calibration Standards 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Absorbance at 
244 nm 
Predicted 
Absorbance 
(Pred. Abs. – Abs.)
2
 
1 1.010 0.043 0.042435 0.000000319225 
 2.020 0.085 0.08637 0.000001876900 
 4.040 0.171 0.17424 0.000010497600 
 6.060 0.256 0.26211 0.000037332100 
 8.080 0.346 0.34998 0.000015840400 
 10.100 0.433 0.43785 0.000023522500 
2 1.028 0.045 0.043218 0.000003175524 
 2.056 0.089 0.087936 0.000001132096 
 4.112 0.178 0.177372 0.000000394384 
 6.168 0.266 0.266808 0.000000652864 
 8.224 0.355 0.356244 0.000001547536 
 10.280 0.443 0.44568 0.000007182400 
3 1.044 0.046 0.043914 0.000004351396 
 2.088 0.089 0.089328 0.000000107584 
 4.176 0.179 0.180156 0.000001336336 
 6.264 0.264 0.270984 0.000048776256 
 8.352 0.359 0.361812 0.000007907344 
 10.440 0.453 0.45264 0.000000129600 
4 1.020 0.045 0.04287 0.000004536900 
 2.040 0.087 0.08724 0.000000057600 
 4.080 0.175 0.17598 0.000000960400 
 6.120 0.264 0.26472 0.000000518400 
 8.160 0.356 0.35346 0.000006451600 
 10.200 0.446 0.4422 0.000014440000 
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Table D5 (continued) 
Calculation of the Standard Error of Regression for Low Level Calibration Standards 
Calibration 
Set Number 
Bronopol 
Conc. 
(µg/ml) 
Absorbance at 
244 nm 
Predicted 
Absorbance 
(Pred. Abs. – Abs.)
2
 
5 1.006 0.047 0.042261 0.000022458121 
 2.012 0.090 0.086022 0.000015824484 
 4.024 0.169 0.173544 0.000020647936 
 6.036 0.253 0.261066 0.000065060356 
 8.048 0.345 0.348588 0.000012873744 
 10.060 0.449 0.43611 0.000166152100 
6 1.012 0.043 0.042522 0.000000228484 
 2.024 0.087 0.086544 0.000000207936 
 4.048 0.169 0.174588 0.000031225744 
 6.144 0.267 0.265764 0.000001527696 
 8.192 0.359 0.354852 0.000017205904 
 10.120 0.451 0.43872 0.000150798400 
   Sum 0.000711856296 
Note.  Predicted absorbance is calculated using Equation 12, the least-squares 
regression calibration line.  N = 36. 
 
 
 
 
Standard Error of Regression for Calibration Standards 
 
 
sy = [∑(ŷi – yi)
2
/(N – 2)]
1/2
        (7) 
 
 
sy = [0.000711856296/(36 – 2)]
1/2
 
 
 
sy = 0.00452853 
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Calculated Instrument Limit of Detection 
 
 
 From Equation 12, the least-squares regression calibration line, the slope m 
is 0.0435. 
 
 
LOD = 3 sy/m          (8) 
 
 
LOD = (3 x 0.00452853)/0.0435 
 
 
LOD = 0.31 
 
 
Calculated Instrument Limit of Quantitation 
 
 
The instrumental limit of quantitation (LOQ) is calculated using Equation 9.  The 
most appropriate value for the LOD is 1 µg/ml, which the lowest concentration for 
calibration curve standards used in this work. 
 
 
LOQ = 3.33 x LOD         (9) 
 
 
LOQ = 3.33 x 1 µg/ml 
 
 
LOQ = 3.33 µg/ml 
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Filter Blank Count 
 
 
 Twelve treated glass fiber filters with no bronopol were extracted and analyzed.  
Sodium hydroxide concentration in solution was 0.03 molar.  Filter extract solutions were 
drawn through a syringe filter prior to analysis.  Data and the calculated average filter 
blank count are presented in Table E1. 
 
 
Table E1 
Blank Treated Glass Fiber Filter 
Extracts Filtered through Syringe Filters 
Filter No. Absorbance Value 
1 0.023 
2 0.015 
3 0.024 
4 0.021 
5 0.004 
6 0.003 
7 0.024 
8 0.019 
9 0.004 
10 0.005 
11 0.018 
12 0.016 
Average 0.015 
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Filter Spiking Data 
 
 
Treated glass fiber filters were spiked with aqueous bronopol solutions then 
evaluated for analytical recovery by comparing the adjusted absorbance reading obtained 
(i.e., actual absorbance read minus filter blank count) versus that calculated from the 
bronopol spike quantity.  Three sets of ten each treated filters were spiked with 19, 44, or 
113 µg bronopol and were designated as the Low, Medium, and High Ranges. 
Filter spiking data and calculations are presented in Tables E2, E5, and E8.  The 
Q-test for outliers is performed on intra-set values in Tables E3, E6, and E9.  The F-test 
for variances is performed on inter-set values in Tables E4, E7, and E10.  Filter spiking 
average analytical recovery and pooled coefficient of variation are presented at the end of 
the appendix. 
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Table E2 
Filter Spiking Data and Calculations – Low Range 
Filter 
Number 
Actual 
Absorbance 
Adjusted 
Absorbance 
Percent Recovery 
Low Range Set No. 1, filter spike quantity 19.04 µg bronopol, 
predicted absorbance value 0.164 
1 0.173 0.158 96.3 
2 0.168 0.153 93.2 
3 0.177 0.162 98.7 
4 0.171 0.156 95.0 
5 0.169 0.154 93.8 
  AVG 95.4 
  SD 2.18 
  CV % 2.28 % 
Low Range Set No. 2, filter spike quantity 19.00 µg bronopol, 
predicted absorbance value 0.164 
1 0.180 0.165 100.7 
2 0.177 0.162 98.9 
3 0.173 0.158 96.5 
4 0.175 0.160 97.7 
5 0.174 0.159 97.1 
  AVG 98.2 
  SD 1.69 
  CV % 1.73 % 
Note.  Adjusted absorbance is the actual absorbance read for 
the sample minus the filter blank count of 0.015 absorbance 
units. 
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Table E3 
Low Range Filter Spiking Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Low Range Set No. 1 
 93.2  
 93.8 0.6 
 95.0 1.2 
 96.3 1.3 
 98.7 2.4 
Range 5.5  
 Calculated Q for highest data point 0.436 
 Critical Q Value 0.710 
 Result Accept Value 
Low Range Set No. 2 
 96.5  
 97.1 0.6 
 97.7 0.6 
 98.9 1.2 
 100.7 1.8 
Range 4.2  
 Calculated Q for highest data point 0.429 
 Critical Q Value 0.710 
 Result Accept Value 
 
 
 
 
Table E4 
Low Range Filter Spiking F-Test For Variances 
 Low Range Set No. 1 Low Range Set No. 2 
Mean 95.402 98.168 
Variance 4.750 2.870 
Observations 5 5 
df 4 4 
F Calculated 1.655  
F Critical one-tail 6.388  
Result Variance is consistent between data sets 
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 Calculated average analytical recovery for Low Range filter spiking sets is: 
 
 
95.4 % + 98.2 % = 96.8 % 
2  
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Table E5 
Filter Spiking Data and Calculations – Medium Range 
Filter 
Number 
Actual 
Absorbance 
Adjusted 
Absorbance 
Percent Recovery 
Medium Range Set No. 1, filter spike quantity 43.04 µg 
bronopol, predicted absorbance value 0.373 
1 0.363 0.348 93.3 
2 0.354 0.339 90.9 
3 0.363 0.348 93.3 
4 0.356 0.341 91.4 
5 0.357 0.342 91.7 
  AVG 92.1 
  SD 1.12 
  CV % 1.21 % 
Medium Range Set No. 2, filter spike quantity 44.16 µg 
bronopol, predicted absorbance value 0.383 
1 0.385 0.370 96.7 
2 0.388 0.373 97.5 
3 0.381 0.366 95.6 
4 0.389 0.374 97.7 
5 0.384 0.369 96.4 
  AVG 96.8 
  SD 0.84 
  CV % 0.87 % 
Note.  Adjusted absorbance is the actual absorbance read for 
the sample minus the filter blank count of 0.015 absorbance 
units. 
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Table E6 
Medium Range Filter Spiking Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Medium Range Set No. 1 
 90.9  
 91.4 0.5 
 91.7 0.3 
 93.3 1.6 
 93.3 0 
Range 2.4  
 Calculated Q for highest data point 0.667 
 Critical Q Value 0.710 
 Result Accept Value 
Medium Range Set No. 2 
 95.6  
 96.4 0.8 
 96.7 0.3 
 97.5 0.8 
 97.7 0.2 
Range 2.1  
 Calculated Q for lowest data point 0.381 
 Critical Q Value 0.710 
 Result Accept Value 
 
 
 
 
Table E7 
Medium Range Filter Spiking F-Test For Variances 
 Medium Range Set No. 1 Medium Range Set No. 2 
Mean 92.131 96.788 
Variance 1.244 0.703 
Observations 5 5 
df 4 4 
F Calculated 1.769  
F Critical one-tail 6.388  
Result Variance is consistent between data sets 
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 Calculated average analytical recovery for Medium Range filter spiking sets is: 
 
 
92.1 % + 96.8 % = 94.5 % 
2  
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Table E8 
Filter Spiking Data and Calculations – High Range 
Filter 
Number 
Actual 
Absorbance 
Adjusted 
Absorbance 
Percent Recovery 
High Range Set No. 1, filter spike quantity 113.24 µg 
bronopol, predicted absorbance value 0.984 
1 0.943 0.928 94.3 
2 0.942 0.927 94.2 
3 0.918 0.903 91.8 
4 0.945 0.930 94.5 
5 0.952 0.937 95.3 
  AVG 94.0 
  SD 1.31 
  CV % 1.39 % 
High Range Set No. 2, filter spike quantity 113.12 µg 
bronopol, predicted absorbance value 0.983 
1 0.988 0.973 99.0 
2 0.961 0.946 96.3 
3 0.960 0.945 96.2 
4 0.968 0.953 97.0 
5 0.977 0.962 97.9 
  AVG 97.3 
  SD 1.20 
  CV % 1.23 % 
Note.  Adjusted absorbance is the actual absorbance read for 
the sample minus the filter blank count of 0.015 absorbance 
units. 
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Table E9 
High Range Filter Spiking Q-Test For Outliers 
 Ranked Recovery (%) Gap 
High Range Set No. 1 
 91.8  
 94.2 2.4 
 94.3 0.1 
 94.5 0.2 
 95.3 0.8 
Range 3.5  
 Calculated Q for lowest data point 0.686 
 Critical Q Value 0.710 
 Result Accept Value 
High Range Set No. 2 
 96.2  
 96.3 0.1 
 97.0 0.7 
 97.9 0.9 
 99.0 1.1 
Range 2.8  
 Calculated Q for highest data point 0.393 
 Critical Q Value 0.710 
 Result Accept Value 
 
 
 
 
Table E10 
High Range Filter Spiking F-Test For Variances 
 High Range Set No. 1 High Range Set No. 2 
Mean 94.034 97.268 
Variance 1.721 1.436 
Observations 5 5 
df 4 4 
F Calculated 1.198  
F Critical one-tail 6.388  
Result Variance is consistent between data sets 
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 Calculated average analytical recovery for High Range filter spiking sets is: 
 
 
94.0 % + 97.3 % = 95.7 % 
2  
 
 
Filter Spiking Average Analytical Recovery 
 
 
 Calculated average analytical recovery for all filter spiking sets is: 
 
 
96.8 % + 94.5 % + 95.7 % = 95.7 % 
3  
 
 
Filter Spiking Pooled Coefficient of Variation 
 
 
 The pooled coefficient of variation for all six filter spike sets at the three different 
spiking concentrations is calculated as follows.  Coefficient of variation is expressed as 
percent. 
 
 
Sr = 4(2.28)
2
 + 4(1.73)
2
 + 4(1.21)
2
 + 4(0.87)
2
 + 4(1.39)
2
 + 4(1.23)
2
 
1/2 
= 1.52 
 ( 24 )   
 
 
Sr = 1.52 % 
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Appendix F: Sampling Chamber Particulate Concentration Distribution 
 
 
Distribution of Bronopol Particulate Concentration in the Sampling Chamber 
 
 
To verify consistent presentation of the bronopol aerosol to the chamber samplers, 
inert PVDF filters were used to collect samples from the chamber for several trials.  A 
total of nine chamber particulate concentration distribution runs were performed, 
generating a total of twenty-seven samples.  Each sampling event lasted 20 minutes.  The 
quantity of bronopol collected on the filters was varied by sampling at different filter 
flow rates.  Flow rates used were 300, 450, and 600 ml/min and were designated as the 
Low, Medium, and High Ranges.  The filters were extracted in a derivatizing solution 
and analyzed for bronopol; sodium hydroxide concentration in solution was 0.03 molar.  
Chamber particulate distribution data and calculations are presented in Tables F1, F5, and 
F9; the Q-test for outliers is performed on intra-set values in Tables F2, F6, and F10.  
Camber flow calibration data and calculations are presented in Tables F3, F7, and F11; 
sampling pump flow calibration data and calculations are presented in Tables F4, F8, and 
F12. 
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Table F1 
Chamber Particulate Concentration Data and Calculations – Low Range 
Filter 
Number 
Pump 
Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
Low Range Set No. 1 
1 290.8 0.993 170.7 19.65 
2 291.0 1.027 176.5 20.31 
3 300.6 0.995 165.5 19.05 
  AVG 170.9 19.67 
  SD 5.48 0.63 
  CV % 3.21 % 3.21 % 
Low Range Set No. 2 
4 290.8 0.733 126.0 14.52 
5 291.0 0.746 128.2 14.76 
6 300.6 0.770 128.1 14.75 
  AVG 127.4 14.68 
  SD 1.21 0.14 
  CV % 0.95 % 0.95 % 
Low Range Set No. 3 
7 290.8 0.592 101.8 11.73 
8 291.0 0.622 106.9 12.31 
9 300.6 0.672 111.8 12.88 
  AVG 106.8 12.31 
  SD 4.99 0.57 
  CV % 4.68 % 4.68 % 
Note.  Sampling time 20 minutes for each chamber particulate 
concentration distribution set.  Bronopol Concentration in mg/m
3
 is 
obtained using Equation 12 from the bronopol calibration curve. 
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Table F2 
Low Range Chamber Particulate Concentration Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Low Range Set No. 1 
 19.05  
 19.65 0.60 
 20.31 0.66 
Range 1.26  
 Calculated Q for highest data point 0.524 
 Critical Q Value 0.970 
 Result Accept Value 
Low Range Set No. 2 
 14.52  
 14.75 0.23 
 14.76 0.01 
Range 0.24  
 Calculated Q for lowest data point 0.958 
 Critical Q Value 0.970 
 Result Accept Value 
Low Range Set No. 3 
 11.73  
 12.31 0.58 
 12.88 0.57 
Range 1.15  
 Calculated Q for lowest data point 0.504 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for Low Range chamber particulate concentration distribution sets is: 
 
 
Sr = 2(3.21)
2
 + 2(0.95)
2
 + 2(4.68)
2
 
1/2 
= 3.32 
 ( 6 )   
 
 
Sr = 3.32 % 
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Table F3 
Chamber Flow Calibration – Low Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2012 2008 
 2013 2008 
 2012 2008 
 2014 2007 
 2012 2008 
 2012 2007 
 2013 2006 
 2012 2007 
 2012 2006 
 2012 2006 
AVG 2012 2007 
SD 0.70 0.88 
CV % 0.035 % 0.044 % 
Chamber Average Flow 2010 ml/min 
 
 
 
Table F4 
Pump Flow Calibration – Low Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 287.7 295.5 294.4 287.3 296.4 303.3 
 287.7 295.5 294.3 288.1 296.7 303.7 
 287.6 294.9 294.5 288.7 296.9 303.9 
 287.6 294.7 294.4 287.9 296.9 304.1 
 287.6 294.2 294.3 288.1 297.1 303.7 
 287.3 293.9 294.4 288.0 297.3 304.0 
 287.4 293.9 294.4 287.5 297.2 304.2 
 286.9 293.9 292.2 287.3 297.0 304.5 
 286.5 293.2 294.7 287.1 297.3 304.9 
 286.7 293.2 294.9 287.7 297.2 305.6 
AVG 287.3 294.3 294.3 287.8 297.0 304.2 
SD 0.44 0.84 0.74 0.49 0.29 0.67 
CV % 0.15 % 0.28 % 0.25 % 0.17 % 0.10 % 0.22 % 
Pump 
Avg. 
290.8 ml/min 291.0 ml/min 300.6 ml/min 
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Table F5 
Chamber Particulate Concentration Data and Calculations – Medium Range 
Filter 
Number 
Pump 
Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
Medium Range Set No. 1 
1 464.6 1.577 169.7 19.53 
2 463.0 1.523 164.5 18.92 
3 456.5 1.498 164.1 18.88 
  AVG 166.1 19.11 
  SD 3.15 0.36 
  CV % 1.90 % 1.90 % 
Medium Range Set No. 2 
4 464.6 1.470 158.2 18.20 
5 463.0 1.403 151.5 17.43 
6 456.5 1.498 164.1 18.88 
  AVG 157.9 18.17 
  SD 6.29 0.72 
  CV % 3.98 % 3.98 % 
Medium Range Set No. 3 
7 464.6 1.126 121.2 13.95 
8 463.0 1.197 129.3 14.88 
9 456.5 1.144 125.3 14.42 
  AVG 125.2 14.42 
  SD 4.04 0.46 
  CV % 3.23 % 3.23 % 
Note.  Sampling time 20 minutes for each chamber particulate 
concentration distribution set.  Bronopol Concentration in mg/m
3
 is 
obtained using Equation 12 from the bronopol calibration curve. 
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Table F6 
Medium Range Chamber Particulate Concentration Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Medium Range Set No. 1 
 18.88  
 18.92 0.04 
 19.53 0.61 
Range 0.65  
 Calculated Q for highest data point 0.938 
 Critical Q Value 0.970 
 Result Accept Value 
Medium Range Set No. 2 
 17.43  
 18.20 0.77 
 18.88 0.68 
Range 1.45  
 Calculated Q for lowest data point 0.531 
 Critical Q Value 0.970 
 Result Accept Value 
Medium Range Set No. 3 
 13.95  
 14.42 0.47 
 14.88 0.46 
Range 0.93  
 Calculated Q for lowest data point 0.505 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for Medium Range chamber particulate concentration distribution sets 
is: 
 
 
Sr = 2(1.90)
2
 + 2(3.98)
2
 + 2(3.23)
2
 
1/2 
= 3.16 
 ( 6 )   
 
 
Sr = 3.16 % 
 
 139
Appendix F (continued) 
 
 
Table F7 
Chamber Flow Calibration – Medium Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2025 2005 
 2025 2006 
 2026 2005 
 2026 2005 
 2025 2004 
 2024 2005 
 2024 2005 
 2024 2005 
 2025 2004 
 2025 2004 
AVG 2025 2005 
SD 0.74 0.63 
CV % 0.036 % 0.032 % 
Chamber Average Flow 2015 ml/min 
 
 
 
Table F8 
Pump Flow Calibration – Medium Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 456.8 473.3 464.1 462.2 448.7 462.5 
 456.9 473.7 464.7 463.1 448.6 462.6 
 457.9 473.6 464.5 463.0 449.6 463.7 
 457.6 473.1 464.3 463.0 449.9 463.5 
 458.7 468.9 464.4 463.0 449.9 463.5 
 458.3 468.8 464.5 463.5 449.6 463.5 
 459.1 468.9 464.0 463.3 449.0 463.2 
 459.9 469.2 464.0 463.2 449.2 463.3 
 460.0 468.5 457.9 463.0 449.9 463.2 
 460.5 468.3 458.1 462.4 451.3 464.3 
AVG 458.6 470.6 463.1 463.0 449.6 463.3 
SD 1.30 2.42 2.67 0.39 0.78 0.52 
CV % 0.28 % 0.51 % 0.58 % 0.08 % 0.17 % 0.11 % 
Pump 
Avg. 
464.6 ml/min 463.0 ml/min 456.5 ml/min 
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Table F9 
Chamber Particulate Concentration Data and Calculations – High Range 
Filter 
Number 
Pump 
Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
High Range Set No. 1 
1 604.8 1.968 162.7 18.72 
2 585.3 1.921 164.1 18.88 
3 610.9 1.977 161.8 18.61 
  AVG 162.9 18.74 
  SD 1.16 0.13 
  CV % 0.71 % 0.71 % 
High Range Set No. 2 
4 604.8 1.732 143.2 16.47 
5 585.3 1.782 152.2 17.51 
6 610.9 1.695 138.7 15.96 
  AVG 144.7 16.65 
  SD 6.88 0.79 
  CV % 4.75 % 4.75 % 
High Range Set No. 3 
7 604.8 1.373 113.5 13.06 
8 585.3 1.276 109.0 12.54 
9 610.9 1.357 111.1 12.78 
  AVG 111.2 12.80 
  SD 2.26 0.26 
  CV % 2.03 % 2.03 % 
Note.  Sampling time 20 minutes for each chamber particulate 
concentration distribution set.  Bronopol Concentration in mg/m
3
 is 
obtained using Equation 12 from the bronopol calibration curve. 
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Table F10 
High Range Chamber Particulate Concentration Q-Test For Outliers 
 Ranked Recovery (%) Gap 
High Range Set No. 1 
 18.61  
 18.72 0.11 
 18.88 0.16 
Range 0.27  
 Calculated Q for highest data point 0.593 
 Critical Q Value 0.970 
 Result Accept Value 
High Range Set No. 2 
 15.96  
 16.47 0.51 
 17.51 1.04 
Range 1.55  
 Calculated Q for highest data point 0.671 
 Critical Q Value 0.970 
 Result Accept Value 
High Range Set No. 3 
 12.54  
 12.78 0.24 
 13.06 0.28 
Range 0.52  
 Calculated Q for highest data point 0.538 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for High Range chamber particulate concentration distribution sets is: 
 
 
Sr = 2(0.71)
2
 + 2(4.75)
2
 + 2(2.03)
2
 
1/2 
= 3.01 
 ( 6 )   
 
 
Sr = 3.01 % 
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Table F11 
Chamber Flow Calibration – High Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2016 2007 
 2016 2006 
 2015 2008 
 2020 2007 
 2015 2006 
 2015 2006 
 2017 2005 
 2016 2006 
 2012 2005 
 2015 2002 
AVG 2016 2006 
SD 2.00 1.62 
CV % 0.10 % 0.08 % 
Chamber Average Flow 2011 ml/min 
 
 
 
Table F12 
Pump Flow Calibration – High Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 597.4 612.1 587.0 577.1 611.6 609.9 
 597.0 612.0 587.9 577.1 611.8 610.0 
 596.6 612.0 588.9 577.0 611.8 609.8 
 597.0 612.0 595.5 577.1 612.0 609.8 
 596.9 612.2 595.7 577.2 612.2 609.6 
 597.3 612.2 595.7 577.0 612.2 609.5 
 597.3 612.6 595.6 578.3 612.0 609.6 
 598.1 612.5 595.0 578.0 612.2 609.6 
 597.9 612.5 595.0 578.1 612.2 609.5 
 597.7 612.5 594.4 578.1 612.3 609.4 
AVG 597.3 612.3 593.1 577.5 612.0 609.7 
SD 0.47 0.24 3.60 0.55 0.23 0.19 
CV % 0.08 % 0.04 % 0.61 % 0.09 % 0.04 % 0.03 % 
Pump 
Avg. 
604.8 ml/min 585.3 ml/min 610.9 ml/min 
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Sampling Chamber Bronopol Particulate Concentration Pooled Coefficient of Variation 
 
 
 The pooled coefficient of variation for all nine chamber particulate concentration 
distribution sets at the three different sampling flow rates is calculated as follows.  
Coefficient of variation is expressed as percent. 
 
 
Sr = 2(3.21)
2
 + 2(0.95)
2
 + 2(4.68)
2
 + 2(1.90)
2
 + 2(3.98)
2
 + 
2(3.23)
2
 + 2(0.71)
2
 + 2(4.75)
2
 + 2(2.03)
2
 
1/2 
= 3.17 
 ( 18 )   
 
 
Sr = 3.17 % 
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Sampling of Generated Bronopol Atmospheres 
 
 
For sampling of bronopol particulate in the chamber, one inert PVDF filter and 
two treated glass fiber filters were used simultaneously.  Each sampling event lasted 20 
minutes.  The quantity of bronopol collected on the filters was varied by sampling at 
different filter flow rates.  Flow rates used were 300, 450, and 600 ml/min and were 
designated as the Low, Medium, and High Ranges. 
In all this produced eighteen bronopol samples collected on treated glass fiber 
filters.  The analytical results from the treated glass fiber filters are compared against the 
nine inert PVDF filters that were sampled concurrently.  PVDF filters were extracted in a 
derivatizing solution; glass fiber filters were extracted in spectrophotometric grade water.  
Sodium hydroxide concentration in solution for all filter types was 0.03 molar.  Chamber 
sampling data and bronopol concentration calculations are presented in Tables G1, G6, 
and G11; the Q-test for outliers is performed on intra-set values in Tables G2, G7, and 
G12.  Recovery data and calculations are presented in Tables G3, G8, and G13.  Chamber 
flow calibration data and calculations are presented in Tables G4, G9, and G14.  
Sampling pump flow calibration data and calculations are presented in Tables G5, G10, 
and G15. 
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Table G1 
Chamber Sampling Data and Concentration Calculations – Low Range 
Filter 
Number 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
Low Range Set No. 1 
1 (PVDF) 316.8 1.156 182.4 21.00 
2 (GFF) 303.4 1.097 180.8 20.81 
3 (GFF) 328.0 1.116 170.1 19.58 
  AVG 177.8 20.46 
  SD 6.69 0.77 
  CV % 3.76 % 3.76 % 
Low Range Set No. 2 
4 (PVDF) 316.8 0.885 139.7 16.08 
5 (GFF) 303.4 0.851 140.2 16.15 
6 (GFF) 328.0 0.847 129.1 14.87 
  AVG 136.4 15.70 
  SD 6.26 0.72 
  CV % 4.59 % 4.59 % 
Low Range Set No. 3 
7 (PVDF) 316.8 0.729 115.1 13.25 
8 (GFF) 303.4 0.745 122.8 14.14 
9 (GFF) 328.0 0.777 118.4 13.64 
  AVG 118.8 13.68 
  SD 3.87 0.45 
  CV % 3.26 % 3.26 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Bronopol 
Concentration in mg/m
3
 is obtained using Equation 12 from the bronopol 
calibration curve. 
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Table G2 
Low Range Chamber Sampling Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Low Range Set No. 1 
 19.05  
 19.65 0.60 
 20.31 0.66 
Range 1.26  
 Calculated Q for highest data point 0.524 
 Critical Q Value 0.970 
 Result Accept Value 
Low Range Set No. 2 
 14.52  
 14.75 0.23 
 14.76 0.01 
Range 0.24  
 Calculated Q for lowest data point 0.958 
 Critical Q Value 0.970 
 Result Accept Value 
Low Range Set No. 3 
 11.73  
 12.31 0.58 
 12.88 0.57 
Range 1.15  
 Calculated Q for lowest data point 0.504 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for concentration in Low Range chamber sampling sets including all 
GFF and PVDF filters is: 
 
 
Sr = 2(3.76)
2
 + 2(4.59)
2
 + 2(3.26)
2
 
1/2 
= 3.91 
 ( 6 )   
 
 
Sr = 3.91 % 
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Table G3 
Chamber Sampling Data and Recovery Calculations – Low Range 
Filter 
Number 
(Type) 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Concentration 
(abs/m
3
) 
Recovery 
Versus 
Standard 
Low Range Set No. 1 
1 (PVDF) 316.8 1.156 182.4 - 
2 (GFF) 303.4 1.097 180.8 99.1 % 
3 (GFF) 328.0 1.116 170.1 93.3 % 
  AVG 177.8 96.2 % 
  SD 6.69 4.13 
  CV % 3.76 % 4.30 % 
Low Range Set No. 2 
4 (PVDF) 316.8 0.885 139.7 - 
5 (GFF) 303.4 0.851 140.2 100.4 % 
6 (GFF) 328.0 0.847 129.1 92.4 % 
  AVG 136.4 96.4 % 
  SD 6.26 5.63 
  CV % 4.59 % 5.83 % 
Low Range Set No. 3 
7 (PVDF) 316.8 0.729 115.1 - 
8 (GFF) 303.4 0.745 122.8 106.7 % 
9 (GFF) 328.0 0.777 118.4 102.9 % 
  AVG 118.8 104.8 % 
  SD 3.87 2.66 
  CV % 3.26 % 2.54 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Recovery 
Versus Standard is the concentration for each GFF filter as a percent of the 
concentration for the concurrently sampled PVDF filter. 
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 Calculated average analytical recovery for the Low Range chamber sampling 
sets is: 
 
 
96.2 % + 96.4 % + 104.8 % = 99.1 % 
3  
 
 
 Pooled CV for analytical recovery in Low Range chamber sampling sets with 
glass fiber filter (GFF) data exclusively is: 
 
 
Sr = 1(4.30)
2
 + 1(5.83)
2
 + 1(2.54)
2
 
1/2 
= 4.43 
 ( 3 )   
 
 
Sr = 4.43 % 
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Table G4 
Chamber Flow Calibration – Low Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2010 2002 
 2010 2001 
 2010 2003 
 2009 2002 
 2008 2002 
 2010 1998 
 2009 2000 
 2009 2000 
 2009 2001 
 2008 2000 
AVG 2009 2001 
SD 0.79 1.45 
CV % 0.039 % 0.072 % 
Chamber Average Flow 2005 ml/min 
 
 
 
Table G5 
Pump Flow Calibration – Low Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 323.6 309.2 299.2 307.3 331.8 322.9 
 323.9 309.1 299.2 307.1 330.9 323.5 
 323.7 309.0 299.1 306.9 331.7 323.6 
 323.7 310.2 299.1 306.7 331.9 323.7 
 323.6 310.7 299.4 309.9 331.9 323.8 
 323.7 310.6 299.3 306.9 332.1 324.4 
 324.4 310.2 299.7 306.7 332.4 324.5 
 323.9 310.1 302.1 306.4 332.1 324.2 
 323.6 309.6 299.9 306.5 332.2 324.8 
 323.8 309.1 300.4 306.2 332.6 325.1 
AVG 323.8 309.8 299.7 307.1 332.0 324.1 
SD 0.24 0.66 0.93 1.05 0.46 0.67 
CV % 0.07 % 0.21 % 0.31 % 0.34 % 0.14 % 0.21% 
Pump 
Avg. 
316.8 ml/min 303.4 ml/min 328.0 ml/min 
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Table G6 
Chamber Sampling Data and Concentration Calculations – Medium Range 
Filter 
Number 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
Medium Range Set No. 1 
1 (PVDF) 463.7 1.812 195.4 22.48 
2 (GFF) 456.1 1.619 177.5 20.42 
3 (GFF) 452.6 1.722 190.2 21.89 
  AVG 187.7 21.59 
  SD 9.22 1.06 
  CV % 4.91 % 4.91 % 
Medium Range Set No. 2 
4 (PVDF) 463.7 1.667 179.8 20.68 
5 (GFF) 456.1 1.688 185.0 21.29 
6 (GFF) 452.6 1.745 192.8 22.18 
  AVG 185.9 21.38 
  SD 6.55 0.75 
  CV % 3.52 % 3.52 % 
Medium Range Set No. 3 
7 (PVDF) 463.7 1.543 166.4 19.14 
8 (GFF) 456.1 1.443 158.2 18.20 
9 (GFF) 452.6 1.365 150.8 17.35 
  AVG 158.5 18.23 
  SD 7.80 0.90 
  CV % 4.92 % 4.92 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Bronopol 
Concentration in mg/m
3
 is obtained using Equation 12 from the bronopol 
calibration curve. 
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Table G7 
Medium Range Chamber Sampling Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Medium Range Set No. 1 
 20.42  
 21.89 1.47 
 22.48 0.59 
Range 2.06  
 Calculated Q for highest data point 0.714 
 Critical Q Value 0.970 
 Result Accept Value 
Medium Range Set No. 2 
 20.68  
 21.29 0.61 
 22.18 0.89 
Range 1.50  
 Calculated Q for lowest data point 0.593 
 Critical Q Value 0.970 
 Result Accept Value 
Medium Range Set No. 3 
 17.35  
 18.20 0.85 
 19.14 0.94 
Range 1.79  
 Calculated Q for lowest data point 0.525 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for concentration in Medium Range chamber sampling sets including 
all GFF and PVDF filters is: 
 
 
Sr = 2(4.91)
2
 + 2(3.52)
2
 + 2(4.92)
2
 
1/2 
= 4.50 
 ( 6 )   
 
 
Sr = 4.50 % 
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Table G8 
Chamber Sampling Data and Recovery Calculations – Medium Range 
Filter 
Number 
(Type) 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Concentration 
(abs/m
3
) 
Recovery 
Versus 
Standard 
Medium Range Set No. 1 
1 (PVDF) 463.7 1.812 195.4 - 
2 (GFF) 456.1 1.619 177.5 90.8 % 
3 (GFF) 452.6 1.722 190.2 97.4 % 
  AVG 187.7 94.1 % 
  SD 9.22 4.61 
  CV % 4.91 % 4.90 % 
Medium Range Set No. 2 
4 (PVDF) 463.7 1.667 179.8 - 
5 (GFF) 456.1 1.688 185.0 103.0 % 
6 (GFF) 452.6 1.745 192.8 107.3 % 
  AVG 185.9 105.1 % 
  SD 6.55 3.04 
  CV % 3.52 % 2.89 % 
Medium Range Set No. 3 
7 (PVDF) 463.7 1.543 166.4 - 
8 (GFF) 456.1 1.443 158.2 95.1 % 
9 (GFF) 452.6 1.365 150.8 90.6 % 
  AVG 158.5 92.9 % 
  SD 7.80 3.14 
  CV % 4.92 % 3.38 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Recovery 
Versus Standard is the concentration for each GFF filter as a percent of the 
concentration for the concurrently sampled PVDF filter. 
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 Calculated average analytical recovery for the Medium Range chamber sampling 
sets is: 
 
 
94.1 % + 105.1 % + 92.9 % = 97.4 % 
3  
 
 
 Pooled CV for analytical recovery in Medium Range chamber sampling sets with 
glass fiber filter (GFF) data exclusively is: 
 
 
Sr = 1(4.90)
2
 + 1(2.89)
2
 + 1(3.38)
2
 
1/2 
= 3.82 
 ( 3 )   
 
 
Sr = 3.82 % 
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Table G9 
Chamber Flow Calibration – Medium Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2022 2012 
 2020 2013 
 2021 2010 
 2019 2012 
 2017 2011 
 2018 2011 
 2020 2013 
 2020 2012 
 2019 2009 
 2020 2010 
AVG 2020 2011 
SD 1.43 1.34 
CV % 0.071 % 0.066 % 
Chamber Average Flow 2015 ml/min 
 
 
 
Table G10 
Pump Flow Calibration – Medium Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 455.9 472.4 461.0 449.7 457.7 449.9 
 454.7 472.5 461.2 449.3 457.0 450.4 
 455.4 472.0 461.9 448.6 457.5 449.1 
 455.1 472.3 462.2 448.9 457.6 449.5 
 454.9 472.7 462.3 449.4 451.4 449.1 
 454.5 472.6 462.6 451.3 456.9 448.3 
 454.7 472.5 462.5 450.8 456.9 448.1 
 454.6 472.7 462.9 450.7 456.7 447.8 
 454.0 473.0 463.5 450.1 456.5 447.9 
 453.8 473.3 464.0 449.7 456.6 447.7 
AVG 454.8 472.6 462.4 449.9 456.5 448.8 
SD 0.62 0.36 0.93 0.87 1.83 0.95 
CV % 0.14 % 0.08 % 0.20 % 0.19 % 0.40 % 0.21 % 
Pump 
Avg. 
463.7 ml/min 456.1 ml/min 452.6 ml/min 
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Table G11 
Chamber Sampling Data and Concentration Calculations – High Range 
Filter 
Number 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Bronopol 
Concentration 
(abs/m
3
) 
Bronopol 
Concentration 
(mg/m
3
) 
High Range Set No. 1 
1 (PVDF) 604.4 1.959 162.1 18.64 
2 (GFF) 602.5 1.911 158.6 18.24 
3 (GFF) 598.9 1.819 151.9 17.47 
  AVG 157.5 18.12 
  SD 5.19 0.60 
  CV % 3.29 % 3.29 % 
High Range Set No. 2 
4 (PVDF) 604.4 1.619 133.9 15.41 
5 (GFF) 602.5 1.779 147.6 16.98 
6 (GFF) 598.9 1.781 148.7 17.11 
  AVG 143.4 16.50 
  SD 8.23 0.95 
  CV % 5.74 % 5.74 % 
High Range Set No. 3 
7 (PVDF) 604.4 1.113 92.07 10.60 
8 (GFF) 602.5 1.095 90.87 10.46 
9 (GFF) 598.9 1.179 98.43 11.33 
  AVG 93.79 10.80 
  SD 4.06 0.47 
  CV % 4.33 % 4.33 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Bronopol 
Concentration in mg/m
3
 is obtained using Equation 12 from the bronopol 
calibration curve. 
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Table G12 
High Range Chamber Sampling Q-Test For Outliers 
 Ranked Recovery (%) Gap 
High Range Set No. 1 
 17.47  
 18.24 0.77 
 18.64 0.40 
Range 1.17  
 Calculated Q for highest data point 0.658 
 Critical Q Value 0.970 
 Result Accept Value 
High Range Set No. 2 
 15.41  
 16.98 1.57 
 17.11 0.13 
Range 1.70  
 Calculated Q for lowest data point 0.924 
 Critical Q Value 0.970 
 Result Accept Value 
High Range Set No. 3 
 10.46  
 10.60 0.14 
 11.33 0.73 
Range 0.89  
 Calculated Q for lowest data point 0.839 
 Critical Q Value 0.970 
 Result Accept Value 
 
 
 
 
 Pooled CV for concentration in High Range chamber sampling sets including all 
GFF and PVDF filters is: 
 
 
Sr = 2(3.29)
2
 + 2(5.74)
2
 + 2(4.33)
2
 
1/2 
= 4.57 
 ( 6 )   
 
 
Sr = 4.57 % 
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Table G13 
Chamber Sampling Data and Recovery Calculations – High Range 
Filter 
Number 
(Type) 
Pump Flow 
(ml/min) 
Sample 
Absorbance 
Concentration 
(abs/m
3
) 
Recovery 
Versus 
Standard 
High Range Set No. 1 
1 (PVDF) 604.4 1.959 162.1 - 
2 (GFF) 602.5 1.911 158.6 97.9 % 
3 (GFF) 598.9 1.819 151.9 93.7 % 
  AVG 157.5 95.8% 
  SD 5.19 2.94 
  CV % 3.29 % 3.06 % 
High Range Set No. 2 
4 (PVDF) 604.4 1.619 133.9 - 
5 (GFF) 602.5 1.779 147.6 110.2 % 
6 (GFF) 598.9 1.781 148.7 111.1 % 
  AVG 143.4 110.7 % 
  SD 8.23 0.56 
  CV % 5.74 % 0.50 % 
High Range Set No. 3 
7 (PVDF) 604.4 1.113 92.07 - 
8 (GFF) 602.5 1.095 90.87 98.7 % 
9 (GFF) 598.9 1.179 98.43 106.9 % 
  AVG 93.79 102.8 % 
  SD 4.06 5.81 
  CV % 4.33 % 5.65 % 
Note.  Sampling time 20 minutes for each chamber sampling set.  Recovery 
Versus Standard is the concentration for each GFF filter as a percent of the 
concentration for the concurrently sampled PVDF filter. 
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 Calculated average analytical recovery for the High Range chamber sampling 
sets is: 
 
 
95.8 % + 110.7 % + 102.8 % = 103.1 % 
3  
 
 
 Pooled CV for analytical recovery in High Range chamber sampling sets with 
glass fiber filter (GFF) data exclusively is: 
 
 
Sr = 1(3.06)
2
 + 1(0.50)
2
 + 1(5.65)
2
 
1/2 
= 3.72 
 ( 3 )   
 
 
Sr = 3.72 % 
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Table G14 
Chamber Flow Calibration – High Range 
 Pre-Calibration 
Flow 
(ml/min) 
Post-Calibration 
Flow 
(ml/min) 
 2012 1993 
 2012 1994 
 2012 1997 
 2011 1999 
 2010 1997 
 2009 1998 
 2009 2002 
 2010 2001 
 2009 1999 
 2010 2000 
AVG 2010 1998 
SD 1.26 2.87 
CV % 0.063 % 0.144 % 
Chamber Average Flow 2004 ml/min 
 
 
 
Table G15 
Pump Flow Calibration – High Range 
 Pump 1 Pump 2 Pump 3 
 Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
Pre 
(ml/min) 
Post 
(ml/min) 
 612.2 595.8 605.8 598.7 593.9 603.5 
 612.5 595.8 605.7 598.9 594.1 605.7 
 614.5 595.7 605.5 599.3 594.3 603.0 
 615.5 595.3 605.4 599.9 594.3 603.4 
 614.4 595.3 605.0 600.0 594.2 603.3 
 613.8 595.3 604.9 600.0 594.4 603.0 
 613.6 595.7 604.8 599.8 594.0 603.2 
 613.1 595.5 605.2 599.9 594.1 603.3 
 612.4 595.3 605.0 600.4 593.6 603.7 
 611.7 595.3 605.4 601.1 593.7 605.4 
AVG 613.4 595.5 605.3 599.8 594.1 603.8 
SD 1.20 0.23 0.34 0.70 0.26 0.97 
CV % 0.20 % 0.04 % 0.06 % 0.12 % 0.04 % 0.16 % 
Pump 
Avg. 
604.4 ml/min 602.5 ml/min 598.9 ml/min 
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Sampling of Airborne Bronopol Pooled Coefficient of Variation 
 
 
 The pooled coefficient of variation for all nine chamber sampling sets at the three 
different sampling flow rates is calculated as follows.  PVDF and GFF filter data are 
included in the calculation.  Coefficient of variation is expressed as percent. 
 
 
Sr = 2(3.76)
2
 + 2(4.59)
2
 + 2(3.26)
2
 + 2(4.91)
2
 + 2(3.52)
2
 + 
2(4.92)
2
 + 2(3.29)
2
 + 2(5.74)
2
 + 2(4.33)
2
 
1/2 
= 4.33 
 ( 18 )   
 
 
Sr = 4.33 %  (Including all PVDF and GFF filters) 
 
 
 The pooled coefficient of variation for all nine chamber sampling sets at the three 
different sampling flow rates is calculated as follows.  Only GFF filter data are included 
in the calculation.  Coefficient of variation is expressed as percent. 
 
 
Sr = 1(4.30)
2
 + 1(5.83)
2
 + 1(2.54)
2
 + 1(4.90)
2
 + 1(2.89)
2
 + 
1(3.38)
2
 + 1(3.06)
2
 + 1(0.50)
2
 + 2(5.65)
2
 
1/2 
= 4.00 
 ( 9 )   
 
 
Sr = 4.00 %  (Including only GFF filters) 
 
 
Sampling of Airborne Bronopol Average Recovery 
 
 
 Calculated average recovery for all of the glass fiber filters used in chamber 
sampling sets is: 
 
 
99.1 % + 97.4 % + 103.1 % = 99.9 % 
3  
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Derivatized Bronopol Solutions 
 
 
Aqueous bronopol was spiked onto 18 treated glass fiber filters; the filters were 
allowed to air dry.  Six filters were spiked with 25 µg bronopol, six with 60 µg bronopol, 
and six with 125 µg bronopol; these were designated as the Low, Medium, and High 
Ranges.  Filters were extracted and analyzed on the same day.  The solutions from day 
one were stored and analyzed again after fourteen days.  Coefficient of variation analysis 
was performed for filter sets at each spike loading level; a change of 10% or less was 
considered acceptable (NIOSH, 1995). 
Bronopol solution sample storage stability data and calculations are presented in 
Tables H1, H4, and H7.  The Q-test for outliers is performed on intra-set values in Tables 
H2, H5, and H8.  The F-test for variances is performed on inter-set values in Tables H3, 
H6, and H9.  The calculated average change in absorbance values from the first day to 
day fourteen is presented at the end of the appendix. 
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Table H1 
Bronopol Solution Storage Stability Data and Calculations – Low Range 
 
Solution 
Number 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
Day Fourteen 
 
Recovery 
(%) 
1 0.217 99.7 0.217 99.7 
2 0.206 94.6 0.211 96.9 
3 0.206 94.6 0.208 95.5 
4 0.212 97.4 0.209 96.0 
5 0.208 95.5 0.211 96.9 
6 0.213 97.8 0.213 97.8 
AVG 0.210 96.6 0.212 97.1 
SD 0.004 2.03 0.003 1.47 
CV % 2.10 % 2.10 % 1.52 % 1.52 % 
Note.  Each treated GFF filter spiked with 25.2 µg bronopol; predicted absorbance for 
the derivatized bronopol is 0.218.  The adjusted absorbance is calculated as the 
absorbance read from each sample minus the filter blank count of 0.015 absorbance 
units; Recovery is then the adjusted absorbance divided by the predicted absorbance 
expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to day fourteen is: 
 
 
׀   0.210 - 0.212   ׀ 100 % = 0.95 % 
(0.210 + 0.212)/2   
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Table H2 
Low Range Solution Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Low Range Set First Day 
 94.6  
 94.6 0 
 95.5 0.9 
 97.4 1.9 
 97.6 0.2 
 99.7 2.1 
Range 5.1  
 Calculated Q for highest data point 0.412 
 Critical Q Value 0.625 
 Result Accept Value 
Low Range Set Day Fourteen 
 95.5  
 96.0 0.5 
 96.9 0.9 
 96.9 0 
 97.8 0.9 
 99.7 1.9 
Range 4.2  
 Calculated Q for highest data point 0.452 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H3 
Low Range Solution Storage Stability F-Test For Variances 
 First Day Day Fourteen 
Mean 96.6 94.9 
Variance 4.09 3.55 
Observations 6 6 
df 5 5 
F Calculated 1.15  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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Table H4 
Bronopol Solution Storage Stability Data and Calculations – Medium Range 
 
Solution 
Number 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
Day Fourteen 
 
Recovery 
(%) 
1 0.482 93.0 0.482 93.0 
2 0.503 97.0 0.499 96.3 
3 0.492 94.9 0.502 96.8 
4 0.502 96.8 0.499 96.3 
5 0.494 95.3 0.479 92.4 
6 0.494 95.3 0.489 94.3 
AVG 0.495 95.4 0.492 94.8 
SD 0.008 1.47 0.010 1.88 
CV % 1.54 % 1.54 % 1.98 % 1.98 % 
Note.  Each treated GFF filter spiked with 59.76 µg bronopol; predicted absorbance 
for the derivatized bronopol is 0.518.  The adjusted absorbance is calculated as the 
absorbance read from each sample minus the filter blank count of 0.015 absorbance 
units; Recovery is then the adjusted absorbance divided by the predicted absorbance 
expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to day fourteen is: 
 
 
׀   0.495 - 0.492   ׀ 100 % = 0.61 % 
(0.495 + 0.492)/2   
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Table H5 
Medium Range Solution Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Medium Range Set First Day 
 93.0  
 94.9 1.9 
 95.3 0.4 
 95.3 0 
 96.8 1.5 
 97.0 0.2 
Range 4.0  
 Calculated Q for lowest data point 0.475 
 Critical Q Value 0.625 
 Result Accept Value 
Medium Range Set Day Fourteen 
 92.4  
 93.0 0.6 
 94.3 1.3 
 96.3 2 
 96.3 0 
 96.8 0.5 
Range 4.4  
 Calculated Q for lowest data point 0.136 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H6 
Medium Range Solution Storage Stability F-Test For Variances 
 First Day Day Fourteen 
Mean 95.4 94.9 
Variance 2.11 3.55 
Observations 6 6 
df 5 5 
F Calculated 0.595  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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Table H7 
Bronopol Solution Storage Stability Data and Calculations – High Range 
 
Solution 
Number 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
Day Fourteen 
 
Recovery 
(%) 
1 1.077 98.3 1.066 97.3 
2 1.058 96.6 1.041 95.0 
3 1.019 93.0 1.006 91.8 
4 1.043 95.2 1.028 93.8 
5 1.021 93.2 1.019 93.0 
6 1.042 95.1 1.062 96.9 
AVG 1.043 95.2 1.037 94.6 
SD 0.022 2.02 0.024 2.18 
CV % 2.12 % 2.12 % 2.30 % 2.30 % 
Note.  Each treated GFF filter spiked with 126.12 µg bronopol; predicted absorbance 
for the derivatized bronopol is 1.096.  The adjusted absorbance is calculated as the 
absorbance read from each sample minus the filter blank count of 0.015 absorbance 
units; Recovery is then the adjusted absorbance divided by the predicted absorbance 
expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to day fourteen is: 
 
 
׀   1.043 – 1.037   ׀ 100 % = 0.58 % 
(1.043 + 1.037)/2   
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Table H8 
High Range Solution Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
High Range Set First Day 
 93.0  
 93.2 0.2 
 95.1 1.9 
 95.2 0.1 
 96.6 1.4 
 98.3 1.7 
Range 5.3  
 Calculated Q for highest data point 0.321 
 Critical Q Value 0.625 
 Result Accept Value 
High Range Set Day Fourteen 
 91.8  
 93.0 1.2 
 93.8 0.8 
 95.0 1.2 
 96.9 1.9 
 97.3 0.4 
Range 5.5  
 Calculated Q for lowest data point 0.218 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H9 
High Range Solution Storage Stability F-Test For Variances 
 First Day Day Fourteen 
Mean 95.2 94.6 
Variance 4.08 4.75 
Observations 6 6 
df 5 5 
F Calculated 0.858  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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 The calculated average change in absorbance values for all derivatized bronopol 
solutions from the initial analysis to day fourteen is: 
 
 
0.95 % + 0.61 % + 0.58 % = 0.71 % 
3  
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Bronopol on Treated Glass Fiber Filters 
 
 
Aqueous bronopol was spiked onto 36 treated glass fiber filters; the filters were 
allowed to air dry.  Twelve filters were spiked with 25 µg bronopol, twelve with 60 µg 
bronopol, and twelve with 125 µg bronopol.  Six of each set were extracted and analyzed 
on the same day; six of each set were extracted and analyzed after 48 hours.  Coefficient 
of variation analysis was performed for filter sets at each spike loading level; a change of 
10 % or less was considered acceptable (NIOSH, 1995). 
Bronopol spiked sample storage stability data and calculations are presented in 
Tables H10, H13, and H16.  The Q-test for outliers is performed on intra-set values in 
Tables H11, H14, and H17.  The F-test for variances is performed on inter-set values in 
Tables H12, H15, and H18.  The calculated average change in absorbance values from 
the same day to 48 hours later is presented at the end of the appendix. 
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Table H10 
Spiked Filter Storage Stability Data and Calculations – Low Range 
 
Filter Numbers 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
48 Hours 
 
Recovery 
(%) 
1 / 7 0.216 96.6 0.211 94.3 
2 / 8 0.214 95.7 0.217 97.0 
3 / 9 0.206 92.1 0.215 96.1 
4 / 10 0.218 97.5 0.204 91.2 
5 / 11 0.206 92.1 0.201 89.9 
6 / 12 0.200 89.4 0.208 93.0 
AVG 0.210 93.9 0.209 93.6 
SD 0.007 3.15 0.006 2.78 
CV % 3.35 % 3.35 % 2.97 % 2.97 % 
Note.  Each treated GFF filter spiked with 25.88 µg bronopol; predicted absorbance 
for the derivatized bronopol is 0.224.  Filter Numbers reflect the filter number 
extracted and analyzed on the first day and the filter number extracted and analyzed 
after 48 hours.  The adjusted absorbance is calculated as the absorbance read from 
each sample minus the filter blank count of 0.015 absorbance units; Recovery is then 
the adjusted absorbance divided by the predicted absorbance expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to 48 hours later is: 
 
 
׀   0.210 - 0.209   ׀ 100 % = 0.48 % 
(0.210 + 0.209)/2   
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Table H11 
Low Range Spiked Filter Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Low Range Set First Day 
 89.4  
 92.1 2.7 
 92.1 0 
 95.7 3.6 
 96.6 0.9 
 97.5 0.9 
Range 8.1  
 Calculated Q for lowest data point 0.444 
 Critical Q Value 0.625 
 Result Accept Value 
Low Range Set After 48 Hours 
 89.9  
 91.2 1.3 
 93.0 1.8 
 94.3 1.3 
 96.1 1.8 
 97.0 0.9 
Range 7.1  
 Calculated Q for lowest data point 0.254 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H12 
Low Range Spiked Filter Storage Stability F-Test For Variances 
 First Day After 48 Hours 
Mean 93.9 93.6 
Variance 10.0 7.62 
Observations 6 6 
df 5 5 
F Calculated 1.32  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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Table H13 
Spiked Filter Storage Stability Data and Calculations – Medium Range 
 
Filter Numbers 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
48 Hours 
 
Recovery 
(%) 
1 / 7 0.478 92.8 0.497 96.5 
2 / 8 0.496 96.3 0.498 96.7 
3 / 9 0.508 98.7 0.506 98.3 
4 / 10 0.488 94.8 0.492 95.5 
5 / 11 0.500 97.1 0.500 97.1 
6 / 12 0.484 94.0 0.491 95.4 
AVG 0.492 95.6 0.497 96.6 
SD 0.011 2.15 0.006 1.07 
CV % 2.25 % 2.25 % 1.11 % 1.11 % 
Note.  Each treated GFF filter spiked with 59.36 µg bronopol; predicted absorbance 
for the derivatized bronopol is 0.515.  Filter Numbers reflect the filter number 
extracted and analyzed on the first day and the filter number extracted and analyzed 
after 48 hours.  The adjusted absorbance is calculated as the absorbance read from 
each sample minus the filter blank count of 0.015 absorbance units; Recovery is then 
the adjusted absorbance divided by the predicted absorbance expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to 48 hours later is: 
 
 
׀   0.492 - 0.497   ׀ 100 % = 1.01 % 
(0.492 + 0.497)/2   
 
 
 
 
 173
Appendix H (continued) 
 
 
Table H14 
Medium Range Spiked Filter Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
Medium Range Set First Day 
 92.8  
 94.0 1.2 
 94.8 0.8 
 96.3 1.5 
 97.1 0.8 
 98.7 1.6 
Range 5.9  
 Calculated Q for lowest data point 0.458 
 Critical Q Value 0.625 
 Result Accept Value 
Medium Range Set After 48 Hours 
 95.4  
 95.5 0.1 
 96.5 1 
 96.7 0.2 
 97.1 0.4 
 98.3 1.2 
Range 2.9  
 Calculated Q for lowest data point 0.207 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H15 
Medium Range Spiked Filter Storage Stability F-Test For Variances 
 First Day After 48 Hours 
Mean 95.6 96.6 
Variance 4.68 1.16 
Observations 6 6 
df 5 5 
F Calculated 4.03  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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Table H16 
Spiked Filter Storage Stability Data and Calculations – High Range 
 
Filter Numbers 
Adjusted 
Absorbance 
First Day 
 
Recovery 
(%) 
Adjusted 
Absorbance 
48 Hours 
 
Recovery 
(%) 
1 / 7 0.993 92.1 1.041 96.6 
2 / 8 1.036 96.1 0.996 92.4 
3 / 9 0.986 91.5 1.015 94.2 
4 / 10 1.055 97.9 1.051 97.5 
5 / 11 1.010 93.7 1.007 93.4 
6 / 12 1.016 94.2 1.030 95.5 
AVG 1.016 94.2 1.023 94.9 
SD 0.026 2.41 0.021 1.95 
CV % 2.56 % 2.56 % 2.05 % 2.05 % 
Note.  Each treated GFF filter spiked with 124.08 µg bronopol; predicted absorbance 
for the derivatized bronopol is 1.078.  Filter Numbers reflect the filter number 
extracted and analyzed on the first day and the filter number extracted and analyzed 
after 48 hours.  The adjusted absorbance is calculated as the absorbance read from 
each sample minus the filter blank count of 0.015 absorbance units; Recovery is then 
the adjusted absorbance divided by the predicted absorbance expressed as percent. 
 
 
 
 
 The calculated percent difference in average absorbance values from the initial 
analysis to 48 hours later is: 
 
 
׀   1.016 – 1.023   ׀ 100 % = 0.69 % 
(1.016 + 1.023)/2   
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Appendix H (continued) 
 
 
Table H17 
High Range Spiked Filter Storage Stability Q-Test For Outliers 
 Ranked Recovery (%) Gap 
High Range Set First Day 
 91.5  
 92.1 0.6 
 93.7 1.6 
 94.2 0.5 
 96.1 1.9 
 97.9 1.8 
Range 6.4  
 Calculated Q for lowest data point 0.266 
 Critical Q Value 0.625 
 Result Accept Value 
High Range Set After 48 Hours 
 92.4  
 93.4 1 
 94.2 0.8 
 95.5 1.3 
 96.6 1.1 
 97.5 0.9 
Range 5.1  
 Calculated Q for lowest data point 0.235 
 Critical Q Value 0.625 
 Result Accept Value 
 
 
 
 
Table H18 
High Range Spiked Filter Storage Stability F-Test For Variances 
 First Day After 48 Hours 
Mean 94.3 94.9 
Variance 5.85 3.80 
Observations 6 6 
df 5 5 
F Calculated 1.54  
F Critical one-tail 5.05  
Result Variance is consistent between data sets 
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Appendix H (continued) 
 
 
 The calculated average change in absorbance values for all treated/spiked filters 
from the initial analysis to 48 hours later is: 
 
 
0.48 % + 1.01 % + 0.69 % = 0.73 % 
3  
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Appendix I: Outline of Method Development 
 
 
Analytical Method 
 
 
• Review Sanyal et al. (1996) publication. 
• Conduct spectrophotometric scan of non-derivatized bronopol in aqueous 
solution. 
 No derivatizing agent present. 
 Scan through entire working range of UV-VIS spectrophotometer. 
 Examine absorbance spectrum for peaks that may potentially interfere 
with absorbance maximum reported in Sanyal et al. 
• Verify absorbance maximum of bronopol derivatized with sodium hydroxide. 
 Derivatizing sodium hydroxide agent present. 
 Scan through wavelength region of interest. 
 Examine spectrophotometric scan for absorbance maximum reported in 
Sanyal et al. 
 Examine spectrophotometric scan for peaks that may potentially interfere 
with absorbance maximum reported in Sanyal et al. 
 Manually scan a derivatized bronopol solution in the region of the 
absorbance maximum reported in Sanyal et al. 
• Evaluate potential time dependence of chromophore development upon addition 
of sodium hydroxide to bronopol 
 Add derivatizing sodium hydroxide agent. 
 Manually scan the derivatized solution at 244 nm at specific time intervals 
for a period of one hour. 
 Evaluate absorbance data for potential time dependence of chromophore 
development. 
• Evaluate potential sodium hydroxide concentration dependence on chromophore 
development. 
 Formulate solutions containing derivatizing sodium hydroxide agent in 
varying concentrations; include sodium hydroxide  
 Include sodium hydroxide concentration specified in Sanyal et al. 
 Evaluate absorbance data for potential sodium hydroxide concentration 
dependence. 
• Develop calibration curve for derivatized bronopol. 
 Minimum calibration curve range initially includes range from Sanyal et 
al. publication. 
 Nine different concentrations of derivatized bronopol. 
 Include dilutions from different bronopol stock solutions to minimize 
effects from dilution errors. 
 Include calibration curve data from different time periods to minimize 
effects of instrument drift. 
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Appendix I (continued) 
 
 
Sampling Filters 
 
• Review literature for filter types used for derivatizing air sampling methods. 
• Develop filter treatment procedures. 
 Review literature for hydroscopic filter treatments. 
 Evaluate quantity of filter treatment solution needed to saturate filter to 
assure complete filter coverage. 
 Develop filter drying procedures. 
• Develop filter spiking procedures. 
 Determine quantity of filter spiking solution needed to saturate 
approximately half of filter area. 
• Conduct filter spiking trials. 
 Determine bronopol spike solution concentrations needed to span 
calibration curve range. 
 Spike treated filters while holding treated filter by edge; prohibit spike 
solution from contacting forceps. 
 Allow filter to dry completely prior to placement in extraction vessel. 
 Extract filters with 5 ml spectrophotometric grade water. 
 Sonicate filters for 5 minutes prior to removal of filter extract. 
 Evaluate efficiency of recovery of derivatized bronopol from spiked 
filters. 
 Evaluate consistency of recovery from spiked filters. 
 
Sampling Chamber and Dust Generator 
 
• Select dust generator and sampling chamber materials of construction. 
• Measure internal dimensions of dust generator and sampling chamber. 
 Calculate nitrogen gas flow rate necessary to achieve appropriate particle 
size selection in dust generator. 
 Calculate nitrogen gas flow rate and flow duration needed to purge dust 
generator and sampling chamber of oxygen and water vapor. 
• Conduct sampling of bronopol aerosols to verify even distribution of particulate 
in sampling chamber. 
 Sample using non-treated HVHP filters; extract filters in derivatizing 
solution. 
 Determine appropriate time to initiate sampling after activation of dust 
generator. 
 Conduct chamber particulate concentration distribution trials. 
 Conduct sampling at differing filter flow rates to vary bronopol loading on 
filters. 
 Evaluate filter-to-filter variation for each chamber run to assure even 
bronopol concentration in chamber during individual runs. 
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Appendix I (continued) 
 
 
Chamber Sampling 
 
• Conduct chamber sampling using treated GFF 
 Chamber sampling using two treated GFF and one HVHP filters 
simultaneously. 
 Conduct sampling at differing filter flow rates to vary bronopol loading on 
filters. 
 Compare treated GFF results against concurrently sampled PVDF results 
to evaluate efficacy of derivatizing sampling process. 
 Evaluate filter-to-filter variation for each chamber run to assure even 
bronopol concentration in chamber during individual runs. 
 
 
Sample Storage Stability 
 
• Storage stability of filter extract solutions. 
 Spike treated filters with varying bronopol concentrations. 
 Follow procedures developed in filter spiking trials. 
 Extract and analyze spiked filters on the same day. 
 Store filter extract solutions and analyze after an appropriate storage 
period. 
 Evaluate efficiency of recovery of derivatized bronopol from spiked 
filters. 
 Evaluate consistency of recovery from spiked filters. 
 Compare filter recovery from day one versus after storage period. 
 
• Storage stability of spiked filters. 
 Spike treated filters with varying bronopol concentrations. 
 Follow procedures developed in filter spiking trials. 
 Extract and analyze half of the spiked filters on the same day. 
 Store the second half of the spiked filters and extract and analyze after an 
appropriate storage period. 
 Evaluate efficiency of recovery of derivatized bronopol from spiked 
filters. 
 Evaluate consistency of recovery from spiked filters. 
 Compare filter recovery from day one versus after storage period. 
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